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Abstract 
Foot-and-mouth disease virus (FMDV) causes an acute vesicular disease of 
domesticated and wild ruminants, and pigs.  The virus is highly variable with 7 serotypes 
and numerous subtypes.  A method was developed to sequence the complete genome 
of the Pan Asia O serotype FMDV that caused the UK 2001 epidemic.  The sequence 
data was used to quantify the genetic diversity of FMDV that arose over the course of 
this epidemic. 197 nucleotide substitutions were observed at 191 different sites across 
the genome, with a ratio of non-synonymous to synonymous change of 0.09.  It was 
estimated that the date at which FMDV first infected livestock in the UK was the 7
th 
February 2001 (95% CI Jan 20
th – Feb 19
th) using coalescent methods, which is in close 
agreement to that generated on the basis of lesion aging at the first infected premises.  
The rate of nucleotide substitution during the epidemic was estimated to be 2.26 x 10
-5 
per site per day (95% CI 1.75-2.80 x 10
-5).  This was a sufficiently high rate that detailed 
histories of transmission pathways could be reliably reconstructed and motivated a 
comprehensive study of genetic changes that arose between infected premises in the 
Darlington area.  This study highlighted the potential of tracing virus transmission 
between farms using genetic data.  A maximum likelihood methodology was proposed to 
combine epidemiological data (describing the infection profile of individual farms) with the 
genetic data.  Integration of genetic and epidemiological data reduced the number of 
transmission trees (describing infection transmission within this cluster) that were 
consistent with the genetic data from 41,472, to 1,728, of which 9 represented 95% of 
the total likelihood calculated.  An average of 4.3 (S.D. 2.1) variant nucleotides within the 
complete genome, were observed between consecutive farm infections. Difficulties in 
identifying direct transmission events in this analysis arose mainly as a result of limited 
data on the extent of genetic variation on a single premises (complicated by variation in 
animal types, and farm sizes), and the manner in which mutations become fixed within 
the consensus sequence (i.e. upon replication and selection, and transmission through a 
‘bottleneck’).  This encouraged an analysis of the minimum mutant frequency of Pan Asia 
O FMDV from a single lesion sampled from naturally infected hosts which led to an 
estimate of 3.06 x 10
-4 mutations per nucleotide sequenced (this parameter has 
previously only been measured in cell culture).  In addition an experiment was initiated to 
measure the spontaneous mutation rate of O1BFS FMDV. The relevance of this analysis 
of the evolution of FMDV during the UK 2001 epidemic was demonstrated during the 
outbreak of O1BFS FMDV in Surrey in 2007, where complete genome sequencing was 
used in real time to trace virus spread.  Genetic analysis of complete viral genomes 
generated in real-time revealed a chain of transmission events, predicting undisclosed 
infected premises, and connecting a second cluster of outbreaks in September to the 
initial outbreaks in August.  Thus, this thesis has pioneered the use of complete genome 
sequencing for fine scale molecular epidemiology. 
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1.1 Introduction 
1.1.1 Summary 
This chapter provides an introduction to foot-and-mouth disease (FMD) and the virus that 
causes it.  The virus genetic and protein structure is discussed followed by a detailed 
description of the replication cycle of the virus.  Section 1.2 provides background 
information regarding the UK 2001 FMD outbreak, which is studied extensively during 
this thesis.  Sections 1.3 and 1.4 discuss the evolution of the virus, and finally the 
rationale and objectives of the whole project are considered in section 1.5. 
1.1.2 Foot-and-mouth disease 
FMD is an extremely contagious disease affecting cattle, pigs, sheep, goats, and other 
cloven-hoofed animals.  The disease causes typically only low mortality in adult animals, 
but frequently a high mortality in young animals due to myocarditis.  Although the 
majority of animals recover, the disease leaves them debilitated causing severe losses in 
meat and milk production.  This, combined with the disruption of international livestock 
trade and the cost of disease eradication, results in severe economic consequences of 
FMDV outbreaks. 
 
FMD is endemic in parts of Asia, Africa and South America, with sporadic outbreaks 
occurring in the FMD free areas within these continents.  The causative agent is foot-
and-mouth disease virus (FMDV); a member of the virus family Picornaviridae, genus 
Aphthovirus.   Transmission of the virus can be direct from animal contact or indirect via 
fomites carried on animate/inanimate vectors such as humans or vehicles, or airborne in 
aerosols. 
1.1.3 Clinical disease 
The disease is characterised by fever and blister-like lesions or vesicles occurring on the 
tongue, dental pad, gums, hard palate, lips, nostrils, muzzle, coronary bands, teats,    23
udder, snout of pigs, and inter-digital spaces.  Clinically, these lesions result in excessive 
salivating and lameness.  In sheep and goats, the lesions are usually less pronounced.  
FMD is clinically indistinguishable from vesicular stomatitis, swine vesicular disease and 
vesicular exanthema of pigs, which are notifiable diseases for this reason.  The 
pathogenesis and diagnosis of FMD has been reviewed by Alexandersen et al 2003c.   
1.1.4 Foot-and-mouth disease virus 
The causative agent of FMD, first discovered by Loeffler and Frosch in 1898, is a positive 
strand RNA virus.  The FMDV genome is approximately 8500 nucleotides in length 
(Forss et al. 1984), contained within a non-enveloped icosahedral capsid about 30nm in 
diameter.  The RNA on its own is infectious if inside a cell.  The virus is sensitive to 
acidic conditions (<pH6.0) (Randrup 1954), temperatures above 50°C and UV light, but 
persistance in contaminated fodder and the environment for up to 1 month is possible in 
temperate climates. 
 
There are seven serotypes of the virus, namely A, C, O, Asia 1, and South African 
Territories (SAT) 1-3.  The serotypes are determined by the antigenic structure of the 
virus capsid.  Sixty copies of four structural proteins come together to make up the virus 
capsid (Wild et al. 1969); VP1, VP2, VP3 on the surface and VP4 internally in contact 
with the RNA.  VP1, 2 and 3 proteins have a similar eight-stranded beta-barrel topology, 
although there is no sequence homology between the genes, whereas VP4 has a distinct 
extended conformation (Acharya et al. 1989; Domingo et al. 2002).  There are 5 known 
neutralising antigenic sites located within the capsid structure. 
Field strains of FMDV attach to cells using integrin receptors αvβ6, αvβ3 and αvβ8 (Jackson 
et al. 2003; Jackson et al. 2000).  The virus enters the cell via receptor-mediated 
endocytosis, and uncoating occurs due to acidification within the endosomal pathway. 
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1.1.5 Structure of the Foot-and-mouth disease virus genome 
The positive sense RNA genome of FMDV is covalently attached to a protein (VPg) at its 
5’ end.  The genome consists of a protein coding section flanked by two untranslated 
regions (UTR) (Figure 1.1).  The RNA is highly structured throughout the genome with 
the 5’ and 3’ UTRs containing specific structures.  The 5’ UTR consists of the s fragment, 
a poly ‘C’ tract, several pseudoknots, a cis-acting replication element (cre), and an 
Internal Ribosome Entry Site (IRES).     
 
The s fragment is approximately 360 nucleotides in length and predicted to form a hairpin 
structure (Witwer et al. 2001), it’s precise function is unknown as yet, although it is 
possible that it prevents exonuclease digestion of the virus genome in infected cells 
(Mason et al. 2003a).  Although the importance and role of the poly ‘C’ tract is uncertain, 
if shortened to 2 residues, it has been shown to elongate again in cell culture (Rieder et 
al. 1993). 
 
The precise role of pseudoknots is again unknown.  The cre element is involved in 
genome replication as described later and the IRES is involved in cap independent 
translation of the genome.  The 3’ UTR is shorter than the 5’ UTR, and contains 2 stem-
loops and a poly ‘A’ tract.  The s fragment and the IRES have recently been shown to 
interact specifically with the 3’ UTR which could play a role in translation and or 
replication of the genome (Serrano et al. 2006).    25
 
Figure 1.1  
Schematic of the FMDV genome showing the translated polyprotein and final cleaved 
proteins. The schematic represents the layout of the FMDV RNA genome which is covalently 
attached to the protein VPg at the 5’ end.  Flanking a single open reading frame are two 
untranslated regions (UTR).  P1 represents the capsid coding region for viral proteins (VP) 1 
to 4.  The remainder encodes non-structural proteins.  Block arrows represent cleavage sites 
that produce the final mature proteins. (Racaniello 1996)  
 
1.1.6 Foot-and-mouth disease virus replication 
FMDV replication is thought to mirror that of the picornavirus Poliovirus, taking place 
solely within the cytoplasm of the cell (Follett et al. 1975).  The molecular aspects of 
FMDV have been reviewed recently (Mason et al. 2003a).  On entry into a cell the 
genome is immediately translated.  The VPg protein is cleaved by a cellular enzyme and 
the IRES directs translation in a cap independent manner to produce a polyprotein.  This 
polyprotein then undergoes cleavage, resulting in various structural and non-structural 
proteins which assist in the replication of the genome.    26
1.1.6.a The Proteins 
The viral capsid proteins are encoded by the P1 region, and regions P2 and P3 encode 
the non structural proteins involved in protein processing (2A, 3C) and genome 
replication (2B, 2C, 3AB, 3B, 3CD, and 3D) (Figure 1.1).  The L protein is a protease; 
one of its cleavage targets is host cell initiation factor eIF4G whose cleavage leads to 
shut off of host cap dependent translation (Medina et al. 1993; Racaniello 1996).  Protein 
2A mediates auto cleavage at its C terminus, and is also thought to have a role in viral 
RNA replication, although its exact function is not known.  It has been determined that 2B 
and 2C work together to inhibit the secretary pathway blocking transport from the 
endoplasmic reticulum to the golgi apparatus, 2C determining the site of the block 
(Moffat et al. 2007).  2B and 3C have been found to be the most conserved genes inter-
serotypically (Carrillo et al. 2005).  3A co-localises with 3D in the ER membrane 
associated replication complexes assisting in viral RNA synthesis by 3D and stimulating 
cleavage of the 3CD precursor.  The strategy of translation of a polyprotein followed by 
cleavage allows for protein expression to be controlled by the extent and rate of 
proteolytic processing. 
1.1.6.b The genome 
Replication of the genome occurs via a negative-stranded RNA intermediate (Racaniello 
1996).  The VPg protein is used to prime the replication reactions following addition of 
two uridylate (U) residues to its tyrosine residue.  The replication of the genome is 
carried out by the 3D protein (RNA Polymerase) with the help of the cis-acting replication 
element (cre) (Bedard & Semler 2004; Goodfellow et al. 2003).  The cre element serves 
as a template for 3D mediated uridylation of VPg which serves as a primer for RNA 
replication (Mason et al. 2002).  The 3’ poly ‘A’ tract is the initiation site for the synthesis 
of negative sense RNA.  A double-stranded RNA intermediate termed RF (replicative 
form) is formed at this stage.  Newly synthesised negative strand templates provide the 
templates for multiple initiation events resulting in positive strand genome RNA.  VPg is    27
found attached to the 5’ ends of both the positive and negative strands (Bedard & Semler 
2004).  The RNA synthesis is asymmetric in that the synthesis of positive strands can be 
30-50 times more than that of negative strands (Novak & Kirkegaard 1991).   The RNA 
dependent polymerase of FMDV is reported to have low fidelity and is predicted to give 
rise to mutant progeny with a mutation rate of 1 per 10
3 to 10
5 nucleotides copied 
(Holland et al. 1982; Sobrino et al. 1983). 
1.1.6.c Virus assembly 
The 60-subunit capsid particle self-assembles, beginning with 5S protomers of VP0, 
VP3, and VP1, which join to produce a 14S pentamer, which subsequently creates the 
80S empty capsid.  Only positive strand RNA and not negative strand viral RNA or viral 
mRNA, is incorporated producing the 150S provirion.  The final maturation step involves 
cleavage of VP0 to VP2 and VP4 resulting in the 160S virion which is then released 
(Mason et al. 1994; Racaniello 1996).    28
1.2 UK 2001 Outbreaks of Foot-and-mouth disease 
1.2.1 Overview 
FMD was confirmed present in the UK for 214 days in 2001, from 20
th February until 30
th 
September.  The main affected areas were Dumfries and Galloway, Cumbria, 
Northumberland, Yorkshire, Lancashire, Anglesey, Powys, Hereford, and Devon 
(Gibbens et al. 2001; Gibbens & Wilesmith 2002).  There were also a limited number of 
outbreaks in Ireland, France and the Netherlands.  The virus responsible for the 
epidemic was characterised as the Pan Asia O strain, with the closest sequenced 
relative being from South Africa in 2000 (Mason et al. 2003b).  During the epidemic 2030 
premises were declared infected (Figure 1.2) and culled.  A further 8131 premises were 
culled as dangerous contacts or as a result of 3km or contiguous culls; the cumulative toll 
of animals killed being at least 6.5 million (Scudamore 2002).  The economic cost of the 
outbreak to agriculture and the food chain in the UK was estimated to exceed £3 billion, 
with similar costs to the tourist industry (Thompson et al. 2002). 
1.2.2 The main events 
A single primary outbreak triggered the epidemic, identified as Burnside Farm, Heddon-
on-the-Wall, Northumberland (Scudamore 2002).  It is likely that clinical signs of virus 
were present on this farm for at least a week prior to the first laboratory confirmation of 
disease (Anderson 2002; Scudamore 2002).  Transport of pigs to Cheale’s abattoir in 
Essex resulted in the outbreaks identified in the Southeast of England on 19
th February 
2001, confirmed positive for FMDV the following day.  Presumed airborne spread from 
Burnside Farm infected Prestwick Hall Farm, Ponteland, 7km away (Gloster & 
Alexandersen 2004) and sheep from this farm were taken to market before the first case 
had been identified (Alexandersen et al. 2003a).   These sheep subsequently moved 
through Hexham and Longtown markets to 96 locations resulting in outbreak clusters 
throughout the UK.      29
 
Figure 1.2  
The figure shows a map of the United Kingdom with the location of all 2030 designated 
FMDV infected premises in 2001 depicted by a red dot. 
 
On the 20
th February 2001, movement restrictions were placed around farms in Stroud, 
Gloucestershire, Great Horwood, Buckinghamshire and Isle of Wight, following contact 
tracing from Cheale’s abattoir in Essex where disease was detected.  Two days later, an 
8km restriction was placed around Burnside farm in Northumberland, while it was 
investigated by Defra (Department for environment, food and rural affairs, formerly 
known as MAFF).  Also on the 21
st of February a ban on export of UK livestock, meat 
products and milk was instigated.  At the same time, the Countryside Alliance banned    30
hunting throughout the UK to help prevent the spread of disease.  Foot-and-mouth 
disease was confirmed the next day (23
rd February) on Burnside farm, Heddon-on-the-
Wall.  At this point, the agriculture minister ordered a 7 day ban on all livestock 
movements excluding horses, milk and poultry, throughout the UK.  Even with a national 
movement ban (NMB) in place by the end of February it was clear that the virus was 
disseminated throughout the UK with over 30 confirmed outbreaks.  Footpaths in all 
infected areas were closed on Tuesday 27
th February, adding to losses to the tourist 
industries.  On the 15
th March, it was decided in Cumbria, Dumfries and Galloway, to not 
only cull animals on infected premises but also all those in a 3km ring surrounding each 
infected premise.  Later on in March, this policy was extended to some other areas, but 
also other control measures such as a cull of contiguous premises within 48 hours, and a 
24 hour report to slaughter policy were implemented to various degrees throughout the 
UK (Anderson 2002). 
 
Despite these rigorous control measures, the epidemic continued until September.  It is 
thought that the absence of obvious clinical signs in sheep infected with virus hampered 
the attempts to control the epidemic by allowing virus to replicate in an area for a length 
of time before being detected.  The outbreak demonstrated the highly infectious nature of 
the virus, as it spread between farms with no animal movements and in the majority of 
cases there is little evidence to suggest that it spread via the airborne route.  This 
suggests that once the movement standstill had been put in place the majority of 
transmissions in the outbreak were caused by contaminated vehicles or persons.   
Many studies since 2001 have attempted to characterise virus spread during the 
outbreak with a focus on geographical distance, temporal infection characteristics, and 
airborne fomites (Gloster et al. 2003; Honhold et al. 2004; Keeling et al. 2001; Taylor et 
al. 2004).  However, the source of infection for many farms remains elusive and further 
research is required to improve our understanding of how the virus spread so 
successfully.    31
 
1.3 Foot-and-mouth disease virus evolution 
1.3.1 Overview of RNA virus evolution 
The genetic evolution of RNA viruses is governed by the interplay of forces such as 
mutation, recombination, natural selection, and genetic drift.   
 
Studies of RNA virus evolution primarily consider the dynamics of mutation, selection 
and genetic drift in relation to the two important RNA virus properties of 1) explosive 
replication to produce vast population sizes and 2) high mutation rates acting on a short 
genome.   
 
The fast generation of large populations (~100,000 viral copies in 10 hours) suggests 
that natural selection should be able to work efficiently on a complete array of all possible 
mutants; RNA viruses should evolve in a deterministic manner with the fate of a given 
mutation being determined by its initial frequency, the mutation rate and the probability of 
selection of that particular mutant.  However, while individual populations may be large 
the effective population is often potentially much smaller.  The effective population is 
influenced by the probability of population bottlenecks caused by migration within a host 
to different replication sites, transmission between hosts and between populations of 
hosts, and could also be influenced by variation in replication potential among virus 
variants.  It has been predicted that in populations where the effective population is 
small, that genetic drift is critical in determining the frequency and fate of mutations 
(Rouzine et al. 2001) and hence evolution progresses in a much less predictable fashion. 
 
It has been proposed that RNA viruses evolve to maximise their mutation rate such that 
beneficial mutations can arise at a rate sufficient for the requirement to adapt, yet 
deleterious mutations are kept at a level at which they can be excised from the    32
population by the forces of selection (Domingo et al. 1978; Holland et al. 1982).  The 
high mutation rates of RNA viruses are thought to be partly responsible for their limited 
genome sizes as a rate too high would prevent reproduction of the fittest genome and 
cause a reduction in viral population size, possibly resulting in eventual extinction 
(Holmes 2003).  Coronaviruses are an exception to the rule because they have unusually 
large genomes of 16 to 31Kb.  Recent studies suggest however that these viruses 
encode specific enzymes that increase their replication fidelity (Eckerle et al. 2007).     
However, high mutation rates of RNA viruses may not occur solely to improve virus 
adaptability, because the vast majority of mutations are deleterious.  Another possibility 
could be that the low fidelity of RNA virus polymerases is a by-product of selection for 
fast replication.  This can also explain the limited genome size, as shorter genomes 
would be favoured by natural selection due to their faster replication.  A trade off 
between replication efficiency and replication fidelity has been documented (Back et al. 
1996).  It has yet to be proved that increases in the mutant spectrum within a population 
due to low fidelity replication result in an increased rate of adaptation (Keulen et al. 1999; 
Lee et al. 1997). 
 
Recombination has been shown to be an important evolutionary mechanism for some 
RNA viruses.  An extreme example is HIV where the genomic recombination rate 
exceeds the genomic mutation rate (Rhodes et al. 2003).  Recombination may play more 
of a role for some viruses than others and its importance in FMDV evolution is uncertain 
although recombination between FMDV isolates has been shown to occur (Heath et al. 
2006; Jackson et al. 2007); Haydon, 2004 #56}.  Indeed, very recently a recombined 
Asia 1 and O Pan Asia FMD virus was reported (Li et al. 2007). 
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1.3.2 Constraints and limitations on FMDV evolution and mutation 
FMDV may have evolved to preserve the ability to adapt quickly, by maintaining an error 
prone RNA dependent RNA polymerase for its replication.  There are other virus 
properties that could also promote viable mutation.  Firstly, within the FMDV genome 
there are no overlapping open reading frames, which are often found in other viruses 
such as Paramyxoviruses.  The lack of overlapping open reading frames reduces the 
constraint on viable mutation as for each possible point mutation only one protein is 
affected.  Secondly, in other positive strand RNA viruses (e.g. Poliovirus, Cardiovirus, 
Human Rhinitis Virus 2) the cre is encoded within the open reading frame forcing a 
requirement that any mutation within this region be viable for both the protein and the cre 
element.  The FMDV cre element is encoded within the 5’UTR relaxing the constraint on 
viable mutation.   
 
Although the above properties of FMDV can be thought to promote successful virus 
mutation and evolution it is important to realise the numerous constraints that restrict 
viable virus mutation.  Many studies have investigated an alleged error threshold, which 
is a limit on acceptable mutation rates (Domingo et al. 2005; Holmes 2003; Pariente et 
al. 2003).  Beyond this limit, ‘fit’ genomes are unable to precisely reproduce themselves 
resulting in the accumulation of deleterious mutations and population extinction.  Another 
limit on the rate of mutation could be epistasis where for a particular mutation to be 
viable it is necessary for a compensatory change to occur elsewhere in the genome to 
counteract any deleterious effect, thus requiring multiple point mutations and not 1 for a 
viable progeny virus. 
 
When a non-synonymous mutation occurs the resulting amino acid change may 
negatively affect protein function and this may be expected to constrain possible 
replacement of amino acids.  Synonymous changes that don’t affect the translated 
product may still result in non viable virus progeny, since RNA structure has been    34
increasingly found to influence virus pathogenesis and survival (Simmonds et al. 2004).  
It is also possible that the specific secondary structure of the RNA could encourage or 
discourage the polymerase to introduce an error in certain areas of the genome.  For 
example it might be advantageous to have a higher rate of change in the capsid protein 
genes than in the IRES structure. 
 
Finally, an important constraint on FMDV evolution is the continually changing 
environment.  The virus may benefit from the ability to escape the host immune 
response, and to transmit to and successfully infect a new host animal (of a number of 
species).  Potentially virus could evolve to reach a high fitness that is specific to a 
particular environment, which could be detrimental upon spread to a new host.  The fast 
spread of FMD may prevent this occurring, by restricting the time available for the virus 
to adapt to a specific host. 
 
1.3.3 Quasispecies 
Many RNA viruses are often described as quasispecies (Domingo 2002; Moya et al. 
2004).  For a quasispecies population the target of natural selection is not the fastest 
growing replicator but a broad spectrum of mutants that are produced by erroneous 
copying of the most quickly replicating virus.  Natural selection acts on the entire 
quasispecies because mutation rates close to the error threshold mean that individual 
viral genomes are linked by a mutational coupling – all the possible mutational links 
between viral genomes are established – so that the whole population evolves as a 
single unit. 
 
Much research has been undertaken to prove or disprove the theory that some RNA 
viruses conform to a quasispecies population structure.  Although high levels of genetic 
variation have been demonstrated for many RNA viruses this is not sufficient to prove the 
existence of quasispecies.  A quasispecies dynamic can only be proved by    35
demonstration that natural selection acts on viral populations as a unit.  In support of the 
quasispecies theory, a high fitness Vesicular stomatitis virus variant was suppressed by 
one of lower fitness, which could have resulted from the latter having a high probability of 
being generated by mutation from closely related variants (de la Torre & Holland 1990).  
This observation, however, could be explained equally by genetic drift where the 
frequency of a viral variant is dependent upon its initial frequency within the population.  
More recent studies have investigated the possible quasispecies structure of poliovirus 
through an altered polymerase with increased fidelity.  It was shown that increased 
fidelity of the virus polymerase can lead to reduced pathogenicity (Pfeiffer & Kirkegaard 
2005), and also that high fidelity replication can alter the virus pathogenicity in preventing 
spread to the brain (Vignuzzi et al. 2006).  However, again this does not necessarily 
prove the existence of quasispecies, only the effect that an error prone polymerase can 
have.   
 
Many studies in vitro have determined virus population properties that are consistent with 
the quasispecies theory such as an error threshold and differences in mutation spectra 
affecting fitness.  However, the relevance of the quasispecies dynamic, if it does exist, in 
nature is not known.  The effective population size of FMDV is likely to be small due to 
bottleneck transmission events between animals and between farms, and perhaps also 
within an animal.  A recent study on Poliovirus demonstrated the effect of bottleneck 
events on the virus population structure within a single host (Pfeiffer & Kirkegaard 2006).  
Therefore the term quasispecies to describe FMDV populations in nature should be used 
with caution until it has been categorically shown that natural selection acts on the virus 
population as a unit within a natural setting. 
 
1.3.4 Studies on Foot-and-mouth disease virus evolution 
The micro-evolution of FMDV has been extensively investigated in cell culture, largely 
focusing upon serotype C, revealing high levels of genetic variability (Arias et al. 2001;    36
Ruiz-Jarabo et al. 2004; Sobrino et al. 1983) and adaptability (Garcia-Arriaza et al. 
2004).  Viral populations have been shown to evolve to resist antibody induced selection 
(Borrego et al. 1993; Diez et al. 1989; Holguin et al. 1997; Sevilla et al. 1996), and to 
exhibit what has been referred to as genomic ‘memory’ (Arias et al. 2004; Ruiz-Jarabo et 
al. 2000).  Genomic memory refers to the maintenance of a virus variant that was 
previously dominant, in low numbers within a population.  They have also been shown to 
adapt to different multiplicities of infection (moi) (Sevilla et al. 1998) incurring the effects 
of Muller’s ratchet at low moi through the irreversible accumulation of deleterious 
mutations (Escarmis et al. 1996), although the virus population can subsequently recover 
(Escarmis et al. 1999; Lazaro et al. 2003).  The virus population has also been shown to 
maintain defective RNAs (Charpentier et al. 1996), and to persist and co-evolve 
alongside cell lines (de la Torre et al. 1988).  All serotypes of FMDV have been shown to 
exhibit substantial levels of genetic diversity in the field, particularly within the nucleotide 
sequence encoding the capsid proteins, over broad temporal and spatial scales (Carrillo 
et al. 2005). This is typified by a continuous accumulation of silent changes over time 
and a more restricted set of amino-acid substitutions (Martinez et al. 1992). 
 
1.3.5 Foot-and-mouth disease virus mutation rates and frequencies 
The mutation rate of FMDV is an extremely important parameter because it impacts upon 
the speed and degree to which the virus can change to adapt to new environments and 
also to escape the immune system and protective effect of vaccines.  It could also assist 
in determining the relevance of the quasispecies concept as discussed in section 1.3.3.  
The rate of change observed in the field has been measured over long time periods for 
different serotypes and found to lie within 0.0004 – 0.045 substitutions/nucleotide/year 
(Bastos et al. 2003; Haydon et al. 2001; Sobrino et al. 1986).  This represents nucleotide 
substitutions that have become fixed within the consensus of the virus population and not 
the spontaneous mutation rate of FMDV.  The rate of nucleotide change has also been 
studied in vivo by sequencing the VP1 coding region from persistently infected cattle to    37
give a rate of 0.913-7.41 x 10
-2 substitutions/site/year (Gebauer et al. 1988).  A study of 
persistent infection of buffalo with SAT 2 and SAT 1 found substitution rates 1.5 x 10
-2 
and 1.6 x 10
-2 substitutions/nucleotide/year respectively (Vosloo et al. 1996).  Another 
study found no change within the consensus nucleotide sequence of the VP1 region in 
acute infection in swine, although monoclonal antibody escape mutants were detected 
(Carrillo et al. 1990).   
 
The actual spontaneous mutation rate of the FMDV RNA dependent polymerase is often 
reported as being very high (in the order of 1 x 10
-3 to 1 x 10
-5 misincorporations per 
nucleotide per genome replication).  This is based upon a review of other RNA viruses in 
1982 (Holland et al. 1982), which noted high mutation rates in Vesicular Stomatitis Virus 
and some negative strand viruses (Portner et al. 1980).  Although the genetic 
heterogeneity that is introduced upon virus propagation in cell culture has been noted 
(Sobrino et al. 1983), the actual spontaneous mutation rate of FMDV has never been 
measured. 
 
Many  in vitro studies to look at mutation rates have assessed the within population 
mutation frequency of FMDV, of mainly serotype C but also a single study on serotype O 
(Gu et al. 2006), by molecular cloning and sequencing of PCR products from VP1 and 
occasionally the IRES or the 3D region.  All have found a mutation frequency of mutants 
of the order of 10
-4 per nucleotide sequenced (Airaksinen et al. 2003; Arias et al. 2001; 
Gu et al. 2006; Pariente et al. 2001; Sierra et al. 2000).  However a mutation frequency 
does not directly translate into a mutation rate, as the frequency of mutants is dependent 
upon their initial frequency within the population and the forces of selection.   
 
Poliovirus RNA polymerase mutation rate has been studied more thoroughly.  An early 
estimate of the polymerase fidelity assessed by copying of homopolymeric RNA 
templates gave a mutation rate of 7 x 10
-4 - 5.4 x 10
-3 (Ward et al. 1988), however this    38
was unlikely to be an accurate representation of polymerase fidelity within a real cell and 
working upon its usual RNA template.  A more recent in vitro study came to a similar 
conclusion of a mutation rate of 4.5 x 10
-4 mutations per nucleotide copied (Wells et al. 
2001).  However the enzyme analysed was produced in E.coli and thus may not be 
completely representative of that produced in mammalian cells during normal virus 
replication, and again the enzyme was assessed in an artificial environment acting upon 
an RNA template that was not Poliovirus genome RNA.  Another study assessing mutant 
frequency following a single replication cycle determined a mutation rate of 4.1 x 10
-3 ± 
0.6 x 10
-3 (Ward & Flanegan 1992), which is very high and would result in a mutation 
being present in all virus progeny.  Other studies of the Poliovirus RNA polymerase 
mutation rate have found much lower rates.  For example, in assessing the rate of 
reversion of an amber mutant (requiring a single point mutation within the 3D polymerase 
coding region) a mutation rate of 2.5 x 10
-6 was observed (Sedivy et al. 1987).  In 
addition a study sequencing Poliovirus VP1 from 105 individual virus plaques found no 
mutations, suggesting a mutation rate of less than 2.1 x 10
-6 mutations per nucleotide per 
infectious cycle (Parvin et al. 1986).  A recent paper on the fidelity of the RNA 
polymerase of Poliovirus also suggests that previous results may be over estimates of 
the mutation rate as it found the polymerase fidelity to be in the range of 1.2 x 10
4 to 1 x 
10
6 for transition mutations, and 3.2 x 10
5 to 4.3 x 10
7 for transversion mutations 
(Freistadt et al. 2007). 
 
1.4 Molecular evolution of RNA viruses 
1.4.1Analytical tools for the study of virus evolution  
Currently the genetic evolution and relationships of viruses are studied by analysing their 
genetic sequence data by phylogenetic methods.  Phylogenetic trees are constructed 
and used to deduce the genetic relatedness of the viruses.  There are different methods 
for constructing phylogenetic trees; the first approach developed was Maximum    39
Parsimony methodology, but more recently Maximum Likelihood (Felsenstein 1981) and 
Bayesian methods (Huelsenbeck et al. 2001) are the preferred technique for tree 
construction.  Maximum parsimony determines the most parsimonious tree requiring the 
least evolutionary steps.  This method is simple, and as such makes very few 
assumptions about the evolutionary process.  However certain features of genetic 
evolution of organisms present problems when using this method of tree construction.  
Firstly inaccuracies can occur as a result of the existence of homoplasy.  Homoplasy 
describes processes such as convergent evolution where a single mutation can occur 
twice on independent branches of a tree, and hence does not necessarily determine that 
two sequences sharing a mutation were derived from a common ancestor which also 
contained this mutation.  Another hurdle to overcome is back mutation, where a mutation 
reverts to its original genotype.  This would cause the specific sequence to look more 
ancestral than is necessarily the case.  A further draw back to the method of Maximum 
Parsimony is that it takes no account of the rate at which mutations arise and the varying 
probabilities of different mutations occurring (i.e. transversions vs transitions).  For these 
reasons the parametric method of Maximum Likelihood provides an improved alternative, 
because the most probable tree that suits a specific evolutionary model is determined.  A 
parametric method is potentially much more powerful providing that the model employed 
is a reasonable approximation of the evolutionary processes that gave rise to the 
observed genetic data.  The evolutionary model may include a large number of 
parameters accounting for differences in the probabilities of various character states, 
differences in the occurrence of particular substitutions/mutations, and differences in the 
probabilities of change among characters.  With the sophisticated models now developed 
(eg the Hasegawa-Kishino-Yano (HKY) model (Hasegawa et al. 1985) and the General 
Time Reversible (GTR) model (Lanave et al. 1984)) an improved idea of phylogeny is 
achieved, although fitting an incorrect model can give incorrect results.  The suitability of 
models can be tested using a program such as ModelTest (Posada & Crandall 1998).  
Maximum Likelihood estimation of tree phylogeny is generally preferable to Maximum    40
Parsimony because it is statistically consistent with a better statistical foundation and it 
allows complex modeling of evolutionary processes.  To infer statistical confidence in 
either Maximum Parsimony or Maximum Likelihood constructed phylogenies bootstrap 
analyses are performed, which can be time consuming.  A further method to infer 
phylogenies is that of Bayesian inference which generates a posterior distribution for a 
parameter, based on the prior for that parameter and the likelihood of the data, 
(represented by the sequence alignment).  In other words where as Maximum Likelihood 
analysis investigates the probability of the observed data given a specific evolutionary 
model, Bayesian inference looks at the probability that a model is correct given the 
observed dataset.  With the availability of MCMC (Markov chain Monte Carlo) methods 
(Yang & Rannala 1997) Bayesian inference can be a preferred choice for tree estimation 
because it can be faster than Maximum Likelihood and no bootstrapping is required as 
the posterior probabilities determine the statistical confidence in the tree. 
 
Although in the majority of incidences Maximum likelihood or Bayesian inference is 
preferable for tree construction, in certain situations Maximum Parsimony can be a viable 
alternative.  When studying closely related sequences over a short time period the 
likelihood of back mutation is relatively low and hence Maximum Parsimony tree 
construction is likely to give an accurate estimation of tree phylogeny.  In this thesis the 
phylogenetic analysis is often performed with the aim of tracing specific virus history and 
in these cases the method of statistical parsimony was used.  The distances depicted by 
parsimony trees represent the actual number of differences between sequences, 
whereas for a Maximum Likelihood tree the probability of change is shown.  Within this 
thesis closely related sequences were investigated, with a focus on the accumulation of 
changes, and in this case a simpler representation of the raw data as depicted by 
Parsimony is desirable.  The TCS statistical parsimony program (Clement et al. 2000) 
used within this thesis can position sequences internally on a branch which assists in 
depicting directly ancestral sequences.  Although the statistical parsimony trees drawn    41
have not been bootstrapped, the fact that the data comprises the complete genome 
sequences of the sampled viruses indicates that the tree is as accurate and as 
representative as it can be, and is not sensitive to the choice of a single arbitrary locus.  
There is no further genetic data retrievable. 
 
Bayesian and MCMC techniques have enabled more computationally demanding 
analyses of data, the software program BEAST (Drummond & Rambaut 2007) harnesses 
these techniques and allows the relatively straightforward implementation of evolutionary 
models that contain parameters relating to viral demography.  By implementing a relaxed 
molecular clock model (Drummond et al. 2006) BEAST explicitly models the rate of 
molecular evolution on each branch of a tree, when given time stamped data to analyse.  
This enabled the informed determination of the rate of evolution of virus genetic 
sequences obtained during this PhD project, by incorporating sophisticated substitution, 
site rate, and branch rate models. 
1.4.2 Tracing 
The movement of FMDV worldwide can be successfully traced using genetic sequence 
data.  Spread of FMDV was successfully traced through Asia, Africa and into Europe 
(Knowles & Samuel 2003).  Using genetic data a possible introduction of virus into Africa 
from Saudi Arabia was identified (Bronsvoort et al. 2004), additionally, the close 
relationship between the virus in Taiwan in 1997 and isolates from Hong Kong and 
Russia was identified through genetic analysis (Tsai et al. 2000).   However, this is broad 
scale tracing between countries and for other viruses higher resolution tracing has been 
demonstrated (Table 1.1).  For example, it has been possible to distinguish between 
rhinovirus epidemics, seasons, and co-circulating strains using genetic data based on a 
short 420nt stretch (Savolainen et al. 2002).  An investigation of the Classical swine fever 
outbreak in the Netherlands in 1997-1998 showed the existence of two sub-populations 
within one outbreak (Widjojoatmodjo et al. 1999),  and previous analysis of outbreaks in 
Italy enabled the identification of separate introductions of virus (Lowings et al. 1994).     42
Tracing the origin and evolution of avian influenza viruses among bird populations is also 
common (Banks et al. 2001).  Also, forensic genetics has been important in determining 
Norovirus transmission between and within hospitals (Lopman et al. 2006).  Direct 
human-to-human transmission has also been traced using nucleotide sequence data for 
Hepatitis C virus (HCV), human immunodeficiency virus (HIV), and SARS corona virus 
infections. 
 
FMDV is an RNA virus that is reported to have a high mutation rate in accord with many 
of the viruses for which transmission tracing has been successful.  For this reason it is 
highly likely that sequence data could be used to trace the virus movement between 
hosts.  However, it is unknown to what extent this will be possible as selection events 
may purge many changes from the consensus virus, and also bottleneck events may 
confuse interpretation of the results.  A previous study investigated tracing the virus 
within an epidemic using VP1 sequences (Christensen et al. 2005) and found that there 
was not enough variation to distinguish between farms.  However VP1 represents less 
than 8% of the genome, and thus increased amounts of sequence data might improve 
the resolution at which the virus can be traced.    43
Table 1.1 Examples of sequence based transmission tracing of RNA viruses 
Virus 
Nucleic  
acid type 
Disease 
infectious 
period 
Fragment 
Length (nt) 
% of genome 
(genome size 
in nt) 
Sequence 
origin 
Tracing 
Resolution 
Reference 
Ebola  - ss RNA  Short  2049 
10.80% 
(19000) 
genbank 
Followed 
spread from 
village to village 
(Walsh et 
al. 2005) 
+ ss 
RNA 
Long 966 
10.50% 
(9200) 
Blood 
Human to 
human 
(Albert et 
al. 1994) 
HIV 
+ ss 
RNA 
Long 1130 
12.30% 
(9200) 
Blood 
Human to 
human 
(Salzberger 
et al. 
2000) 
+ ss 
RNA 
Short 29800 
100% 
(29800) 
Primary 
tissue and 
cell culture 
Human to 
human 
(Vega et al. 
2004)  SARS 
Coronavirus 
+ ss 
RNA 
Short 29800 
100% 
(29800) 
genbank 
Human to 
human 
(Zhao et al. 
2004) 
+ ss 
RNA 
Short 123 
1.64% 
(7500) 
Faecal 
samples 
Linked human 
outbreak with 
oysters 
(Dowell et 
al. 1995) 
Norovirus 
+ ss 
RNA 
Short  280 + 80 
4.80% 
(7500) 
Faecal 
samples 
Distinguished 
transmission 
between and 
within hospitals 
(Lopman et 
al. 2006) 
Hepatitis A 
+ ss 
RNA 
Short -  -  Serum 
Linked an 
outbreak in 
homosexuals 
with one in a 
family 
(Stene-
Johansen 
et al. 
2002) 
+ ss 
RNA 
Long 472 
4.90% 
(9600) 
Serum 
Distinguished 
between 6 
patients 
(Gonzalez-
Candelas 
et al. 
2003) 
+ ss 
RNA 
Long 188 
1.90% 
(9600) 
Bone 
marrow 
smear 
sample 
Determined 
source of 
outbreak and 
patient-to-
patient 
transmission 
chain 
(Spada et 
al. 2004) 
Hepatitis C 
+ ss 
RNA 
Long  337 + 472 
8.43% 
(9600) 
Serum 
Determined 
transmission 
events between 
patients 
(Bracho et 
al. 2005) 
Rhinovirus 
+ ss 
RNA 
Short 420 
5.25% 
(8000) 
Cell culture 
1 or 2 
passages 
Distinguished 
between 
epidemics, 
seasons and 
co-circulating 
strains 
(Savolaine
n et al. 
2002) 
Classical 
Swine Fever 
virus 
+ ss 
RNA 
Short  321 + 850 
9.37% 
(12500) 
Epithelium 
and cell 
culture 
Detection of 2 
sub-populations  
(Widjojoat
modjo et 
al. 1999)    44
1.5 Objectives of PhD thesis 
The procedure by which mutations are fixed into the consensus of FMDV populations is 
highly complicated stemming from an intricate process of mutation and selection.   
However, this overall process can be broken down into defined events to assist our 
understanding of FMDV evolution.  These events include initial spontaneous mutation 
rate of the virus at cell level, the maintenance and characteristics of a virus mutant 
spectrum, the pressure of immune selection, the effect of transmission within a host, the 
effect of transmission between hosts and populations of hosts, and the accumulation of 
genetic mutations over time in an epidemic.  The objective of this PhD thesis is to 
characterise further the evolution of FMDV both in the field and in vitro by investigating 
nucleotide variation, with a broader aim of applying the data in an epidemiological 
context.    
 
Chapter 2 describes initial development of a method to obtain complete consensus 
genome sequence from original epithelium.  The objective was to design a method that 
was robust, reliable and simple such that it could be used to examine a large number of 
virus samples.  In Chapter 3 this method was used to analyse the extent of nucleotide 
variation that was apparent within an epidemic, by studying infected epithelium samples 
from the UK 2001 FMDV epidemic.  Genetic evolution was studied across the entire 
genome investigating the type and frequency of changes that occurred.  Also 
investigated were the relationships of virus genetic evolution during the epidemic to time 
and geography of virus spread and transmission.  This included assessing whether Pan 
Asia O FMDV evolved during the epidemic in a manner such that mutations were 
inherited along a transmission chain in a regular fashion.  The potential of using the 
genetic data for epidemiological tracing studies, including dating the start of the epidemic 
was also considered. 
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Following the new observation that the virus evolution during the outbreak conformed to 
a molecular clock with nucleotide changes being inherited along an infection 
transmission tree (Cottam et al. 2006) the potential of using complete genome sequence 
data for transmission tracing was assessed in Chapter 4.  Epidemiological data 
concerning infection profiles of individual farms were also incorporated improving the 
tracing potential of the genetic data by allowing statistical evaluation of the likely 
transmission trees estimated. 
 
With the objective of increasing our understanding of the virus evolution, and the fixation 
of mutations into the consensus sequence, the mutant frequency within virus populations 
from naturally infected animals was assessed in Chapter 5.  This type of study can 
provide information regarding the type and distribution of mutations within a virus 
population and is imperative to understanding how nucleotide changes become fixed into 
the consensus sequence of a virus population.  Chapter 6 describes a study to gain an 
understanding of the spontaneous mutation rate of the virus, a process underpinning the 
nucleotide variation seen in the field.   
 
The findings of this thesis are concluded and discussed in Chapter 7.  Chapter 8 reports 
on the recent use of complete genome sequencing in real-time during the UK 2007 
outbreaks of O1BFS FMDV.    46
Chapter 2  
 
Development and optimisation of 
protocols for complete genome 
amplification and sequencing of Foot-
and-mouth disease virus: Pan Asia O 
serotype  
 
 
The work in this chapter is expected to be published; 
Cottam, E.M., King D.P., edited by Caugant, D.A. Molecular Epidemiology of 
Microorganisms: Viral genome sequencing, Chapter 21, Methods in Molecular Biology, 
Human Press 
 
I would like to thank the Wellcome Trust Sanger Institute for their collaboration and 
contribution to the pilot study detailed within this chapter.    47
2.1 Summary 
A method was developed for complete genome sequencing of foot-and-mouth disease 
virus from the UK 2001 epidemic from the archive of epithelium samples held at the 
World Reference Laboratory, Institute for Animal Health, Pirbright.  This method reliably 
produces sequence data spanning the entire genome of the virus, directly from 
epithelium samples that have been stored in 50% glycerol for 5 years or more. In 
addition a successful pilot study was undertaken in collaboration with the Wellcome Trust 
Sanger Institute to sequence large proportions of the genome from a single RT-PCR 
product.  A RT-PCR that amplifies the whole poly-protein coding region, and also one 
that represents 80% of the genome have been designed and used to amplify virus RNA 
extracted from epithelium samples.  The sequencing strategy designed for use at the IAH 
produces identical results to the sequencing method used at the Wellcome Trust Sanger 
Institute, supported by the independent analyses of four virus infected epithelium 
samples.    48
2.2 Introduction 
2.2.1 Overview 
The overall objective of this project was to develop and optimise a method for 
sequencing a significant number of complete genomes of the Pan Asia O serotype of 
FMDV from the UK 2001 outbreak held within the library of epithelium samples at the 
World Reference Laboratory (WRL) Pirbright.  Epithelium samples were submitted to the 
WRL, IAH Pirbright from 1224 FMDV positive infected premises, and there was 
epithelium remaining from 92% of these.  However, epithelium was not stored from 
infected premises that were designated as laboratory negative for FMDV, or from farms 
whose animals were culled as dangerous contacts and not subject to definitive laboratory 
diagnosis. 
 
The FMDV genome is a highly structured positive sense single stranded RNA of 
approximately 8500 nucleotides.  Within the 5’ UTR is a long stretch of cytosine residues 
(poly ‘C’ tract) which prevent direct PCR through this region.  At the 3’ end of the genome 
is a long poly adenosine tail (poly ‘A’ tract).  The genome structure is described in more 
detail in Chapter 1; section 1.1.5. 
 
2.2.2 Literature review of methods to sequence the complete genome 
Since 1999 there have been many projects to sequence the complete genome of FMDV, 
the majority on a small scale of 1 or 2 genomes (Toja et al. 1999) and more recently in 
2005 a study to sequence 103 genomes across all serotypes (Carrillo et al. 2005).  Only 
one study (Oem et al. 2004) did not amplify the virus by in vitro propagation prior to 
sequencing.  Some studies incorporated a separate reverse transcription step prior to 
PCR (Carrillo et al. 2005; Mason et al. 2003b; Nobiron et al. 2005), and some carried out 
a one step RT-PCR (Kanno et al. 2002; Oem et al. 2004).  Carrillo et al 2005 amplified    49
the full length cDNA non-specifically prior to PCR to increase its concentration.  All 
studies amplified the genome in overlapping PCR fragments ranging from 5 fragments 
(Nobiron et al. 2005) to as many as 21 fragments (Carrillo et al. 2005).  Nobiron et al 
2005 cloned the fragments before sequencing, whereas the other studies sequenced the 
PCR products directly.  When the PCR products were cloned prior to sequencing, 
specific PCRs were later performed on the original material to confirm any nucleotide 
sequence changes found.   
 
Sequence from PCR products contain the predetermined primer sequence at either end, 
and in some studies PCR RACE (Rapid amplification of cDNA ends) has been performed 
in order to obtain the viral sequence for the extreme ends of the genome (Kanno et al. 
2002; Nobiron et al. 2005).  In other studies, it was argued that if an oligo dT primer was 
used to amplify the 3’ end, only the 5’ ends of the s- and l-fragments would be 
predetermined and these sites are known to be highly conserved across serotypes 
(Mason et al. 2003b).  Studies on other RNA viruses such as Dengue (Barrero & 
Mistchenko 2004) and Ebola (Sanchez & Rollin 2005) have used similar methods 
including overlapping PCR reactions, cloning and sequencing. 
 
2.2.3 Study objective 
The aim of this study was to develop a method to analyse the complete genome of foot-
and-mouth disease virus (FMDV) with high sensitivity from raw epithelial clinical 
samples.  Nucleotide sequencing of virus direct from epithelium samples would increase 
confidence that any nucleotide changes seen were present within the infected animal 
and were not a consequence of virus propagation in cell culture.  However, the quantity 
and quality of viral RNA recovered from stored epithelium is likely to be lower or less 
consistent than that following propagation in cell culture, which may hinder attempts to 
amplify the genome by PCR. 
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The final method developed needed to be sensitive in order that virus could be 
sequenced directly from the epithelium without propagation.  It also needed to be 
accurate, involving the least amount of in vitro amplification possible to minimise the 
introduction of copying errors, particularly where the starting concentration was low as 
would be likely for some samples.  A method with high redundancy is also desirable in 
order to provide high confidence in the results.  Finally, if a large number of FMDV 
genomes were to be sequenced the assay must be simple and robust. 
 
It was attempted to amplify the genome in multiple overlapping PCR fragments, and also 
in two fragments (one of the short s-fragment and one long PCR fragment of the 
remainder of the genome from the poly ‘C’ tract to the poly ‘A’ tract).  The amplification of 
the majority of the genome in one fragment provided an opportunity to collaborate 
externally with the Wellcome Trust Sanger Institute to explore an alternative sequencing 
strategy.  However, the bio-security regulations at IAH require that only 80% of the 
FMDV genome (6560nt) may be transported off site as a PCR product at any one time, 
and thus amplification of a fragment of this size was prioritised. 
 
2.3 Development of methods 
2.3.1 General methods used 
2.3.1.a Original sample suspension and RNA extraction 
Approximately 1.5g of vesicular epithelium (originally stored in 0.04 M25 phosphate 
buffer [disodium hydrogen phosphate, potassium dihydrogen phosphate, pH 7.5] and 
50% [vol/vol] glycerol) was ground by using a pestle and mortar in a class II safety 
cabinet and resuspended to a 10% suspension with 0.04 M phosphate buffer. The 
solution was then centrifuged for 10 minutes at 3,500g at room temperature, and the    51
supernatant was removed and stored at -70°C until testing.  RNA extraction was 
performed using TRIzol reagent (Invitrogen) as described previously (Reid et al. 1998). 
2.3.1.b Reverse transcription 
Reverse transcription reactions were set up according to manufacturers instructions 
unless otherwise stated.  Briefly, RNA, Primer, and dNTPs were incubated at 70
oC for 3 
minutes, followed by incubation on ice for 3 minutes.  Fresh reverse transcriptase mix 
including 10x RT buffer, 25mM MgCl2, 0.1M DTT, RNase OUT and Superscript III 
reverse transcriptase (Invitrogen) were then added to the reaction, which was then 
incubated at 42
oC for 4 hours. 
2.3.1.c PCR 
The PCR reactions were set up (unless otherwise stated) using Platinum High Fidelity 
Taq (Invitrogen) following the manufacturer’s recommendations per reaction.  Each 
comprised 5µl 10x Hi-Fi buffer, 2µl 50mM MgSO4, 1µl 10mM dNTPs, 1µl 10mM forward 
primer, 1µl 10mM reverse primer, 0.2µl Taq (5 units/µl), plus nuclease free water and 
cDNA to make up a reaction volume of 50µl.  The PCR reactions were subject to a basic 
amplification procedure in 0.2ml tubes on thermal cyclers (MJ Research PTC-100).  The 
results of PCR reactions were visualised using a UV Camera after running 2-10µl of PCR 
product on a 1.2% Agarose gel with 0.002% Ethidium bromide at 90v for 40 minutes.  
The quantitative DNA ladder HyperLadder 1 (Bioline) was run alongside the products for 
comparative quantification of product size and quantity. 
2.3.1.d Sequencing reactions 
The sequencing reactions were set up using the master mix supplied with the Beckman 
DTCS Quick start sequencing kit following the manufacturer’s protocol. Briefly 8µl of 
Beckman Master-mix was added to 8µl of DNA of a suitable concentration (dependant 
upon the PCR product size) and 4µl of primer.  4pmol of primer was used per reaction as 
opposed to the 3.2pmol suggested.  The reactions were run on a programme of 30    52
cycles of 96
oC for 20 seconds, 50
oC for 20 seconds, and 60
oC for 4 minutes, followed by 
holding at 4
oC. 
2.3.2 Strategy  for  complete genome amplification with overlapping PCR 
products 
2.3.2.a From epithelium to DNA 
The strategy designed in this study for the amplification of the complete FMDV genome 
was similar to those used previously; including virus suspension from original material, 
RNA extraction, reverse transcription, PCR amplification and degenerate sequencing.   
The genome was amplified in a small number of overlapping PCR fragments <3kb.   
Finally the sequencing strategy was constrained to use no more than one 96 well 
sequencing plate for each FMDV genome. 
 
Following sample suspension preparation from epithelium, the RNA was extracted 
manually using TRIzol reagent as the RNA yield from manual extraction is higher than 
robotic extraction (S Reid, A Shaw personal communication).  Also to avoid cross-
contamination, each sample was processed individually and consequently the number of 
samples for RNA extraction was not large enough at any one time to warrant using the 
robotic system for RNA extraction. 
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Figure 2.1  
The gel depicts the products obtained from initial PCR amplification of the FMDV genome 
using the six primer sets (1-6) outlined in Table 2.1.  Only sets 1, 2, 4, and 5 gave a visible 
product. 
 
In order to amplify large size PCR fragments, it is essential that the cDNA is of good 
quality, especially if the RNA has been stored for a long period of time as its quality may 
have declined.  Superscript III reverse transcriptase (Invitrogen) was used to reverse 
transcribe the RNA.  It was decided to use an oligo dT primer in the RT reaction to 
improve specificity and concentration of full length cDNA.  However, during replication of 
FMDV a negative sense copy of the genome is formed and so random primers which 
could bind to the negative strand as well as the positive strand were included to 
potentially improve cDNA concentration.  The RT enzyme, Superscript III, had the ability 
to transcribe through the poly ‘C’ tract that is present within the FMDV genome.  This 
characteristic was shown in initial experiments by PCR amplification of the S fragment 
(upstream of the poly ‘C’ tract) from RT products made using only the oligo dT primer 
(data not shown).  The reverse transcription was run for 4 hours to improve the quality of 
the cDNA for the purpose of long PCR (personal communication with V Fowler).  The    54
cDNA was then cleaned up prior to PCR, removing the oligo dT primer to prevent 
interference with any subsequent PCR reaction. 
2.3.2.b Amplification of complete genome in overlapping PCR products 
Initially, it was decided to amplify the genome in six overlapping fragments.  The 
published genetic sequence for FMDV UKG 35/2001 (AJ539141) and other Pan Asia O 
sequences were aligned (AJ539136-AJ539140) using ClustalW implemented in Bioedit.  
This alignment was then used to design suitable primers (Table 2.1).  For initial testing, 
the following thermal cycling conditions were used; 94
oC for 5 minutes, then 39 cycles of 
94
oC for 1 minute, 62
oC for 1 minute, 72
oC for 2 minutes 42 seconds, followed by 72
oC 
for 7 minutes.  Only 4 of the 6 primer sets worked (Figure 2.1).   
 
 
Figure 2.2 
Initial PCR amplification of FMDV genome with 5 primer sets.  Initial amplification of the final 
PCR products 1-5 from primer sets UKFMD/For and Rev 1-7 prior to optimization.  Non 
specific products were visible in lanes 1 to 4. 
 
It was possible to combine the primer sets 5 and 6 to create one long PCR product, and 
a new primer was designed to pair with UKFMD/For3 to amplify the capsid region 
(UKFMD/Rev7 Table 2.1).   These five primer sets worked (Figure 2.2) but showed non    55
specific priming under the PCR conditions used (94
oC 4 minutes, 40 cycles of 94
 °C 1 
minute, 65
 °C 1 minute, 72
 °C 3 minutes, followed by 72
 °C 7 minutes). 
 
2.3.2.c Optimisation of PCR reactions 
To optimise the PCR for fragments 3 and 4 the annealing temperature was increased to 
68
oC and it was determined that the Mg
++ concentration used was correct.   
 
Figure 2.3  
Overlapping PCR products spanning the entire FMDV genome. Optimised amplification of five 
overlapping PCR products spanning the complete genome of FMDV from epithelium sample 
UKG 126/2001. 
 
 
However, in order to improve the yield of fragment 5, the amplification programme was 
modified lowering the annealing temperature to 60
oC.  When PCR reactions with primers 
UK/FMD Forward and Reverse 1-4 were run on the higher annealing temperature 
programme and fragment 5 (UK/FMD Forward 5 and Reverse 6) was run on the lower 
annealing temperature good clean PCR products were obtained (Figure 2.3). 
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The PCR products were cleaned up directly without running through an agarose gel and 
this improved the success of subsequent sequencing reactions. The primer sets amplify 
overlapping fragments the location and size of which are illustrated in Figure 2.4. 
 
Figure 2.4  
Schematic showing size and position of 5 overlapping PCR products spanning the complete 
genome of FMDV.  Vertical arrows indicate the start of specific UTR features and coding 
regions. 
 
2.3.3 Amplification of complete genome in 2 PCR products 
The PCR reaction to amplify the s fragment was optimised as described in section 2.3.2.  
The remainder of the genome is ~7840 nt in length, the poly protein is encoded by a 
stretch of 6996 nt, and if the final product is to be sent off site it must be no more than 
6560 nt in length.  It was decided to attempt to amplify as large a proportion as possible 
that incorporated the entire poly protein, and also design primers that would amplify a 
product no more than 6560 nt in length (i.e. 80% of the FMDV genome). 
2.3.3.a Initial attempts to amplify large fragment by PCR 
Many different combinations of primer sets were tried, however the only result obtained 
was a high molecular weight smear.  Different variables were investigated to try and    57
resolve this problem including Taq concentration (Figure 2.5a), and annealing 
temperature and Mg
++ concentration (Figure 2.5b), with no success. 
 
 
Figure 2.5  
Attempt to optimise long PCR.  a) Agarose gel depicting the PCR products from PCR reactions 
differing in Taq concentration from 0.5µl to 1µl.  b) PCR reactions with 2.5µl and 2.0µl MgSO4 
with temperatures at 0.64oC increments from 66.4 to 69.6oC 
 
A literature search suggested that a touch down or the reverse PCR thermal cycling 
programme could improve yields of long PCR products (Don et al. 1991).  This was 
investigated as shown in Figure 2.6 with no success.  It was possible that the intricate 
RNA secondary structure was causing the problem and so the effect of adding DMSO to 
the PCR reaction was investigated.  Again no improvement was seen, Figure 2.7. 
 
Ultimately, a clean PCR product of a correct size using a normal PCR thermal cycling 
protocol was obtained.  This suggested that the success of the long PCR was 
determined by the quality of the cDNA sample, as this was the only variable.  Using this 
successful sample the candidate primer sets were tested (Figure 2.8), determining that it 
was possible to amplify a product as large as 7258 nt (88.5% of FMDV genome using 
primer set Forec6 and Revec43, Figure 2.8f), and also identifying it as the best candidate 
fragment for sending to Wellcome Trust Sanger Institute (6526 nt, primer set Forec6 and 
UKFMD/Rev5).    58
 
Figure 2.6  
Investigation of touch down PCR.  Agarose gel depicting PCR products from PCR reactions run 
on dec (lane 3); touch down thermal cycling conditions (9 cycles annealing at 70oC, 14 cycles 
annealing at 68oC, and 19 cycles annealing at 66oC) and inc (lane 4); the reverse (9 cycles at 
66oC, 14 cycles at 68oC, and 19 cycles at 70oC).  The negative control is shown in lane 2. 
 
 
Figure 2.7  
Investigation of the effect of DMSO.  Agarose gel depicting the effect of adding DMSO to the 
PCR reaction using primer sets a) UKFMD/For 2 and UKFMD/Rev 6, b) Fcodreg and Rcodreg. 
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2.3.3.b Final amplification of 6526nt fragment for 5 samples and transportation 
to the Sanger Institute 
To improve the RNA quality of the virus samples the RNA extraction was repeated and 
the pellet was re-suspended in only 12µl of nuclease free water, and all of this was used 
for the subsequent reverse transcription and PCR reactions.  This was successful as 
shown in Figure 2.9, and these 5 samples were sent to the Sanger Institute in ethanol 
after phenol/chloroform extraction (according to the IAH bio security regulations), for 
precipitation at the Sanger Institute. 
 
 
Figure 2.8 
Determination of successful primer sets for long PCR.  Agarose gel depicting PCR products 
produced from different primer sets (see Table 2.1 and 2.2); a) UKFMD/For 3 and 
UKFMD/Rev 5, b) UKFMD/For 3 and Rcodreg, c) UKFMD/For 3 and Revec 43, d) Fcodreg and 
UKFMD/Rev 5, e) Forec6 and UKFMD/Rev 5, and f) Forec6 and Revec43. 
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Figure 2.9 
Amplification of FMDV genome for transportation to the Sanger Institute.  Agarose gels 
depicting PCR products produced from primers Forec 6 and UKFMD/Rev 5 (6526b) from 
samples; 1) UKG 127/2001, 2) UKG 11676/2001, 3) UKG 14603/2001, 4) UKG 
14339/2001, 5) UKG 14391/2001. 
 
2.3.4 Sequencing of PCR products 
To achieve maximum redundancy, allowing for the occasional failure of a sequencing 
reaction without the need to repeat the whole process, 84 sequencing primers were 
designed (42 forward and 42 reverse) approximately 200nt apart and offset by 
approximately 100nt resulting in a primer every 100nt (Table 2.2).  A liquid handling robot 
(Qiagen Biorobot 3000) was used to set up the sequencing reactions in order to reduce 
operator error and also to make the method suitable for high throughput.  The robot 
programme set up the reactions adding the master-mix first, followed by the DNA, then 
the primer, using only one box of tips.  This method for sequencing the complete genome 
results in an average of 5x coverage of each nucleotide.  The final method used for the 
remainder of the project including details concerning reagent volumes and 
concentrations is detailed in the methods section 3.3, Chapter 3, and the protocol is 
included as Appendix 1.    61
2.3.5 Assessing confidence of sequence data 
2.3.5.a Reproducibility of sequencing via overlapping PCR products 
This complete method was tested for reproducibility by a repeat of the whole process 
from a single piece of epithelium.  The epithelium for virus UKG 1961/2001 was cut in 
half and each half was sequenced independently. 
2.3.5.b Comparison of sequence data generated by two methods 
Each sequenced determined by the Sanger Institute was directly compared to that of the 
same isolate generated at the IAH. 
Table 2.1 Primer sequences for PCR 
NAME SEQUENCE  (5’-3’) 
UKFMD/FOR1  TTG AAA GGG GGC GTT AGG GTC TCA 
UKFMD/REV1  GGG TGA AAG GTG GGC TTY GGG T 
UKFMD/FOR2  CCC AAG TTT TTA CCG CCT TTC CCG 
UKFMD/REV2  GTT GAT AAT GCT TCC AGT GTT GCC TG 
UKFMD/FOR3  CCA CGC TGG CAT CTT CCT GAA AG 
UKFMD/REV3  GAG CTT GTA CCA GGG TTT GGC CTC A 
UKFMD/FOR4  GTG TTG GAC CTG ATG CAA ACC CC 
UKFMD/REV4  GTC TCT TGC GAG TCT CGC GGA TC 
UKFMD/FOR5  TTC AAG CCT CAA CCG CCC CTC 
UKFMD/REV5  CCT CAA ACA TGA TGT TCA TTG CGT CAC T 
UKFMD/FOR6  GAG AGT GGT GCT CCC CCG ACT G 
UKFMD/REV6  GGC GGC CGC TTT TTT TTT TTT TTT 
UKFMD/REV7  CCA GTG GCC AGT TCC TCA AAT G 
FCODREG  CTT CTA CGC CTG AAT AGG TGA C 
RCODREG  CCT TTC GGA CTT TTC ACT CCT AC    62
Table 2.2 Primer sequences for sequencing and PCR 
 
Name Direction  5'nt  Sequence (5’ to 3’) 
Forec1 Forward 1 TTGAAAGGGGGCGTTAGGGTC
Forec 2 Forward  186 CGTGACTGGTTAATACTCTTACC
Forec 3 Forward  377 CCAAGTTTTTACCGCCTTTCCC
Forec 4 Forward  600 GCTTGAGGAGGACTTGTACAAAC
Forec 5 Forward  757 AGCACTGTTGCTTCGTAGCGG 
Forec 6 Forward  926 CACTGGTGACAGGCTAAGGATG
Forec 7 Forward  1147 CACTGTTCTTATCACGAGCAC 
Forec 8 Forward  1332 GATGCTATCAAACAATTGGAAG
Forec 9 Forward  1584 GAGGACTTTTACCCCTGGACG 
Forec 10  Forward  1763 CAATTACTACATGCAGCAGTACCAG
Forec 11  Forward  1959 ACCGAGGAGACCACTCTTCT 
Forec 12  Forward  2129 GTTCTTCAAAACCCACTTGTTC
Forec 13  Forward  2329 CAGAACTTTGCTCTATTGACAAG
Forec 14  Forward 2552 CAACATCGCCCCTACCAACG 
Forec 15  Forward  2723 GTTCACCAACTTCCTTGATG 
Forec 16  Forward  2912 CACCATCAACCTGCACTTCATG
Forec 17  Forward  3128 GGAGACCACAAATGTACAGG 
Forec 18  Forward  3306 GTTGAGAACTACGGTGGTGAG
Forec 19  Forward  3489 CTAGAAGTGGCAGTGAAACAC 
Forec 20  Forward  3693 GTGAGAGGTGACCTGCAAG 
Forec 21  Forward  3914 GCTCAAGTTGGCAGGAGACG 
Forec 22  Forward  4081 CCACTGGAGTGAAGGCTATCAG
Forec 23  Forward  4265 GAAGATCTCCGACTCGCTCTCC
Forec 24  Forward  4444 CCATTCTCAAGAACGGCGAGTG
Forec 25  Forward  4640 GTGTTTGAAGAGCGGGAACATC
Forec 26  Forward  4838 ACCTGACCCTGACCACTTCGAC
Forec 27  Forward  5030 CAACCTGTACTCGGGCTTCAC 
Forec 28  Forward  5203 ACGACTGTGCCCTTCTCAACG 
Forec 29  Forward  5441 CTTTGAGGGGATGGTGCATGAC
Forec 30  Forward  5606 CAAGAGACAGCAGATGGTGGATG
Forec 31  Forward 5805 GAAGAACAACCACAAGCTGAAGG
Forec 32  Forward  5987 GAAGAAACCTGTCGCTTTGAAAG
Forec 33  Forward  6195 GACAAGATCATGTTGGACGG 
Forec 34  Forward  6400 ACGCTGATGTTGGGAGACTG 
Forec 35  Forward  6562 CTTTCATCGTCGGCACTCAC 
Forec 36  Forward  6759 GGTGTGTTTAACCCCGAATTTGG
Forec 37  Forward  6931 TGCATAGCGTGCTGGGTACG 
Forec 38  Forward  7160 CTTCCTGAAGGACGAGATTCGC
Forec 39  Forward  7351 GATTTGGCACGCATTTTGCTC 
Forec 40  Forward  7574 TTGTTCCGCAACAAGCATCATC
Forec 41  Forward  7773 CCAGCTGACAAAAGCGACAAAG
Forec 42  Forward  7977 TCTGGACCTGACGAGTACCG 
Revec Reverse  8183 GAAATAGGAAGCGGGAAAAAGCC
Revec Reverse  7897 GGTCTTCGAAGCCATCACAG 
Revec Reverse  7707 CTTGCAACCACGATGTCGTC 
Revec Reverse  7503 TCAGGATCCACTCAGCGTTTG 
Revec Reverse  7279 CACAAAATCTGCCAATCATCATC
Revec Reverse  7064 ACCACGGCGTTTCCCCTG 
Revec Reverse  6885 CCTCCTCAGACATCTTTGTGTTTC
Revec Reverse  6671 GTGTGGTTCGGGATCGATGTG 
Revec Reverse  6473 TCCGTCCATGCACACTACAATG
Revec Reverse  6284 GAGCATGTCCTGTCCTTTCAC 
Revec Reverse  6110 GTCGAGGATGAGCTCAACAG 
Revec Reverse  5928 GTTTCTGTCTCTCCATCGGACC   63
Revec Reverse  5714 GGTCTCCAGAGGGTTCTTTTCC
Revec Reverse  5546 CTCAAAGTTTTCCTTCAGGCG 
Revec Reverse  5341 ACCTTCTCGTGGAGCTCGAC 
Revec Reverse  5119 TTGGCGCTCACGTCAATGTC 
Revec Reverse  4956 CCGTAGTTGAAACCATTTGGG 
Revec Reverse  4780 AGCACGTTCGCAAGGAAACTC 
Revec Reverse  4575 GCTGCTTTTCAAGGATGCC 
Revec Reverse  4399 CTCTCAAGGTCTTCGGGTGTG 
Revec Reverse  4196 GTCCTTTGACCGTGCTGCTAC 
Revec Reverse  4063 GACACCAACCGGTTAAAGTCG 
Revec Reverse 3809 CCTCTTCATGCGGTAAAGCAG 
Revec Reverse  3624 CCGTGTAAGGCAGTGCAAGC 
Revec Reverse  3432 GGGTTTGCATCAGGTCCAAC 
Revec Reverse  3215 GCTAGCTAGAACGACCAGTGCG
Revec Reverse  3047 TGTCCCACTCCGCATGAATG 
Revec Reverse  2818 CTGTCTGAGTCCGTCTTTGTGG
Revec Reverse  2642 ACCACCGTAACCGTCGCTAC 
Revec Reverse  2440 CCAACAAAGGGCACAGTGATG
Revec Reverse  2263 CAACCGTTTCTCATGTAAGCATAAG
Revec Reverse  2065 GCTGTTGCGTACCCGTAAGTG 
Revec Reverse  1895 CCAGTCATTGTTCTGAGTGTTGG
Revec Reverse  1671 CTTTCCATTCTCCGTTGAGC 
Revec Reverse  1480 GTCCCGTCTACCATGCACAC 
Revec Reverse  1288 GGTTCATCAACGTACCTAAACAAC
Revec Reverse  1055 GGTCACCTATTCAGGCGTAGAAG
Revec Reverse  864 GTTGCACACATGGTGGGTC 
Revec Reverse  700 CCCCTCTAGACCTGGAAAGACC
Revec Reverse  483 GGGAAAGGCGGTATCATCTTG 
Revec Reverse  371 GGGTGAAAGGTGGGCTTCG 
Revec Reverse  168 GTTCGTCCGCACAGTCCAG 
 
   * Numbered according to AJ539141 
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2.4 Results 
2.4.1 Amplification of complete genome by overlapping PCR products 
A method to amplify the complete genome of Pan Asia O UKG FMDV through 5 
overlapping PCR products, each of <3kb has been established.  The detailed protocol is 
included as Appendix 1.  Sequencing of these PCR products using the primers detailed 
in Table 2.2 provides good coverage of the genome, with 64 primer determined 
nucleotides.  Figure 2.10 outlines the overall protocol for this method. This strategy can 
now be used to investigate FMDV nucleotide evolution during the UK 2001 FMD 
outbreak. 
 
Figure 2.10  
Schematic of sequencing strategy through overlapping PCR products 
    65
2.4.2 Amplification of long PCR fragments 
The region of the FMDV genome that represents the complete poly protein was 
successfully amplified in a single PCR reaction.  Additionally a PCR primer set was 
designed to amplify 80% of the genome, which allowed the exploration of sequencing 
strategies involving external collaborators. 
 
Figure 2.11  
Schematic of sequencing protocol in collaboration with the Wellcome Trust Sanger Institute    66
The Sanger institute use the ‘shot gun’ sequencing method, as outlined in Figure 2.11.  
Although it was only possible to sequence 80% of the genome, this method is 
advantageous because prior knowledge of the expected sequence is not required. 
 
2.4.3 Assessment of the reproducibility of the complete protocol 
One piece of epithelium was sequenced twice independently.  When the two sequences 
were compared they were found to be identical.  The sequences provided by the Sanger 
Institute for the 6526nt PCR product from UKG samples 127/2001, 11676/2001, 
14603/2001, 14339/2001 and 14391/2001, were compared to the complete genome 
sequences generated by the method of overlapping PCR products.  The pairs of 
sequences were all found to be identical.    67
2.5 Discussion 
A method to sequence the complete genome of UK Pan Asia O serotype FMDV using 
overlapping PCR products has been developed.  The complete sequencing of virus from 
an epithelium sample can be completed within a week and costs approximately £500 (in 
reagents) per FMDV genome.   Using the robot for assisting in the sequence reaction set 
up decreases the risk of human error; however it was found that using a multi-pipette 
instead can improve the proportion of successful reactions.  This could be because the 
pipette is more accurate in dispensing liquid, or that the reaction is mixed better, or 
because it is possible to add the DTCS Quickstart master mix last to the reaction when 
setting it up by hand (the robot has to add it first to avoid contamination of the other 
reactions). 
 
A successful pilot study was undertaken to sequence a large proportion of the virus 
genome in collaboration with the Wellcome Trust Sanger Institute, assessing the 
possibility of utilising their genome sequencing expertise and resources to study FMDV.  
Although this has been useful, it is important to note that in providing the PCR product 
much of the time consuming work was done at IAH Pirbright.  Another disadvantage of 
this programme for sequencing was the limitations enforced by bio security, resulting in it 
only being possible to sequence 80% of the FMDV genome which is smaller than the 
poly protein.  However, the method of nucleotide sequencing employed by the Sanger 
Institute does not require prior knowledge of the expected sequences for sequence 
primer design, which would be a clear advantage especially when sequencing FMDV 
strains de novo. 
 
The introduction of error through the amplification process, for example through Taq 
infidelity, was of initial concern.  However, the method for complete genome sequencing 
from overlapping PCR products was found to be reproducible, and this conclusion is    68
reinforced by the fact that four sequences determined at the Sanger Institute from a 
different PCR product were identical to those produced at the Institute for Animal Health 
for the same infected samples. 
 
The method detailed here did not always work if there was a low initial virus 
concentration.  For this reason if the method is to be used in the future, it may be 
worthwhile incorporating a cDNA amplification step (Carrillo et al. 2005).   Another option 
would be to investigate the probability of introducing mutations upon propagation in cell 
culture; if this was negligible it could form an alternative strategy to increase virus 
concentration.   
 
The method is very specific to UK Pan Asia O serotype FMDV, because it was designed 
to investigate the UK 2001 outbreak of the disease.  If complete genome sequencing is 
to be used as an epidemiological tool in the future, it is essential to adapt the method 
such that it holds the capacity to sequence all serotypes.  Another improvement to the 
method would be to optimise the PCR reactions further, so that they are all able to run on 
the same thermal cycling programme, which would make the protocol more user friendly.  
Novel sequencing technologies are continuously being developed such as microarray 
based, and pyrosequencing based technologies that may play a greater role in FMDV 
sequencing in the future. 
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Chapter 3   
 
 
Molecular epidemiology of the Foot-and-
mouth disease outbreak in the United 
Kingdom in 2001 
 
 
The work in this chapter has been published; 
Cottam, E.M., Haydon, D.T., Paton, D.J., Gloster, J., Wilesmith, J.W., Ferris, N.P., 
Hutchings, G.H., King D.P. 2006 Molecular Epidemiology of the Foot-and-Mouth Disease 
Virus Outbreak in the United Kingdom in 2001 Journal of Virology, 80, 22, 11274-11282    70
 
 
Cover photograph (Copyright © 2007, American Society for Microbiology. All Rights Reserved.): The 
transmission history of foot-and-mouth disease virus (FMDV) can be elucidated from complete genome 
sequence analysis of the virus, enabling epidemiological tracing of the virus between infected 
premises. The United Kingdom map shows the location of premises infected during the 2001 FMDV 
outbreak. The structure is a representation of FMDV British field strain (serotype O), showing the alpha-
carbon backbone (accession IFOD), courtesy of Nick Knowles, Institute for Animal Health, Pirbright, 
United Kingdom. (See related article in November 2006: vol. 80, issue 22, p. 11274.)    71
3.1 Summary 
The objective of this study was to quantify the extent to which the genetic diversity of 
Foot-and-Mouth Disease Virus (FMDV) arising over the course of infection of an 
individual animal becomes fixed, transmitted to other animals, and thereby accumulates 
over the course of an outbreak.  Complete consensus sequences of 23 genomes (each 
of 8200 nucleotides) of FMDV were recovered directly from epithelium tissue acquired 
from 21 farms infected during the UK 2001 FMDV outbreak over a period of nearly 7 
months.  Analysis of these consensus sequences revealed very few apparently 
ambiguous sites, but clear evidence of 197 nucleotide substitutions at 191 different sites.  
We estimated the rate of nucleotide substitution to be 2.26×10
-5 per site per day (95% CI 
1.75-2.80×10
-5), and nucleotide substitutions to accrue in the consensus sequence at an 
average rate of 1.5 substitutions per farm infection.  This is a sufficiently high rate that 
detailed histories of the transmission pathways can be reliably reconstructed.   
Coalescent methods indicated that the date at which FMDV first infected livestock in the 
UK was 7
th February 2001 (95% CI Jan 20
th – Feb 19
th), identical to estimates obtained 
on the basis of purely clinical evidence.  Nucleotide changes appeared to have occurred 
evenly across the genome and within the open reading frame the ratio of non-
synonymous to synonymous change was 0.09.  The ability to recover particular 
transmission pathways of acutely acting RNA pathogens from genetic data will help 
resolve uncertainties about how virus is spread, and could help in the control of future 
epidemics.    72
3.2 Introduction 
Foot and mouth disease virus (FMDV), discovered by Loeffler and Frosch in 1898, is a 
member of the genus aphthovirus, in the family Picornaviridae.  The virus replicates 
within pigs, cattle, sheep and other cloven-hoofed animals (Domingo et al. 2002; Hughes 
2004; Racaniello 1996).  FMDV RNA polymerase has a high error rate, estimated to be 
in the order of 10
-3–10
-5 misincorporations/nucleotide/genome replication, which is not 
mitigated by a proof reading mechanism (Carrillo et al. 1998; Domingo et al. 2001; 
Haydon et al. 2001).  Thus nucleotide changes during a single replication event are likely 
to be common since the virus genome is 8,500nt long (including poly ‘A’ and poly ‘C’ 
tracts) and replicates via a negative strand intermediate.  The high mutation rate of this 
virus, coupled with a fast replication rate and extensive population size, results in rapid 
evolution of FMDV (Domingo et al. 2003). 
 
In 2001, the UK livestock industry was devastated by an epidemic of FMDV, caused by 
the Pan Asia O strain of the virus (Gibbens et al. 2001; Gibbens & Wilesmith 2002).  The 
disease was rapidly and widely disseminated throughout the UK and a total of 2030 
farms were declared ‘infected premises’ (IP).  The extent of the outbreak and speed with 
which the virus spread hindered attempts to trace the exact origin of infection for many 
premises; numerous cases were simply attributed to ‘local spread’.  Samples of infected 
tissue were collected from the majority of IP prior to culling of the animals and stored at 
the Institute for Animal Health, Pirbright.  These samples provided a unique opportunity 
to study the micro-evolution of this virus strain over the 7 months that this epidemic 
persisted.   
 
It is evident from previous studies, both in vitro (see Chapter 1; section 1.4.3), and in vivo 
(Carrillo et al. 1998), that FMDV mutation and substitution rates are high. It is much less 
clear as to what extent the genetic diversity, anticipated to be generated over the course    73
of infection within an individual animal, becomes fixed, transmitted to other animals, and 
thereby accumulates over the course of an outbreak. Quantitative models of viral genetic 
change over short time periods suggest this rate of accumulation should be readily 
measurable and informative of transmission pathways at high resolution (Haydon et al. 
2001).  Strong tests of this prediction would be provided by evidence that the consensus 
sequence (acquired directly from tissue samples, rather than through prior passage in 
cell culture), which reflects the average of the viral genetic diversity within a sample, 
evolves at a sufficient rate to enable reliable tracing of transmission pathways. 
 
Studies considering the nucleotide sequence encoding the VP1 capsid protein of FMDV 
alone have provided valuable insight into the emergence of various strains and serotypes 
worldwide over recent decades (Bronsvoort et al. 2004; Knowles & Samuel 2003; 
Sangare et al. 2003).  Changes observed within VP1 over the course of single outbreaks 
have also been previously documented (Christensen et al. 2005; Jinding et al. 2006; 
Mohapatra et al. 2002; Sangare et al. 2003; Tsai et al. 2000), but the relatively short 
length of the sequence encoding VP1 (633nt) together with the short infectious period, 
has limited the power of these analyses to reconstruct transmission pathways at high 
resolution.  Complete genome analysis has the potential to resolve transmission histories 
and improve the precision of epidemiological investigations.  The ability to determine the 
exact source of infection of IP from the UK 2001 outbreak would help us understand the 
route of transmission of infection between farms.  Such information is invaluable for the 
control of future epidemics.   
 
Here we report 23 complete consensus genomes, sequenced directly from clinical 
epithelial samples collected from 21 IP from the UK 2001 outbreak.  These samples were 
carefully chosen with the aim of first characterising the extent of variation within the 
outbreak, secondly analysing the relationship between time and accumulation of genetic    74
change, and thirdly to determine if sequence data can map known transmission events 
and aid analysis of spatio-temporal clusters of IP with uncertain transmission histories.    75
3.3 Methods 
3.3.1 Virus samples 
The consensus FMDV genome was amplified by RT-PCR and sequenced from clinical 
epithelium samples taken from 21 infected premises (Figure 3.1).  All epithelium samples 
had been previously found positive by virus isolation. IP were sampled from every month 
of the outbreak. 
 
Figure 3.1  
Location of FMDV infected premises investigated.  The figure shows a map of Great Britain 
with total designated FMD infected premises (·) in 2001; 20 of those from which virus has 
been sequenced are highlighted (□). 
 
The samples were from the earliest IP and also from a representative IP of eight 
geographical clusters sampled at a later time. The known transmission events studied 
involved IP at the start of the outbreak for which transmission histories were clearly 
established from contact tracing. Uncertain transmission histories were studied by    76
investigating a cluster from County Durham.  Accession numbers and sequence 
coverage are detailed in Table 3.1. 
 
3.3.2 Epithelium Sample Suspension 
As described in Chapter 2, Section 2.4.1a. 
 
3.3.3 RT-PCR amplification of samples 
TRIzol (Invitrogen) RNA extraction was performed as described previously (Reid et al. 
1998).  Ten µl RNA, 4µl 10mM primer UKFMD/Rev6 (
5’GGC GGC CGC TTT TTT TTT TTT 
TTT
3’), 4µl 10mM random hexamers (Promega), 2µl 10mM dNTP mix was incubated at 
68°C for 3 minutes, then on ice for 3 minutes. Eighteen µl of freshly prepared RT mix (4µl 
10x RT buffer (Invitrogen), 8µl 25mM MgCl2, 4µl 0.1M DTT, 2µl RNase OUT (Invitrogen)) 
was added to the sample followed by 2µl Superscript III Reverse Transcriptase 
(Invitrogen).  The sample was then incubated at 42°C for 4 hours after which the reaction 
was stopped by incubation at 85°C for 5 minutes.  The cDNA was then cleaned using 
QIAquick PCR Purification Kits (Qiagen), eluting in 30µl of elution buffer before storage 
at -20°C.  Five overlapping PCR fragments covering the FMD genome were amplified 
from each sample, using 47.5µl of master mix (5µl 10x buffer, 2µl MgSO4, 1µl 10mM 
dNTP mix, 1 µl 10mM forward primer, 1µl 10mM reverse primer, 0.2µl Platinum Taq Hi-
Fidelity (Invitrogen), 37.3 µl nuclease-free water) plus 2.5µl cDNA.  The five primer sets 
were as follows 1) forward 
5’TTG AAA GGG GGC GTT AGG GTC TCA
3’ reverse 
5’GGG TGA AAG 
GTG GGC TTY GGG T
3’, 2) forward 
5’CCC AAG TTT TTA CCG CCT TTC CCG
3’ 
 reverse 
5’GTT GAT 
AAT GCT TCC AGT GTT GCC TG
3’, 3) forward 
5’CCA CGC TGG CAT CTT CCT GAA AG
3’ reverse 
5’CCA GTG GCC AGT TCC TCA AAT GC
3’, 4) forward 
5’GTG TTG GAC CTG ATG CAA ACC CC
3’ 
reverse 
5’GTC TCT TGC GAG TCT CGC GGA TC
3’, 5) forward 
5’TTC AAG CCT CAA CCG CCC CTC
3’  
reverse 
5’GGC GGC CGC TTT TTT TTT TTT TTT
3’ (see also Chapter 2, Table 2.1).  Primer sets 
1-4 were run on a PCR programme cycle of initial denaturation at 94°C for 2 minutes,    77
then 39 cycles of 94°C 30 seconds, 68°C 30 seconds, 72°C 3 minutes, and ending with 
incubation at 72°C for 7 minutes.  Primer set 5 was run on a cycle of initial denaturation 
at 94°C for 2 minutes, then 39 cycles of 94°C 45 seconds, 60°C 45 seconds, 72°C 3 
minutes, and finishing with incubation at 72°C for 7 minutes.  PCR products were 
cleaned up using QIAquick PCR Purification Kits (Qiagen), eluting in 30µl elution buffer.  
In order to estimate DNA content, 2µl of the PCR product was run on a 1.2% agarose gel 
at 90v for 35 minutes alongside a quantitative ladder (HyperLadder I, Bioline).  The DNA 
concentrations of these products were adjusted to give the recommended copy number 
for sequencing; (fragment 1: 20ng/µl, fragment 2: 70ng/µl, fragment 3: 100ng/µl, 
fragment 4: 100ng/µl, fragment 5: 100ng/µl), and stored at -20°C. 
 
3.3.4 Sequencing reactions 
Forty-two forward and 42 reverse sequencing reactions (primers are listed in Table 2.2, 
Chapter 2) were performed in a 96 well Beckman Sequencing plate using 8µl of master 
mix  (CEQ Dye Terminator Cycle Sequencing with Quick Start Kit, Beckman Coulter), 4µl 
of 1mM primer, and 8µl DNA per reaction.  A Qiagen Biorobot 3000 was used to set up 
the reactions.  The plate was run on a programme of 30 cycles of 96°C for 20 seconds, 
50°C for 20 seconds, and 60°C for 4 minutes.  Following thermal-cycling, the reactions 
were cleaned up by ethanol precipitation before running on the Beckman Coulter 
Sequencing machine. 
3.3.5 Data Analysis 
The raw data files were assembled into a contig and edited using Seqman (DNASTAR).  
All further sequence manipulation was performed using Bioedit, and DNAsp freeware.  
The phylogenetic reconstruction (tree shown in Figure 3.2) was carried out using 
maximum likelihood methods as implemented in Paup* (version 4b 10, (Swofford 2001)), 
assuming an HKY model of base substitution (variable base frequencies and variable 
transition and transversion frequencies (Hasegawa et al. 1985)) with rate heterogeneity.     78
Bayesian posterior probabilities were obtained from 500,000 generations sampling every 
100
th tree using the software package Mr Bayes (Huelsenbeck & Ronquist 2001).  The 
genealogical relationships shown in Figure 3.3 were based on statistical parsimony as 
implemented in the software package TCS (Clement et al. 2000) assuming gaps to be 
missing nucleotides (Figure 3.3).  For this statistical parsimony analysis ambiguities were 
replaced with the conserved base.  A molecular clock was fitted using MCMC techniques 
implemented in the software package BEAST (Bayesian Evolutionary Analysis Sampling 
Trees) (Drummond et al. 2002)) assuming a relaxed clock (Ho et al. 2005) with 
exponentially distributed rates and exponentially increasing population size, and the HKY 
model of base substitution (Hasegawa et al. 1985) with rate heterogeneity.  The number 
of substitutions over the phylogeny was estimated using DNASp, and the non-
synonymous: synonymous ratios (dN/dS) were estimated using Hy-Phy software 
package (Pond et al. 2005).  Hy-Phy was also used for partition analysis to determine if 
selective pressures (dN/dS ratios) differed significantly between genes using a Muse-
Gaut 94 substitution model (Muse & Gaut 1994).  The Kolmorogov-Smirnov (KS) test 
was used to investigate the positioning of mutations along the genome.  All sequences 
have been submitted to GenBank and assigned the accession numbers DQ404158-
DQ404180.    79
3.4 Results 
Twenty-three clinical samples selected from the UK 2001 outbreak (Table 3.1) were 
examined by genome sequencing of FMDV.  All sequences were unique and comprised 
the complete genome excluding the poly ‘C’ and poly ‘A’ tracts, and 64 primer 
determined nucleotides (24nt at 5’ end, 19nt and 21nt either side of internal poly ‘C’ 
tract).  The nucleotide sequence changed considerably during the outbreak with variation 
arising at 191 nucleotide sites.  Ambiguities within the sequences were rare, occurring in 
only three isolates (DQ404180, DQ404160, DQ404167).  DQ404180 contained three 
ambiguous sites: two between pyrimidines T/C at nucleotide positions 2833 and 5734 
and one between purines A/G at position 4744.  DQ404160 contained an ambiguity 
between T/C at position 1270.  DQ404167 contained a T/C ambiguity at position 6207 
and also an ambiguity between nucleotides and a deletion at bases 8111-8115.  This 
supports the view that there is a predominant consensus sequence present within an 
epithelium sample (or one that is preferentially amplified by PCR).  Four deletions were 
identified within the 5’ untranslated region (UTR), three of which were inherited by 
progeny viruses recovered later in the course of the outbreak.  The deletion that was 
present in one isolate only was one base and followed a single nucleotide insertion 20nt 
upstream.  A deletion of 5 nucleotides was also identified in the 3’UTR of one isolate 
(DQ404167), although present as an ambiguity with some of the population containing 
the full sequence. 
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Table 3.1 Details of the 23 FMDV consensus genomes sequenced in this study
Accession No. 
Infected 
Premise No. 
World Reference 
Laboratory No. 
Animal 
Date of Sample 
isolation 
County 
Sequence 
length (nt) 
Total nt 
sequenced 
Average times 
coverage of each base 
DQ404180 1  UKG  11/2001  Pig  19/02/2001  Essex  8193  40,050  4.89 
DQ404179 4  UKG  126/2001  Pig  22/02/2001  Northumberland  8193  42,722  5.21 
DQ404178 4  UKG  127/2001  Pig  22/02/2001  Northumberland  8193  48,838  5.96 
DQ404177 4  UKG  128/2001  Pig  22/02/2001  Northumberland  8193  32,044  3.91 
DQ404176 6  UKG  150/2001  Cattle  23/02/2001  Northumberland  8193  44,636  5.45 
DQ404175 7  UKG  173/2001  Cattle  24/02/2001  Devon  8193  44,296  5.41 
DQ404174 1700  UKG  438/2001  Sheep  28/02/2001  Ireland  8193  42,686  5.21 
DQ404173 16  UKG  220/2001  Cattle  26/02/2001  Northampton  8195  42,760  5.22 
DQ404172 38  UKG  621/2001  Cattle  01/03/2001  Staffordshire  8193  44,194  5.39 
DQ404171 1070  UKG  4569/2001  Sheep  06/04/2001  Northumberland  8193  47,008  5.74 
DQ404170 1448  UKG  7675/2001  Sheep  23/04/2001  Durham  8193  39,528  4.82 
DQ404169 1404  UKG  7038/2001  Sheep  20/04/2001  Durham  8193  35,038  4.28 
DQ404168 1575  UKG  9011/2001  Cattle  10/05/2001  W.  Yorkshire 8193  43,915  5.36 
DQ404167 1597  UKG  9327/2001  Sheep  14/05/2001  Durham  8188  48,213  5.89 
DQ404166 1654  UKG  9788/2001  Cattle  28/05/2001  Durham  8193  42,169  5.15 
DQ404165 1692  UKG  9964/2001  Cattle  03/06/2001  Durham  8193  42,147  5.14 
DQ404164 1757 UKG  11676/2001  Cattle  16/07/2001  Devon  8193  44,887  5.48 
DQ404163 1945 UKG  14339/2001  Cattle  31/07/2001  Powys  8191  37,185  4.54 
DQ404162 1956 UKG  14476/2001  Sheep  08/08/2001  W.  Yorkshire 8192  45,421  5.54 
DQ404161 1948 UKG  14391/2001  Cattle  14/08/2001  Cumbria  8189  44,293  5.41 
DQ404160 1970 UKG  14524/2001  Cattle  23/08/2001  Northumberland  8187  42,745  5.22 
DQ404159 1976 UKG  14603/2001  Cattle  26/08/2001  Northumberland  8188  45,752  5.59 
DQ404158 2027 UKG  15101/2001  Sheep  17/09/2001  Northumberland  8187  45,178  5.52    81
3.4.1  Maximum likelihood phylogenetic analysis of complete genome 
sequences 
Groups of viruses that reflect the known geographic spread of FMD were identified by 
phylogenetic reconstruction of the outbreak using maximum likelihood methods (tree 
shown in Figure 3.2).  The transition transversion ratio was estimated to be 7.61 (the 
alpha parameter governing the gamma distribution for rate heterogeneity was estimated 
as infinity).  All internal branches within the phylogeny were supported by high Bayesian 
posterior probabilities in excess of 96%.  Virus in different geographical areas evolved 
along separate lineages resulting in a large breadth of variation within the outbreak with 
197 nucleotide substitutions at 191 sites along the genome.  Thus six sites were 
identified to have been mutated twice, higher than that expected on the basis of a 
Poisson process with mean 197/8196 in which all sites were assumed to be equally 
mutable (in which an average of 2.2 sites would be expected to receive multiple hits). 
 
3.4.2 Fine-scale statistical parsimony analysis (TCS) 
Statistical parsimony analysis (Figure 3.3) revealed that virus isolated from the first 
infected premise (IP4) and the last (IP2027) differed by 44 silent (synonymous) and 8 
non-silent (non-synonymous) substitutions, and there were also 2 nucleotide deletions 
(one of 4 bases and one of 2 bases in the 5’UTR).  At a finer resolution, viruses from 
closely related farms differed by between 1 and 5 nucleotides.   Virus sequences 
obtained from 3 pigs sampled on the same day on a single premise (IP4), where disease 
had been present longer than on other farms, differed in consensus by 1-3 nucleotides. 
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Figure 3.2  
Maximum likelihood phylogenetic reconstruction of 23 virus sequences, named by the 
infected premises (IP) number from which they were taken.  The county where each IP was 
situated are indicated by brackets.  Bayesian posterior probabilities as indicated, were 
obtained from 500,000 generations sampling every 100th tree. 
 
3.4.3 Genomic distribution of nucleotide substitutions 
Twenty-eight substitution sites were identified within the non-coding regions at the 5 and 
3 prime end of the genome, and 163 substitution sites within the open reading frame.  Of 
these, 40 resulted in non-synonymous change, and 123 were synonymous, resulting in 
an overall non-synonymous to synonymous ratio (dN/dS, estimated per synonymous and 
non synonymous site) of 0.09.  The distribution of synonymous changes throughout the 
genome could not be distinguished from a uniform distribution (Figure 3.4) (KS test, 
D=0.0424, P>0.5).  Non-synonymous changes appeared more clustered (Figure 3.4),     83
 
Figure 3.3 
TCS analysis of 23 United Kingdom Pan Asia O FMDV sequences.  Statistical parsimony 
analysis of 23 sequences by TCS; each sequence is represented by the IP number from which 
it was isolated.  Each connecting branch line represents a nucleotide substitution, with each 
dot representing a putative ancestor virus.  Non-synonymous mutations are shown in 
boldface.  The arrow represents the introduction of virus into the United Kingdom via IP4, 
where replication occurred for ~2 weeks before clinical samples were collected.  IP4 was the 
source of virus for IP1, where the disease was first detected, and also for IP6, from where    84
virus was disseminated throughout the United Kin g d o m .   I P 2 0 2 7  i s  t h e  l a s t  I P  f r o m  t h e  
outbreak.  Grey shading indicates changes located within VP1. 
  
although the KS test (D = 0.1845, P>0.2) again did not distinguish their distribution from 
a uniform one.   Only a single amino acid position (position 42 in VP1) underwent two 
independent substitutions.  These were on two distinct geographical genetic lineages as 
a result of different nucleotide substitutions in adjacent sites: in Northumberland, this was 
a change from valine to alanine, and in Devon from valine to isoleucine.  Contrary to 
previous studies (Carrillo et al. 2005), VP1 was not found to be more variable than other 
parts of the genome, incurring less substitutions than other genes such as VP3 (Figure 
3.4). 
  
3.4.4 Pattern of dN/dS ratio throughout genome 
The observed dN/dS ratios (corrected per synonymous and non synonymous site) of 
each genomic region differed as shown in Figure 3.4 (ranging from as low as 0 for 2A, or 
0.1 for 2C to 1 for VP4).  However, fitting models assuming different dN/dS ratios for 
each genomic region (using partition analysis in HyPhy) did not significantly increase the 
likelihood of the model fit (chi-sq.= 7.724, d.f.=11, P=0.74) and the null hypothesis that all 
dN/dS ratios were equal could not be rejected on the basis of these data.  VP4 had the 
highest  dN/dS ratio overall, equal to 1, and thus there was no evidence of positive 
selection occurring at an amino acid level anywhere in the genome. 
 
3.4.5 Rate of nucleotide substitution over time 
Total nucleotide changes from the ancestor virus were shown to accrue linearly with 
time; synonymous changes accumulated faster than non-synonymous changes (Figure 
3.5).  A relaxed molecular clock for the rate of substitution of all nucleotide changes 
(estimated using BEAST was found to advance at a rate of 2.26×10
-5 per site per day 
(95% CI 1.75-2.80×10
-5).      85
 
This analysis also predicted that the most recent common ancestor to the viruses 
sequenced was present 12 days before recovery of the earliest FMDV sequenced in this 
study.  This would date the start of the outbreak to the 7
th February 2001 (95% CI Jan 
20
th – Feb 19
th) which is identical to estimates obtained on the basis of purely clinical 
evidence (Anderson 2002; Scudamore 2002).  Previous studies have suggested that 
there may have been 35 sequential IP-IP transmission events between IP4 and the final 
case (IP2027) (Haydon et al. 2003), suggesting that substitutions were fixed across the 
genome at an average rate of 1.5 nucleotide changes per IP transfer. 
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Figure 3.4 
Synonymous and non-synonymous mutations across the genome.  Shown is a graph of 
cumulative substitutions against nucleotide positions, depicting the rate of substitution for 
total (black), synonymous (grey), and non-synonymous (light grey) point mutations.  The rate 
of accumulation of silent changes throughout the genome is constant and faster than the 
rate of amino acid substitutions which also appears to vary more.  The dN/dS ratio for each 
genomic region is shown in the lower graph, but likelihood analyses provide no support for 
different dN/dS ratios for different genes. 
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Figure 3.5 
Accumulation of substitutions with respect to time. Shown is the accumulation of mutations 
(a measure of genetic distance) increasing linearly with time, compatible with a molecular 
clock.  ■, all substitutions; ◊, silent substitutions; Δ, non silent substitutions. 
 
3.4.6 Use of sequence data to trace transmission pathways 
The potential of genetic analysis to enable tracing of FMD transmission history within the 
outbreak was investigated.  A known chain of transmission events between four farms 
was studied where the routes of virus transmission had been established with confidence 
using contact tracing, and also a cluster of five farms for which the routes of transmission 
were uncertain.   
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Figure 3.6 
TCS analysis of two clusters of infected premises.  Statistical parsimony analysis of known 
and unknown virus transmission events.  Each connecting branch line represents a 
nucleotide substitution, with each dot representing a putative ancestor virus.  Black arrows 
indicate the transmission route determined by traditional contact tracing, grey arrows 
indicate the route supported by the genetic data.  The data show the close genetic 
relationship of IP1692 to IP1597 and IP1654, although epidemiological tracing suggested 
IP1692 was infected from a more distantly related source. 
 
The genetic data were consistent with the results of the conventional contact tracing for 
the known chain of transmissions where virus spread from IP4 to IP6 via an airborne 
route, and then via sheep movement from IP6 through markets to IP7, and subsequently 
to IP16 and IP38 via a lorry (Figure 3.6).  However, parsimony based analysis of a 
cluster of IP in County Durham, for which the transmission sequence was less certain, 
suggested that the ancestor virus of a certain farm differed from that suggested by 
previous tracing studies which had suggested that IP1692 was unrelated to IP 
1404,1448,1597,1654 (Figures 3.6, 3.2 and 3.3).  The genetic data indicated that IP1692 
was very closely related to the others, as shown in Figure 3.6, linking it to the other four 
in the cluster.    89
3.5 Discussion 
By studying virus from 21 premises, infected during the 2001 UK FMDV epidemic we 
have provided the first intra-epidemic analysis of FMDV by full genome sequencing.  This 
has demonstrated the potential of such studies to provide detailed and reliable 
descriptions of the sequence of transmission events at high spatial and temporal 
resolutions and provided useful insights into the mode and tempo of FMD viral micro-
evolution. 
 
Complete consensus sequences were clearly amplified with very few ambiguities found, 
indicating that this method was not affected by the proposed heterogeneous nature of 
virus populations.  Sequence was obtained directly from epithelium samples avoiding 
passaging virus through animals or cell culture.  The virus isolate from the abattoir in 
Essex (IP1) was compared to an isolate sequenced previously O UKG 35/2001 
(AJ539141) (Mason et al. 2003b) from the same abattoir.  O UKG 35/2001 had been 
passaged through 2 pigs prior to direct sequencing.  Notably the virus consensus 
sequence derived directly from epithelium of an animal from IP1 is very close to O UKG 
35/2001 differing only at the three ambiguous sites identified within this isolate.  It also 
differed from the remainder of the UK viruses sequenced at these same 3 sites, 
suggesting that it was an intermediate between the UK viruses and O UKG 35/2001. 
 
The genetic variation observed between viruses was mainly due to synonymous point 
substitutions, the majority of which were transitions.  These nucleotide changes were 
found to occur evenly across the whole genome (as indicated by the KS test).  These two 
factors suggest that the evolution of FMDV demonstrated to have occurred during the 
2001 UK outbreak may have arisen largely as a result of genetic drift subject to purifying 
selection.  Fixation of mutations could have occurred due to bottleneck events on 
transmission between animals or IP.  The study includes only 23 sequences sampled    90
over a short time scale, which has resulted in limited statistical power to discriminate 
differences in substitution rates and selection pressures between genes. 
 
The TCS statistical parsimony analysis showed clearly the genetic evolutionary history of 
the virus.  However, it could not definitively identify the geographic location or IP on 
which a nucleotide substitution had occurred.  This is because the exact time that virus 
was transmitted from a farm in relation to the time at which animals were culled and viral 
samples collected, is unknown.  During the 2001 UK outbreak there was strong pressure 
to cull animals as fast as possible following identification of infection but never-the-less 
there were lengthy delays between the time that some IP were estimated to have 
become infected and the time that samples could be collected from them.  When 
transmission from an IP occurs a long time prior to acquisition of viral samples it will 
remain uncertain on which IP substitutions occurred.  This is apparent in our data, for 
example we do not have the ‘real’ ancestor to the outbreak, as the farm on which the 
outbreak began was not identified as infected until up to 3 weeks after the virus is 
estimated to have been introduced into Britain (Figure 3.3).  This problem, along with the 
observation that virus recovered from closely-housed animals can differ by 1-3 
nucleotides and is likely to pass through a ‘bottle neck’ on passage between farms, 
suggest that if this tool is to be used in future outbreaks a greater number of samples 
taken from each and every farm may improve the resolution of this method. 
 
Virus samples were sequenced from pigs, cattle and sheep.  Although no evidence was 
found of the effect of host tropism within these genetic data, such an effect cannot be 
confidently excluded using these data alone.  The route by which each individual animal 
was infected is unknown. For example the virus could have been circulating in sheep 
before being subsequently identified and sequenced from a cow, which would complicate 
the results. 
    91
Nucleotide change conformed to a relaxed molecular clock corresponding to 0.00825 
substitutions/site/year, thus 0.9% of the genome is predicted to change per annum.   
Additional analyses conducted assuming various strict molecular clocks, and alternate 
demographic models fitted the data with only slightly reduced average posterior 
likelihoods and produced results that were very similar.  These models are suggestive of 
a constant rate of viral replication and transmission during the outbreak.  Independent 
genetic determination of the timing of the first case of the outbreak, matched previous 
estimates based on clinical evidence.  Such a tool for detecting the timing of an initial 
case in an outbreak could, in principle, prove very useful in identifying how virus is 
introduced into the country.  The results reported here were consistent with other studies; 
for example those of serotype ‘O’ virus in Taiwan which found a divergence of 0.2-0.9% 
between VP1 genes sequenced over a two months period (Tsai et al. 2000), serotype 
SAT-2 which was found to change at a rate of 0.009 substitutions/nucleotide/year 
(Bastos et al. 2003), and serotype ‘C1’ which changed at an estimated rate of 0.0004-
0.045 substitutions/nucleotide/year (Sobrino et al. 1986).  They also correspond closely 
to rates measured over longer time periods with the ‘O’ serotype of the virus seen to 
change at a rate of 1.43% per year in the Philippines, and at 0.43% per year in Turkey 
for example (Haydon et al. 2001).   
 
It is well established that detailed high-resolution transmission histories can be 
reconstructed for some RNA viruses.  Transmission events have been reconstructed 
between individuals infected by viruses with long infectious periods using sequence data, 
for example for HIV virus (Leitner & Albert 1999; Zhang et al. 1997), and Hepatitis C 
virus (Spada et al. 2004).  In the recent outbreak of SARS, human to human tracing was 
investigated using virus genetic sequencing (Liu et al. 2005a; Wong et al. 2004).  Broad 
resolution of rabies (Bernardi et al. 2005; Kobayashi et al. 2005; Susetya et al. 2003) and 
rhinovirus (Savolainen et al. 2002) transmission networks have also been studied using 
genetic sequencing.  Using full genome sequences enables tracing of transmission    92
histories of the virus at high resolution (between farms), reliably and with confidence.  
The capacity to conduct animal disease tracing using genetic data is of considerable 
value, particularly considering the difficulties of identifying transmission pathways by 
other means.  Much of FMDV transmission between farms is poorly understood and the 
results of this study demonstrate the potential of this methodology to help in unravelling 
the transmission routes utilised by the virus.  Unknown transmission histories were 
resolved as illustrated by the investigation of the cluster from County Durham.  However, 
less detailed yet informative analyses were also possible.  For example, there was 
uncertainty over the relationship between Northumberland cases that arose in April and 
those that arose mid-August during the epidemic.  Ineffective decontamination and 
cleaning of formerly infected IP could have led to propagation of subsequent outbreaks.  
However, the late Northumberland cases (IP 1970, 1976, 2027) were shown to be only 
distantly related to the early Northumberland case at IP1070 (Figure 3.3) and actually 
originated from Cumbria.   
 
This study shows that complete genome sequencing can be used to resolve inter-farm 
transmission, and as shown previously (Christensen et al. 2005) VP1 sequences alone 
are unlikely to contain sufficient genetic information to enable reconstruction of 
transmission pathways at the highest levels of resolution.  Between the first and the last 
IP there were estimated to be 35 inter-farm transmissions during which there were 52 
nucleotide changes (i.e. 1.486 substitutions/inter-farm transmission), but only 13 of these 
substitutions fell within the capsid genes (0.371 substitutions/inter-farm transmission), 
and only 5 in VP1 (0.143 substitutions/inter-farm transmission). Hence only full genome 
sequences have the capacity to detect more than one nucleotide change per farm 
transfer.  However, with the advance of high-speed sequencing technology, full genome 
sequencing has the potential to be used in real time during future epidemics to further 
inform control policy. 
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4.1 Summary 
Estimating detailed transmission trees that reflect the relationships between infected 
individuals or populations during a disease outbreak often provides valuable insights into 
both the nature of disease transmission and the overall dynamics of the underlying 
epidemiological process.  These trees may be based on epidemiological data that relate 
to the timing of infection and infectiousness; or genetic data, that show the genetic 
relatedness of pathogens isolated from infected individuals.  Genetic data is becoming 
increasingly important in the estimation of transmission trees of viral pathogens due to 
their inherently high mutation rate.  Here we propose a maximum likelihood approach 
that allows epidemiological and genetic data to be combined within the same analysis to 
infer likely transmission trees.  We apply this approach to data from 20 farms infected 
during the UK 2001 foot-and-mouth disease outbreak, using complete viral genome 
sequences from each infected farm, and information on when farms were first estimated 
to have developed clinical disease, and when livestock on these farms were culled.   
Incorporating known infection links due to animal movement prior to imposition of the 
national movement ban results in reduction of the number of trees from 41,472 that are 
consistent with the genetic data, to 1,728, of which 4 represent 95% of the total likelihood 
calculated using a model that accounts for the epidemiological data.  These trees differ in 
several ways from those constructed prior to the availability of genetic data.    95
4.2 Introduction 
Genetic data from RNA viruses have been used increasingly for tracing disease 
transmission pathways, taking advantage of their inherent capacity to evolve quickly.   
Such studies have been carried out with viruses such as HIV (Leitner & Albert 1999; 
Zhang et al. 1997), Hepatitis C virus (Bracho et al. 2005; Spada et al. 2004), SARS 
coronavirus (Liu et al. 2005a; Wong et al. 2004), Ebolavirus (Walsh et al. 2005), 
Rhinovirus (Savolainen et al. 2002) and Noro-viruses (Dowell et al. 1995).  These 
genetic data can be used to complement field epidemiological studies that utilise 
traditional contact tracing information and the relative timing and spatial proximity of 
infection events to each other.   
 
Analysis of the overlapping periods within which individuals or groups are infected and/or 
infectious can help to decide the most likely direction of transmission, while genetic 
pathogen data can identify which infected individuals or groups are most closely 
epidemiologically linked.  Although there may be numerous combinations of transmission 
pathways that are consistent with the genetic data or epidemiological data alone, an 
analysis combining both types of data can lead to identification of a much smaller set of 
plausible transmission pathways.  Analytical methods to integrate these two types of data 
sets are beginning to be developed (Wallace et al. 2007), but the increasing speed and 
economy with which viral genetic data can be generated during epidemics requires the 
development of wider range of approaches if full advantage of these data sources is to 
be taken in improving the tracing of transmission pathways. 
 
Recently, it was shown that Foot-and-mouth disease virus (FMDV) transmission can be 
traced from farm-to-farm using complete genome sequencing (Cottam et al. 2006).   
Viruses were sequenced from farms infected at the beginning of the 2001 UK FMDV 
outbreak and the genetic data were shown to be consistent with the transmission    96
pathways established from contact tracing studies.  However for the remainder of the 
outbreak, and following the national ban on animal movement (NMB), the spread of virus 
is much less well understood, with infection assumed to be transmitted either by airborne 
spread or by mechanical transfer on people or inanimate objects (fomites).  Indeed, the 
precise source and route of infection for the vast majority of the 2030 premises infected 
during the UK 2001 epidemic remain unknown.  
 
During the epidemic, substantial amounts of epidemiological data were recorded for the 
farms involved.  Although the contact tracing data are difficult to use to pinpoint the 
precise origin of infection with high confidence, the information concerning the timing of 
infection is clearer.  For every farm involved, the time at which clinical disease began on 
a farm (estimated from lesion ageing) and the date on which animals were culled was 
recorded.  This information can be used to estimate the most likely date on which a farm 
was infected and, combined with data on when herds were slaughtered, gives the most 
likely period over which a farm would have been infectious.  These temporal data have 
been used previously to estimate sequences of transmission events (Haydon et al. 
2003), referred to henceforth as transmission trees.  While many of the overall 
characteristics of these transmission trees (for example estimates of the average number 
of susceptible farms infected by an infectious farm) are robust to variations in their 
precise structure, the very large numbers of different transmission trees that are 
consistent with these temporal data render them mostly unhelpful with respect to 
identifying particular transmission events with confidence.  
 
An integrated analysis, combining both data on the timing of infection and genetic 
sequence data from each infected farm should improve the resolution and confidence 
with which virus transmission routes can be identified.  It may also highlight anomalous 
epidemiological information, indicative of unidentified intermediate infected premises 
missing from chains of transmission.    97
 
This study focuses on a set of farms in County Durham that were infected early in the 
2001 UK FMDV epidemic.  For each of the premises included in the study we used data 
on the timing of infection and animal culling to establish distributions describing likely 
infection dates and infectious periods, together with complete genomes sequences 
acquired from viruses sampled from these infected premises that provided information on 
their relative relatedness.  We have then combined the inferences from these two types 
of data to determine statistically a set of most likely transmission trees, which we show to 
be a much smaller set than obtained through analysis of either data type alone.  The 
increasing use of genetic data for forensic epidemiological purposes will require the 
integration of genetic and epidemiological data, and this study proposes an initial 
approach to this problem.    98
4.3 Methods 
4.3.1 Infected premises included in study 
The fifteen infected premises in the Durham area (established to be FMDV positive 
through laboratory testing) included in this study were identified from Defra’s Animal 
Health and Welfare FMD Data Archive (http://footandmouth.csl.gov.uk/) which also 
provided epidemiological data (including lesion age and date of cull).  The relative 
locations of these premises are shown in Figure 4.1.  There had been no recorded 
movements of animals between any of the infected premises, the movements of FMD 
susceptible livestock having been prohibited throughout Great Britain since 23 February 
2001.  The details of the clinical samples included in this study are described in Table 
4.1, including source animal, farm type, and details of livestock holdings.  For farm D, the 
epithelium was cut in half, and both halves sequenced independently to investigate the 
repeatability of the amplification and sequencing method used.   
 
4.3.2 Complete genome sequencing of foot-and-mouth disease viruses 
The full genome sequence of the viruses recovered from 4 of the infected premises (F, 
G, I, J) in this cluster had been determined previously together with 7 genomes from 5 
other infected premises from the start of the outbreak included in this study (1-5) 
(DQ404172, DQ404173, DQ404175-DQ404180, DQ404165, DQ404166, DQ404167, 
DQ404169, DQ404170) (Cottam et al. 2006).  Eleven more viral genomes were 
sequenced for this study following the method described previously (Cottam et al. 2006) 
(EF552688-EF552697, and EU214601, Table 4.1).  Briefly, a virus suspension was 
made from original epithelium material, RNA was extracted using TRIzol reagent 
(Invitrogen), the RNA was reverse transcribed using Superscript III Reverse 
Transcriptase (Invitrogen), and the cDNA was cleaned up using GFX PCR DNA and gel 
band purification kit (Amersham Biosciences).  Five overlapping PCR products were    99
obtained spanning the whole genome, cleaned up using the GFX PCR DNA and gel 
band purification kit (Amersham Biosciences), and sequenced using the Beckman 
CEQ8000 Coulter system. The raw data files were assembled into a contig and edited 
using SeqMan (DNAStar), and all further sequence manipulation was performed using 
Bioedit and DnaSP freeware.  The genealogical relationships were based on statistical 
parsimony as implemented in the software package TCS (Clement et al. 2000).  The tree 
was rooted to the closest FMDV strain SAR/19/2000 (Mason et al. 2003b). 
 
 
4.3.3 Enumeration of transmission trees consistent with the sequence data 
Rooting the sequence genealogy with SAR/19/2000 indicated the general direction of the 
transmission events (away from the node between farms 1 and 2).  We took into account 
the known transmission history between farms 1 to 5 and restricted the tree 
configurations to those that included these 4 transmission events as a fixed link.   Prior to 
the movement ban, infected animals could be transferred between farms and we allowed 
for the possibility of virus transmission without mutation. After the movement ban, farm-
to-farm transmission likely required more infection cycles and, given the rate of molecular 
evolution of FMDV, the possibility of farm-to-farm transfer without mutation was 
considered to be negligible. Using the most parsimonious genealogy constructed by 
TCS, a list of plausible farms on which each putative virus haplotype could have been 
located was constructed, assuming no back-mutation and only a single lineage present 
on each farm.  When this list included more than one farm, all transmission trees 
consistent with this ambiguity were counted.  So, for example, haplotypes preceding 
(‘upstream of’) the most recent common ancestor of two farms could have arisen on 
either farm, whereas haplotypes proceeding (‘downstream of’) this common ancestor can 
(under reasonable assumptions) be assigned to either one farm or the other.  The 
likelihood of each tree was estimated based on the available epidemiological data as 
described below.    100
Table 4.1  Farm and animal source details for each of the 22 FMDV consensus genomes 
included  
 
 
*Animals described by one letter coding; P Pig, S Sheep, C Cattle, DC Dairy cattle, BC Beef 
cattle. 
†Virus genomic sequences published previously 
   
Virus 
Sample 
Accession 
no. 
Animal
* 
Date of 
report 
Date of cull 
Oldest 
Lesion 
age 
(days) 
No. and type of 
susceptible 
animals present 
on farm* 
No. and type of 
infected animals 
reported* 
1a† DQ404179  P  24/02/2001 25/02/2001  10  571P 400P 
1b† DQ404178  P  24/02/2001 25/02/2001  10  571P 400P 
1c† DQ404177  P  24/02/2001 25/02/2001  10  571P 400P 
2† DQ404176 C 25/02/2001 25/02/2001  7
 
101BC, 366S  51BC 
3† DQ404175 C 24/02/2001 27/02/2001  4
 
600BC, 1500S  50BC, 17S 
4† DQ404173 C 26/02/2001 28/02/2001  3  558S 6S 
5† DQ404172 C 01/03/2001 03/03/2001  2  450BC 1BC 
A EF552688  S  31/03/2001 02/04/2001  2  167DC, 1600S  3S 
B EF552689 S  02/04/2001 03/04/2001  2  113BC, 130S  130S 
C EF552690 C  20/04/2001 20/04/2001  3  8BC, 400S  3BC 
D EF552691 C  11/05/2001 11/05/2001  1  188DC 2DC 
E EF552692  S  22/04/2001 24/04/2001  7  110BC, 152S  3S 
F† DQ404170 S 23/04/2001 24/04/2001  4  234BC, 340S  17S 
G† DQ404167 S 14/05/2001 14/05/2001  4  5BC, 672S, 2P  35S 
I† DQ404166 C 28/05/2001  28/05/2001 3  186BC, 3909S, 
27P 
2BC, 1S 
J† DQ404165 C 03/06/2001 04/06/2001  2  456DC 2DC 
K EF552693 C  01/04/2001 04/04/2001  1  215BC, 383S  1BC 
L EF552694  C  10/04/2001 10/04/2001  2  107BC, 124S  1BC 
M EF552695 S 17/05/2001 18/05/2001  5  46BC, 188S  14S 
N EF552696 C  12/04/2001 14/04/2001  1  6BC 1BC 
O EF552697 S  15/04/2001  15/04/2001 2  39DC, 47BC, 
197S 
3S 
P EU214601 S  30/04/2001 01/05/2001  4  88BC, 176S  3S    101
4.3.4 Epidemiological data 
The first part of the analysis required estimating a distribution describing the likelihood 
that an individual farm was infected on a particular date, and a distribution describing the 
likelihood that a farm was a source of infection on a particular date  (this has been 
described previously as the temporal risk window; (Taylor et al. 2004; Thrusfield et al. 
2005)).  This analysis required two functions: Ii(t), describing the probability that the ith 
farm was first infected at time t; and L(k), the probability that the first infected individual 
on a given farm incubates virus for k days prior to becoming infectious (and here we 
assume this function to apply to all infected farms).  From these two functions it is 
possible to estimate a further function, Fi(t), describing the probability that the ith farm is 
a source of infection at time t. 
 
The mean incubation period was chosen to be 5 days in common with other studies of 
the UK 2001 outbreak (Keeling et al. 2001), and the distribution of incubation periods, 
L(k), was assumed to follow a discrete form of the gamma-distribution with scale and 
shape parameters of 3.00 and 1.67 respectively (this results in a 95% probability of 
incubation periods between 2 and 12 days, in accord with previous estimates (Gibbens & 
Wilesmith 2002).  Farms were assumed to be a source of infection immediately after the 
incubation period and uninfectious once culled.  This assumption is justified by the 
imposition of intense farm biosecurity, cleansing and disinfection following livestock 
culling.   
 
The most likely date of infection for each farm was estimated to be the date on which 
disease was reported to be present on the farm less the number of days of the oldest 
lesion on the farm less five days for virus incubation.  We represented the uncertainty 
around the most likely date of infection arising from (unknown) error in the lesion dating, 
and possible variation in the incubation period by Ii(t), a discrete form of a beta 
distribution. Three pieces of information were used to inform the shape of Ii(t): the    102
estimated most likely date of infection of farm i - which determined the mode of Ii(t), the 
most likely infection date of the primary case (which determined the earliest possible 
infection time) and the reporting date of the ith farm (less two days to allow for a 
minimum incubation period), which determined the very latest possible infection time.   
 
Fi(t), the probability that the ith farm is infectious at time t was then calculated from Ii(t) 
and L(k) as follows: 
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where Ci was the time at which the ith farm was culled (time in this study is measured in 
days since 26
th January 2001).  This expression sums over the probability of farm i 
becoming infected on day j, and completing the incubation period in no more than t-j 
days.  Now it is possible to calculate the likelihood that farm j infected farm i, assuming 
that farms cannot be multiply infected and that there are only n possible sources of 
infection:   
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This equation sums the product of the likelihoods that farm i was infected, and farm j 
infectious over all possible days that transmission to i could have occurred. The 
denominator is required to ensure the λij sum to 1.  These λij can be calculated for all 
possible pairs of farms, and used to compute the overall log-likelihood of any single 
transmission tree.  We proceeded by computing the likelihoods of all transmission trees 
consistent with the sequence data and to identify which of these trees was the most likely 
based on the epidemiological data. A subset of trees comprising the top 95% of the    103
distribution of tree likelihoods was identified.  For each transmission link in each tree in 
this top 95% we also computed the ratio of the likelihood of the tree to the likelihood of 
the tree that included the next most likely alternative source of infection for the link.  This 
ratio reflects the confidence in the inferred source of infection relative to other possible 
sources. 
 
4.3.5 Rate of nucleotide substitutions per nucleotide per day 
A molecular clock was fitted to the virus sequence data from farms A-P using Markov 
Chain Monte Carlo techniques implemented in the software package BEAST (Bayesian 
evolutionary analysis sampling trees) (Drummond et al. 2002).  A relaxed clock was fitted 
with exponentially distributed rates and exponentially increasing population size with the 
HKY model of base substitution (Hasegawa et al. 1985) with rate heterogeneity 
assumed. 
 
4.3.6 Number of nucleotide substitutions detectable between consecutive 
farm infections 
The distribution of the number of nucleotide substitutions detected between consecutive 
farm infections was estimated using the most likely transmission tree determined as 
described above.  The most recent common ancestor of viral genotypes sampled from 
the source and recipient of infection was assumed to have been present on the source 
farm.  Hence, the number of nucleotide substitutions per farm transfer was estimated as 
the number of nucleotide substitutions that arose between this common ancestor and the 
virus sampled on the recipient farm.  We included 17 of the 19 transmission events 
comprising the most likely transmission tree in the analysis (the two transmission events 
of virus to farms A and K were excluded from the distribution as it is very likely that they 
were infected from farms outside of the study area).   
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Figure 4.1 
Map showing the spatial relationship of 15 infected premises confirmed by laboratory testing 
(filled circles) and 12 infected premises (determined by clinical observations) that were 
subsequently found to be negative for virus by laboratory testing (open circles).  A-P indicate 
the infected premises from which virus has been sequenced.  The direction of most likely 
transmission events as determined by this study are shown by the grey arrows.  Scale 
indicated in kilometres. 
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4.4  Results 
4.4.1  Complete genome sequencing of virus isolates and genetic 
transmission tracing   
Epidemiological data from 20 infected premises were included in this study.  For five of 
these infected premises the transmission tree was determined previously by tracing of 
direct animal movements (farms 1-5), for the other 15 the transmission routes were 
unknown (A-P).  The 11 new sequences (A, B, C, D, E, K, L, M, N, O, and P) were 
between 8193 and 8195 nt in length with no ambiguous nucleotides, determined with an 
average of 4.8 times coverage of each nucleotide.  Between all 15 sequences (A-P) 
there were 85 variant nucleotides, of which 24 resulted in non-synonymous changes.  
Five of the 85 variant nucleotides occurred within the VP1 capsid gene.  The epithelium 
sample from farm D (which was sequenced twice independently) yielded identical 
sequences.  A statistical parsimony tree depicting the genetic relationship between the 
viruses sequenced was generated for the 23 sequences, rooted using the genome 
sequence of the closest previously sequenced virus (from South Africa) as shown in 
Figure 4.2.   
    106
 
Figure 4.2  
Statistical parsimony analysis of 22 United Kingdom Pan Asia O FMDV complete genome 
sequences rooted to the closest relative SAR/19/2000 by TCS; each connecting branch line 
represents a nucleotide substitution, with each dot representing a putative ancestral virus 
haplotype (filled dots indicate sequenced haplotypes).  The farms infected through movement 
of infected livestock are represented by the numbers 1-5 (representing Defra infected 
premises numbers 4,6,7,16 and 38 respectively), and those from a cluster in Durham are 
represented by the letters A-P.  Day zero corresponds to the 26th January 2001. 
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Figure 4.3 
Temporal infection profiles of 20 farms infected with FMDV in 2001.  Black lines indicate the 
likelihood of infection on any particular day, Ii(t); and grey lines the likelihood that a farm was 
infectious on a particular date, Fi(t), prior to culling. 
 
4.4.2  Temporal infection profiles of infected premises and transmission 
tracing 
For each farm the distributions of likely date of infection and the most likely period of 
infectiousness were calculated and are shown in Figure 4.3.  The overlaps of infection 
and infectious periods can be clearly noted, providing a low-resolution impression of 
possible transmission pathways, together with some obvious breaks in the chain of    108
transmission suggesting the presence of additional infected farms or inaccuracies in the 
estimates of time of infection.   
 
 
 
Figure 4.4 
Most likely transmission trees for the sequenced farms. (a) Cumulative likelihood distribution 
of the transmission trees, where the four most likely trees comprise more than 95% of the 
sum of all tree likelihoods (arrow: the most likely tree). (b) Most likely tree, with for each farm 
the number of different sources of infection among the top 95% set of trees (in parentheses), 
and λij, the likelihood that the recipient farm was infected by the indicated source farm (in 
square brackets). The legend indicates the likelihood ratio between the most likely tree and 
the next most likely tree with a different source farm for a given infected farm, when the 
source of infection is not assumed. 
 
4.4.3  Likelihood analysis of integrated epidemiological and genetic data 
sets 
With no knowledge of any transmission routes the number of alternative trees consistent 
with the genetic data is 41,472.  This number reduces to 1,728 if the known transmission 
links between farms 1-5 are fixed.  Four of these 1,728 trees account for 95% of the 
likelihood (see Figure 4.4a). For each farm, a maximum of 3 alternative sources of 
infection can be identified among these 4 most likely trees, but the most likely source of 
infection is always at least 80 times more likely than any other source (except for Farms 
A  for which farm 3 is the alternative source and K for which farms 1 and 2 are alternative 
sources, Figure 4.4b).  
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4.4.4 Rate of nucleotide substitutions per nucleotide per day 
A relaxed molecular clock for the rate of substitution of all nucleotide changes from farms 
A-P was estimated to be 2.76 x 10
-5/site/day (95% CIs 1.00 x 10
-5 to 4.37 x 10
-5). 
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Figure 4.5 
Distribution of the number of variant nucleotides between viruses recovered from 
consecutively infected farms). Those that represent transmissions that occurred before the 
NMB are shown in black.  The number of variant nucleotides was determined from the 
common ancestor of source and daughter farm, as described in material and methods, using 
the transmission events shown in Figure 4.4b.  The distribution has a mean of 4.3, SD=2.1. 
 
 
4.4.5 Number of nucleotide changes upon farm-to-farm transfer 
The distribution of the number of nucleotide changes per farm transfer is shown in Figure 
4.5.  The distribution has a mean of 4.3 nucleotide substitutions, with a standard 
deviation of 2.1.  If this distribution is partitioned into transmission events pre and 
proceeding the NMB then the mean number of substitutions per transmission link    110
proceeding the NMB (farms A-P) is 4.85 and is significantly higher than that preceding 
the NMB, represented by farms 1-5, of 2.5 substitutions (t test; t=2.19, P=0.045).     111
4.5 Discussion 
The method described in this study makes a preliminary attempt at integrating 
information from genetic data with the relative timing of infection events to compute the 
most likely transmission tree that reflects the spread of infection between farms. The 
study has demonstrated the power of forensic genetic tracing for FMDV, and highlights 
the future challenges in analyses of this sort.   
 
Using only the known transmission events relating farms 1-5, 1,728 possible 
transmission trees remain consistent with the rooted parsimony tree identified using the 
genetic data.  This is because while it is possible to identify viruses that share a common 
ancestor, it is often not possible to identify the farm on which the ancestors were present, 
and therefore the exact direction of transmission events.  However, the difficulties in 
interpreting the genetic data can be overcome in part by the addition of epidemiological 
data: here, the most likely time of infection and infectiousness of a farm, which enables 
the likelihood of particular transmission events to be estimated.  This integration of 
information from the two data sets enables identification of the most likely trees at a 
resolution far greater than is possible using either data set alone.   
 
In this study we have generated complete genome sequences from all infected farms 
from a geographic area of approximately 100 km
2 found to be FMDV positive by 
laboratory analysis.  Interpretation of the results is complicated because both the 
epidemiological timing data and the genetic data suggest that there may have been more 
than a single disease introduction event in this area. 
 
Our analysis indicates particularly low probabilities of infection between some pairs of 
infected farms linked in the most likely transmission tree (see Figure 4.4b).  These links 
include those between farms 3 to A, 4 to K, O to M, K to F, and F to G.  In some cases    112
we suspect that additional intermediary infectious farms must exist that are either: 1) 
outside of the geographic area of our study, or 2) located within the study area but from 
which infected tissue samples were not collected (within the study area there were 108 
farms identified as ‘dangerous contacts’ or ‘contiguous premises’ and on which livestock 
were culled prior to the 28
th May, but even if these farms were infected, they may not 
have been very infectious).  Based on the epidemiological activity to the north of our 
study area throughout March, we believe the former may be a reasonable explanation for 
how farms A and K became infected.   
 
Explanations for the source of infections to farms M, F and G are more problematic as 
there are almost no alternative plausible local sources of infection.  Furthermore, the 
possibility of airborne (and potentially longer-range) spread occurring between farms C, 
E, F, G, I, and J was considered improbable on the basis of wind strength and direction 
in relation to potential sources of infection, and is not thought to have played a role in 
dissemination of virus to these premises.  This forces us to question the accuracy of the 
data relating to timing of infection.  Lesion dating is imperfect with an unknown amount of 
error associated with it. However, the dominant source of error associated with using 
lesions to estimate the date of infection is that the oldest lesions may be overlooked 
entirely (and it is for these reasons that the function describing the likelihood that a farm 
was infected on a particular day, Ii(t), was only minimally constrained).  This is 
particularly likely on farms with livestock that include sheep where the clinical symptoms 
of disease are often mild.  Farms M, F, and G all maintained substantial sheep herds in 
which disease was eventually confirmed (Table 4.1) and it is possible that infection was 
present on these farms considerably earlier than estimated, but went unreported. 
 
From the data generated during this study we can estimate the distribution of the number 
of nucleotide changes that arose between consensus sequences recovered from source 
and recipient infected farms. When this number is unusually large it suggests that virus    113
has been replicating in some other livestock population, either on unidentified 
intermediate farms, or on the recipient farm but in a population in which disease had 
previously been overlooked.  For example, the large number of changes observed on 
farm A (more than double the average expected for a single farm-farm transmission 
event) is suggestive of such an intermediate.  It is important to recognize that the number 
of changes detectable between consecutively infected farms will likely depend on the 
mode of infection.  In this study, the number of nucleotide substitutions per infection 
generation interval is lower prior to the imposition of the national movement ban, 
compared to after, probably because there are less viral replication cycles associated 
with infections arising as a result of movement of infected animals, compared to fomite 
associated transmission.  Data of this sort could be used in future investigations to infer 
the presence of undetected sources of infection, or to determine the most likely number 
of infected premises in a transmission chain.  However, for this to be feasible it is 
important that this distribution is characterized in more detail.  
 
The most likely transmission tree shown in Figure 4.4b raises some interesting points 
relating to this particular case study.  This tree differs from the original contact tracing 
tree proposed by Defra (which is inconsistent with the genetic data). First, the separate 
lineage of infected premises represented by A and N is anomalous, and when compared 
to the remainder of the sequences available from the 2001 UK outbreak (Cottam et al. 
2006), represents transmission of the virus directly into the area from the source of the 
outbreak, and not via Longtown and Hexham markets (as is thought to be the case for all 
other infected premises throughout the UK (Gibbens et al. 2001)).  This finding suggests 
further study of the outbreak is necessary to determine the origins of this previously 
unidentified chain of transmission events.   
 
The rate of nucleotide substitution noted in this study for virus from farms A-P over this 
short time period is 2.76 x 10
-5 (95% CIs 1.00 x 10
-5  to 4.37 x 10
-5) which is very close to    114
that estimated previously (2.26 x 10
-5, 95% CIs 1.75 x 10
-5  to 2.80 x 10
-5) for the whole of 
the UK 2001 outbreak (Cottam et al. 2006).  In principle, it would be possible to evaluate 
the likelihood of the transmission trees based on the genetic data, after the imposition of 
a molecular clock.  However, until more is known about the extent of nucleotide variation 
from single animals, herds, and different types of livestock on a single farm, we are 
inclined to view a more detailed and complex quantitative analysis of ‘one-genotype per 
farm’ data with some caution. 
 
Here we have presented a simple method by which the transmission tree-space is 
qualitatively restricted through the use of the genetic data, and the likelihood of trees 
remaining in this space quantitatively evaluated by the use of epidemiological data.  This 
likelihood, estimated from the epidemiological data could be made more sophisticated by 
accounting for the mode of transmission (for example incorporating information about the 
possible movement of animals between farms), or the livestock composition on particular 
farms (for example, pigs are generally regarded as more infectious than cattle or sheep, 
whereas cattle are more susceptible than sheep or pigs (Alexandersen et al. 2003b; 
Alexandersen et al. 2003c; Alexandersen et al. 2002)).  Farm infectiousness is not 
explicitly quantified in this analysis.  While infectiousness is unlikely to remain constant 
over the course of an infection, available data do not enable a parameterization of 
possible change (Savill et al. 2007). Here we have simply assumed that the probability a 
farm was a source of infection varies over time in a way dictated by the timing of 
infection.  It is plausible that susceptibility varies between farms, and if this were 
quantified it could also be incorporated into future models.   
 
Ultimately, the analysis of these sorts of data will be best conducted by development of a 
single likelihood model that accounts for both the evolutionary and epidemiological 
dynamics at the various different scales at which they occur.  Developing models that    115
integrate different data types in this way will be a difficult but exciting future research 
challenge. 
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Chapter 5  
 
Analysis of Foot-and-mouth disease 
virus nucleotide sequence variation 
within naturally infected epithelium    117
5.1 Summary 
The frequency of mutants within a virus population will affect the rate at which mutations 
are fixed in virus populations.  Successful replication and the ability to escape from host 
immune responses are likely to shape the frequency and distribution of mutants within a 
population.  Additionally, the mutant frequency and distribution could differ depending on 
the host animal, and size and age of the virus population.  In this study, genetic variation 
within Foot-and-mouth disease virus (FMDV) populations in lesions from naturally 
infected animals was investigated, through the analysis of 41 complete capsid 
sequences.  Comparisons were made between virus sequences obtained from a 3 day 
old cow lesion and a 1 day old sheep lesion; investigating evolutionary rates, mutation 
type, frequency and distribution.  The overall mutant frequency in this study was 3.06 x 
10
-4 mutations per nucleotide sequenced.  The virus sequences obtained from the cow 
lesion had a high dN/dS ratio of 1.228, whereas the virus sequences from the sheep 
lesion had a lower dN/dS ratio of 0.187.  Changes at important neutralising antigenic 
sites were found within the virus sequences from the cow lesion.  Also, an example was 
found of previously dominant sequences being present as a minor population.  The effect 
of two reverse transcriptase enzymes on the mutant frequency and distribution observed 
was compared, with no significant difference found between the two sequence sets.  This 
is the first investigation of genetic variation within a single virus population from a 
naturally infected host, and the findings encourage further research in this area.    118
5.2 Introduction 
Genetic variability of FMDV populations within an animal have yet to be determined, 
although current reports of the mutation rate of the virus suggest it should be high 
(Carrillo et al. 1998; Domingo et al. 2001; Haydon et al. 2001).  The genetic composition 
of  in vitro cell culture populations has been extensively studied for serotype C 
(Airaksinen et al. 2003; Arias et al. 2001; Pariente et al. 2001; Sierra et al. 2000) and 
once for serotype O (Gu et al. 2006).  However, it is not known how well these studies 
represent what occurs within an infected animal where the virus could be subject to 
different selection pressures and constraints. 
 
In Chapters 3 and 4, it was suggested that nucleotide changes become fixed within the 
virus consensus sequence due to the transmission of the virus through ‘bottlenecks’ 
leading to a founder effect in the new population.  If this is true, then the mutant diversity 
that surrounds the consensus would be a determinant of the rate and manner in which 
the virus consensus sequence evolves.  Thus, it is imperative to study the extent and 
characteristics of the sequence diversity surrounding the consensus sequence, in order 
to further our understanding of the genetic evolution of the virus in the field. 
 
The most widely used method to investigate genetic variation within a virus population is 
molecular cloning of PCR products and nucleotide sequencing of clones produced by 
E.coli from the PCR fragments.  Although this method is sensitive to artificial mutations 
introduced by the various amplification enzymes, when high fidelity enzymes are used it 
can provide an estimate of the upper limit of genetic sequence variability within a sample.  
This method has been compared previously to ‘biological’ cloning, which involves 
plaquing of individual viruses and sequencing of plaques, and was found to give 
statistically indistinguishable results (Arias et al. 2001).   
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Previous studies have investigated virus variation within a host for several different RNA 
viruses, demonstrating that the extent and character of the swarm of genetically variant 
viruses within a population is often highly variable between hosts, and at different 
disease stages within the same hosts, and can also directly correlate with specific virus 
pathogenicity.  For example, a study of Hepatitis C virus (HCV) noted that an increase in 
the genetic diversity within a virus population was associated with progressive hepatitis 
(Farci et al. 2000).  Another study of HCV suggested that genetic bottlenecking and 
hence a reduction in virus intra-population diversity may have assisted patient recovery 
and resistance to the persistent state that the virus can cause (Quer et al. 2005).  Also, in 
studying HCV, it was found that the pattern of within host evolution could differ between 
hosts, and that non-synonymous variation could depend on the stage of infection 
(Alfonso et al. 2005).  The importance of bottleneck events and selection and hence 
evolution within hosts of a virus population was again emphasised in a combined study 
of HCV and HIV (Poon et al. 2007), which found that circulating virus is shaped by the 
transmission rate and the immune diversity of the population.  The extent to which a 
bottleneck can affect virus diversity during HIV-1 transmission was shown in a 99% 
depletion in diversity estimated using coalescent theory (Edwards et al. 2006), which has 
important implications for virus diversity and evolution.  Such extreme bottlenecking 
would require close to all virus variants to be fully viable within a population, and also 
from a diverse population will encourage the fixation of mutation and hence virus 
evolution.  Another virus for which intra-host genetic variation of the virus population has 
been studied is West Nile Virus, which is transmitted by a mosquito vector.  It was found 
that the virus showed different levels of diversity within either the vector or the main 
animal host, and that an increase in diversity could lead to a decrease in pathogenicity 
(Jerzak et al. 2007).  This phenomenon of differences between viruses and between host 
environments affecting viral diversity has also been shown to be true of plant viruses 
(Schneider & Roossinck 2000; Schneider & Roossinck 2001). 
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The majority of the above studies have investigated viruses with long infectious periods 
and the relevance to FMDV, which causes an acute disease over a short infection 
period, is not known.  However, studies on Poliovirus have shown that a variation in the 
fidelity of the virus polymerase, and hence a change in genetic diversity of the resulting 
population, can have a profound affect on the pathogenicity of the virus (Pfeiffer & 
Kirkegaard 2005; Vignuzzi et al. 2006).  Previous studies on FMDV have shown that 
genetic evolution of the consensus virus sequence can occur during persistent infection 
of the virus within a host (Vosloo et al. 1996).  Also, although no changes were found 
within the consensus sequence of the VP1 protein, antigenic variants arose during acute 
infection of pigs, detected in vitro as antibody escapes (Carrillo et al. 1990).  A further 
study noted that a mixed population is maintained within a host and also can be seen in 
secondary lesions (i.e. not at the point of inoculation) suggesting that more than one 
virus will initiate a lesion (Carrillo et al. 1998). 
 
As has been shown for other RNA viruses it is feasible that the within population 
variation of FMDV differs depending upon the host environment and stage of disease, 
and may also be affected by the rate of transmission events and the bottlenecks that 
arise as a result.  For this reason within host genetic variation and evolution of FMDV 
needs to be studied further to assess its potential to improve our understanding of the 
fixation of mutations into the consensus sequence, variation in disease severity between 
hosts, the progression to persistence (a previous study has shown that genetic change is 
a factor in persistence (Horsington & Zhang 2007)), and the probability of immune and 
vaccine escape by the virus. 
 
The aim of this study was to investigate further the nature of genetic evolution of FMDV 
at the level of a single population within a single lesion of a naturally infected host.  An 
increased knowledge of genetic variability within a virus population could potentially 
assist estimates of population genetic parameters such as mutation, replication,    121
recombination and selection.  It is the interaction of these parameters that determines the 
population genetic dynamics illustrated by the mutant frequency within a population, and 
also determines the rate at which the virus changes genetically in the field.   
 
Within this study the performances of two different reverse transcriptase enzymes were 
compared by testing specific hypotheses concerning evolutionary rates and dN/dS ratios 
between the two populations of clones (generated from the same starting epithelium 
material) using likelihood ratio tests.  Furthermore, the genetic variation surrounding the 
virus consensus sequence within the capsid region upon natural infection of both a cow 
and a sheep (infected during the 2001 UK FMD epidemic) was investigated, providing an 
estimate of mutant frequency.   The cloned sequences have enabled sophisticated 
statistical examination of the phylogenetic relationships within two separate virus 
populations, with respect to dN/dS ratios.  Additionally the distribution of mutations 
observed was analysed, with a significantly high number of mutations occurring within 
antigenic sites within one population.   
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5.3 Methods 
5.3.1 Virus samples 
The virus populations investigated were from epithelium originating from a cow UKG 
14524/2001 from Infected Premises (IP) 1970, and a sheep UKG 15101/2001 from 
IP2027.  The consensus sequence of the complete genome for both had been 
determined previously (DQ404160 and DQ404158 respectively).  The two IP were 
situated in Northumberland and infected close to the end of the epidemic.  At the time of 
infection IP1970 held 200 sheep and 62 beef cattle.  Three cattle were reported to have 
been infected, with the oldest lesion being 3 days.  The farm was examined on 23rd 
August 2001 and culled the following day.  A sample of tongue epithelium was sent to 
IAH Pirbright.  IP2027 was also a mixed holding with 1341 sheep and 172 beef cattle.  
The farm was examined on the 24th September 2001 and culled the same day, with 9 
sheep showing lesions representative of FMD.  Epithelium from a 24 hour old lesion on 
the dental pad was sent to IAH Pirbright. 
 
5.3.2 Original epithelium sample suspension 
The epithelium samples were ground using a pestle and mortar and a 10% suspension in 
phosphate buffer was made as described in Chapter 2, section 2.3.1a. 
 
5.3.3 TRIzol RNA extraction 
Two hundred µl of the epithelial tissue suspension was added to 1ml TRIzol (Invitrogen) 
and the RNA extracted as described previously (Reid et al. 1998).  The RNA was re-
suspended in 12µl nuclease free water.    123
5.3.4 Superscript III reverse transcription 
Three µl of 10mM UKFMD/Rev 6 primer and 2µl 10mM dNTP were added to the 12µl 
RNA suspension and incubated at 68
oC for 3 minutes and then on ice for 3 minutes.  
Twenty one µl of freshly prepared RT mix (4µl 10x RT Buffer (Invitrogen), 8µl 25mM 
MgCl2, 4µl 0.1M Dithiothreitol (DTT), 2µl RNase OUT (40 units/µl, Invitrogen), 3µl 
nuclease free water) were added to the sample followed by 2µl Superscript III reverse 
transcriptase (200 units/µl, Invitrogen).  The sample was then incubated at 42°C for 4hrs, 
after which the reaction was terminated by incubation at 85°C for 5 minutes.   
 
5.3.5 Accuscript High Fidelity reverse transcription 
Three µl of 10mM UKFMD/Rev 6 primer (see Table 2.1, Chapter 2), and 2µl 10mM dNTP 
were added to the 12µl RNA suspension and incubated at 68°C for 3 minutes and then 
on ice for 3 minutes.  Twenty one µl of freshly prepared RT mix (4µl 10x RT Buffer 
(Stratagene), 4µl 0.1M Dithiothreitol (DTT), 2µl RNase OUT (40 units/µl, Invitrogen), 11µl 
nuclease free water) were added to the sample followed by 2µl Accuscript High Fidelity 
reverse transcriptase (Stratagene).  The sample was then incubated at 42°C for 4hrs, 
after which the reaction was terminated by incubation at 85°C for 5 minutes.   
 
5.3.6 Amplification of complete capsid sequence by PCR 
The cDNA was cleaned using GFX PCR DNA and gel band purification kit (Amersham 
Biosciences) to remove residual UKFMD/Rev 6 primer, eluting the cDNA in 35µl of 
elution buffer (10mM Tris·Cl, pH 8.5: QIAGEN).  The complete capsid PCR reaction 
contained 5µl 10x Hi-Fi buffer, 2µl 50mM MgSO4, 1µl 10mM dNTP, 1µl 10mM 
UKFMD/For3, 1µl UKFMD/Rev 7 (see Table 2.1, Chapter 2), 0.2µl Platinum Taq Hi-
fidelity (5units/µl, Invitrogen), 35.8µl nuclease free water and 4µl cDNA.  Thermal cycling 
was as follows; initial denaturation at 94°C for 2 minutes followed by 39 cycles of 94°C 
for 30 seconds, 68
oC for 30 seconds, and 72°C for 3 minutes, ending with incubation at    124
72°C for 7 minutes.  The PCR product (2588 bp) was then cleaned using GFX PCR DNA 
and gel band purification kit (Amersham Biosciences). 
 
5.3.7  ‘A’ Tailing of blunt ended PCR product 
Fourteen µl of tailing reaction mix (2µl 10x PCR buffer (Promega), 2µl 25mM MgCl2, 2µl 
0.2mM dATP, 2µl Taq DNA polymerase (5 units/µl, Promega), 6µl nuclease free water) 
was added to 6µl of cleaned PCR product.  The reaction was incubated for 30 minutes at 
70
oC. 
 
5.3.8 pGEMT-Easy Vector Ligation 
One µl of 10x rapid ligation buffer (Promega), 1µl pGEMT-easy vector (50ng), 1µl T4 
ligase (3 units/µl, Promega) and 4µl of nuclease free water were added to 3µl of the 
tailed PCR product.  The ligation reaction was incubated overnight at 4
oC.   
 
5.3.9  Transformation of competent DH5α E. coli cells and selection of 
Ampicillin resistant E.coli with dysfunctional galactosidase 
Five hundred µl of chemically competent DH5α E. coli cells (Invitrogen) were thawed on 
wet ice.  One hundred µl of cells were gently added directly to the appropriate ligation 
reaction.  The reaction was incubated on ice for 30 minutes, followed by heat shock 
treatment in a 37
oC water bath for exactly 45 seconds followed by 2 minute incubation on 
ice.  One ml of SOC media (bacterial growth medium) was added to the cells, before 
incubating at 37
oC for 1hour with shaking at 225rpm.  Two hundred µl of transformed 
cells were spread onto petri dishes containing LB agar with 100µg/ml Ampicillin and 90µl 
X-gal.  The plates were inverted and incubated over night at 37°C. 
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5.3.10 Picking and growing of E. coli colonies 
White colonies were picked with a sterile pipette tip and dropped into 12ml of LB broth 
containing Ampicillin 100µg/ml and incubated overnight in the shaking incubator at 37°C 
at 225rpm. 
 
5.3.11 Qiagen mini-prep plasmid extraction 
The plasmids were extracted from the E. coli cells using the Qiagen mini-prep kit 
following the manufacturer’s instructions and eluting in 50µl. 
 
5.3.12 Restriction digest using EcoR1 
Two µl of the eluted plasmid was added to 18ul of fresh restriction digest reaction mix 
(2µl 10x restriction digest buffer H (Promega), 0.5µl EcoR1 (12 units/µl, Promega), 
15.5µl ddH2O), and incubated at 37°C for 30 minutes. 
 
5.3.13  Sequencing of plasmid clones in Beckman Coulter sequencing 
plates 
One µl of plasmid (approximately 500ng) followed by 7µl of nuclease free H2O was 
added to each well of a Beckman Coulter sequencing plate.  The plasmids were then 
denatured using a thermal-cycler to heat the samples to 94°C for 2 minutes before 
returning to room temperature.  Four µl of 1mM sequencing primer was then added to 
each reaction followed by 8µl of the DTCS Quick Start Master Mix (Beckman Coulter).  
The plate was run on a programme of 30 cycles of 96°C for 20 seconds, 50°C for 20 
seconds, and 60°C for 4 minutes.  Following thermal-cycling, the reactions were ethanol 
precipitated before running on the Beckman Coulter Sequencing (CEQ800) machine. 
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5.3.14 Data analysis 
The raw .scf data files were assembled using the software package DNASTAR, and all 
further sequence manipulation was performed using Bioedit.  The location and number of 
substitutions were determined using DnaSP (Rozas & Rozas 1999). The minimum 
mutation frequency was calculated as the number of unique substitutions/total number of 
nucleotides sequenced.  The Pi (π) statistic, defined as the average number of 
nucleotide differences per site between any two nucleotide sequences chosen randomly 
from the sample population (Nei & Li 1979), was calculated using DNAsp.  Maximum 
likelihood trees were determined using Phylip version 3.66 (Felsenstein 2004), assuming 
a constant rate among sites.  Likelihoods of these trees were compared using models of 
nucleotide substitution that differed in their assumptions regarding evolutionary rates and 
dN/dS ratios between branches using the codeml programme within the PAML3.15 
freeware package (Yang 1997). Codeml was set to run assuming the standard genetic 
code, with the equilibrium codon frequencies in the codon substitution model calculated 
from the average nucleotide frequencies at the three codon positions, and with no 
variation in dN/dS ratios between sites.  Estimated model likelihoods were compared by 
performing likelihood ratio tests. When comparing two evolutionary models, the simpler 
(null) model, having p0 parameters and associated log-likelihood l0, and the more 
complicated (alternative) model having p1 parameters,with associated log-likelihood l1 
twice the log-likelihood difference 2∆l =2(l1-l0), has a χ
2 distribution with degrees of 
freedom (d.f.)= p1-p0 if the null model is true.  Thus the test statistic 2∆l was compared to 
the  χ
2 distribution with appropriate d.f. to test whether the more complex model is 
supported over the simpler model. 
 
Possible differences in the two sets of sequences resulting from the different reverse 
transcriptase enzymes (Superscript III and Accuscript) were investigated to assess the 
enzymes’ performance, by comparing nested models using likelihood ratio tests.  Firstly 
comparing evolutionary rates between the two sequence sets, by including sequences    127
from these two populations in the same alignment and constructing a single tree and 
comparing the model likelihood of the null hypothesis that all branches in the tree are 
restricted to the same rate, with the alternative model likelihood of individual rates for the 
two virus populations, with the dN/dS ratio restricted to one rate for the entire tree. 
Secondly dN/dS ratios were compared, evaluating the model likelihoods of one dN/dS 
ratio for the entire tree, or two different dN/dS  ratios, one for each population.  The 
hypothesis that the dN/dS ratio of virus population UKG 14524/2001 differed from that of 
UKG 15101/2001 was then tested using the same method as detailed above.  To test the 
hypothesis that the distribution of mutations within the two populations UKG 14524/2001 
and UKG 15101/2001 differed, the distribution of mutations across the clones in both 
virus populations were compared to a Poisson distribution using the chi-squared test with 
100,000 Monte Carlo bootstrap replicates.  The exact binomial test was used to 
determine whether or not a significantly high number of mutations had occurred within 
sites of known antigenic importance. 
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5.4 Results 
5.4.1 Overview 
Complete capsids from 26 individual clones from UKG 14524/2001 (13 from cDNA 
synthesised by Superscript III reverse transcriptase and 13 from cDNA synthesised by 
Accuscript reverse transcriptase) and 15 individual clones from UKG15101/2001 were 
sequenced.  Twenty nine unique variant nucleotides, an insertion of a single nucleotide, 
and a deletion of 31 nucleotides were found following comparison of the cloned 
sequences to their respective consensus sequences.  The substitution mutations are 
listed in Table 5.1.  The sequences from UKG 14524/2001 have a minimum mutation 
frequency of 2.79 x 10
-4 mutations per nucleotide sequenced, and the sequences from 
UKG 15101/2001 have a minimum mutation frequency of 3.94 x 10
-4 mutations per 
nucleotide sequenced.  Properties of the two sets of clone sequences are summarised in 
Table 5.2. 
 
5.4.2 Maximum likelihood phylogenetic analysis of sequences   
Maximum likelihood phylogenies were constructed for the sequences representing the 
clonal population of UKG 14524/2001, UKG 15101/2001, and both sequence sets 
combined, and are shown in Figure 5.1 a,b,c respectively.  The two phylogenies from the 
different animal lesions vary in shape, with that representing UKG 14524/2001 containing 
more highly divergent sequences. 
 
5.4.3  Comparison of cloned sequences generated by the two reverse 
transcriptase  enzymes 
To determine whether or not the performances of the two reverse transcriptase enzymes 
differed, the model likelihood of a single evolutionary rate for all of the sequences from 
virus population UKG 14524/2001 was compared to the likelihood of separate rates for    129
the sequences generated by Supercript III and those generated by Accuscript.  No 
significant difference was found between the two groups (P=0.559,  χ
2=0.341,  d.f.=1).   
Additionally the model likelihood of separate dN/dS ratios for the two sequence sets was 
not supported over the model likelihood of one dN/dS ratio for all (P=0.863, χ
2=0.03, 
d.f.=1).  Thus the clones generated by the two enzymes did not differ significantly in 
number or type of mutations. 
5.4.4 dN/dS and Ts/Tv ratios between two virus populations 
The  dN/dS ratio per nucleotide site for the cloned population representing UKG 
14524/2001 was 1.228.  For UKG 15101/2001 it was 0.187.  The results are summarised 
in Table 5.2.  Although these appear quite different, maximum likelihood analysis did not 
significantly support a model of 2 separate dN/dS ratios in preference to a single ratio 
model for all (P=0.097, χ
2=1.572, d.f.=1).  The transition to transversion ratio for the two 
sets of sequences UKG 14524/2001 and UKG 15101/2001 was 28.53 and 8.41 
respectively. No statistical difference in terms of within population genetic diversity was 
detected between the two virus populations. 
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Table 5.1 Variant nucleotides observed in all sequences 
 
Shown in bold are non-synonymous changes in antigenic sites, and in italics are those 
changes that occurred in more than one sequence. 
 
 
Clone 
Capsid 
protein 
Nucleotide 
position 
Nucleotide 
change 
Amino acid change 
UKG 14524 S 09  VP1 2017  G-A  V-I 
UKG 14524 S 10  VP3  1168  T-C  S-P 
UKG 14524 S 11  VP3  1053  T-C  - 
UKG 14524 S 12  VP2  551  C-T  A-V 
UKG 14524 S 12  VP4  156  G-T  - 
UKG 14524 S 13  VP3 1075  C-T  H-Y 
UKG 14524 S 13  VP1  1588  T-C  S-P 
UKG 14524 A 08  VP3  1462  T-C  - 
UKG 14524 A 09  VP2  350  T-C  V-A 
UKG 14524 A 10  VP2 650  T-C  I-T 
UKG 14524 A 11  VP2  575  T-C  V-A 
UKG 14524 A 11  VP3 1080  C-T  - 
UKG 14524 A 12  VP3 1080  C-T  - 
UKG 14524 A 12  VP3  1530  A-G  E-G 
UKG 14524 A 12  VP3  1567  C-T  STOP 
UKG 14524 A 13  VP2  308  G-A  R-H 
UKG 14524 A 13  VP3 1080  C-T  - 
UKG 14524 A 13  VP1  1970  G-A  C-Y 
UKG 15101 S 05  VP3  1098  C-T  - 
UKG 15101 S 06  VP1  1929  G-T  - 
UKG 15101 S 07  VP2  654  C-T  - 
UKG 15101 S 08  VP3  1491  T-G  - 
UKG 15101 S 09  VP3  1518  T-C  - 
UKG 15101 S 10  VP3  1262  A-G  K-R 
UKG 15101 S 11  VP2  385  A-G  S-G 
UKG 15101 S 12  VP2  606  C-T  - 
UKG 15101 S 13  VP1  1668  G-A  - 
UKG 15101 S 14  VP1  2136  G-A  - 
UKG 15101 S 15  VP4  240  C-T  - 
UKG 15101 S 15  VP3  1352  A-G  D-G 
UKG 15101 S 15  VP1  1741  G-A  A-T    131
 
 
Figure 5.1  
Maximum likelihood analysis of complete capsid sequences from UKG 14524/2001 and 
UKG 15101/2001.  a) Maximum likelihood analysis of 26 complete capsid sequences 
representing sample UKG 14524/2001; in blue are the sequences obtained from cDNA 
transcribed by Accuscript reverse transcriptase, in black are sequences obtained from cDNA 
transcribed by Superscript III reverse transcriptase, b) Maximum likelihood analysis of 15 
complete capsid sequences representing sample UKG 15101/2001, c) Maximum likelihood 
analysis of all 41 capsid sequences from UKG 14524/2001 (blue and black) and UKG 
15101/2001 (red).   
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Table 5.2 Genetic characteristics of two natural populations of FMDV 
 
 
πabc  calculated for all nucleotide sitesa, synonymous sitesb, and non-synonymous sitesc 
 
 
5.4.5 Distribution of nucleotide changes between cloned sequences 
Figure 5.2 shows the genetic relationship of each cloned sequence for both the two 
populations from two different RT enzymes (a, b), and the total sequences representing 
UKG 14524/2001 (c), and also the sequences representing UKG 15101/2001 (d). 
 
No. of 
clones 
No. of 
mutant 
free 
clones 
Minimum 
mutant 
frequency 
x10-4 
Ts:Tv 
ratio 
No. of non-
synonymous 
mutations 
No. 
Synonymous 
mutations 
dN/dS  πabc 
14524 26 15  2.79  28.53  12 4  1.228 
a6.2 x 10-4 
b8.0 x 10-4 
c5.6 x 10-4 
Accuscript 13  7  3.14 99.00  7 2  1.352   
Superscript 
III 
13 8  2.45  12.06  5 2  1.086   
15101 15  4  3.94  8.41  4  9  0.187 
a8.0 x 10-4 
b2.2 x 10-3 
c3.3 x 10-4    133
 
 
 
Figure 5.2  
Statistical parsimony analysis of capsid sequences.  Shown are the genetic relationships 
between sequences, with each branch representing a single nucleotide substitution: black 
branches represent synonymous changes, red non-synonymous, and in thick red are those 
that occurred within antigenic sites.  In the centre of each tree the proportion of sequences 
that were identical to the consensus is represented by a pie diagram, with the exact number 
printed in black.  Each oval represents a sequence and each dot a putative ancestral 
sequence.  a) 13 sequences from cDNA transcribed by Accuscript reverse transcriptase from 
UKG 14524/2001, b) 13 sequences from cDNA transcribed by Superscript III reverse 
transcriptase from UKG 14524/2001, c) 26 sequences representing UKG 14524/2001, d) 
15 sequences representing UKG 15101/2001. 
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Figure 5.3 
The schematic shows all mutant sequences reported in this study compared to their 
respective consensus sequences.  Synonymous substitutions are represented by white 
circles, non-synonymous by filled circles and non-synonymous substitutions within antigenic 
sites by red circles.  The insertion is indicated by a down arrow, the substitution resulting in a 
stop codon by a filled rectangle, and the deletion by a double ended arrow.  The sections 
encoding the separate capsid proteins VP1-4 are indicated by the dashed lines, with 
antigenically important residues represented by grey shading. 
 
Within the UKG 15101/2001 virus population a lower proportion of sequences were 
found to have no mutations (n=4) than the proportion that had one or more (n=11).  This    135
distribution of mutations is contrary to what would be expected from a Poisson 
distribution where, for the number of mutations seen, 6 of the sequences should be 
mutant free, however the mutant distribution was not found to significantly differ from a 
Poisson distribution (chi-squared test: P=0.071, χ
2=7.036, 100,000 Monte Carlo 
bootstrap replicates).  In contrast, more UKG 14524/2001 cloned sequences (n=15) were 
found to be identical to the consensus than harbouring 1 mutation (n=6), with the least 
number being those with 2 (n=3) or more (n=2) mutations.  This clearly does not differ 
from a Poisson distribution (chi-squared test: P=0.290, χ
2=3.566, 100,000 Monte Carlo 
bootstrap replicates).  
5.4.6 Genomic location of variant nucleotides 
The relative positions within the capsid coding region of all the mutations found, for both 
groups of sequences, are shown in Figure 5.3.  The only mutation found in more than 
one sequence was the silent C-T mutation in three sequences from sample UKG 
14524/2001.  Overall, taking into consideration coding region length, the majority of 
mutations occurred within the VP3 region (12 out of the 29 substitutions, compared to 8 
in VP1).  Three non-synonymous mutations were observed in known antigenic sites 
within the cloned sequences of virus population UKG 14524/2001.  Using the Exact 
Binomial Test it was found that the probability of observing 3 of the 12 amino acid 
changes seen in virus population UKG 14524/2001 in antigenic sites is extremely low at 
0.0007, hence the occurrence of three mutations within antigenic sites is unusual.  One 
of these non-synonymous substitutions resulted in an amino acid change to a critical 
residue in the VP1 antigenic site 1 G-H loop, another was found to occur in the antigenic 
site 4 within VP3 and was an amino-acid change that has been seen before in 
O/PHI/5/95 (N Knowles, personal communication), and the third lay between two 
residues that form the β-EF loop of antigenic site 2 in VP2.       136
5.5 Discussion 
This study has provided an insight for the first time into the mutant distribution of FMDV 
genomes within populations analysed from naturally infected animals, infected with Pan 
Asia O FMDV.   The average minimum mutant frequency found in this study was 3.06 x 
10
-4 mutations per nucleotide sequenced.  This is close to an in vitro study, for serotype 
O FMDV that sequenced cloned capsids, which found a mutation frequency of 2.1 x 10
-4 
mutations per nucleotide sequenced (Gu et al. 2006).  There have been more studies on 
serotype C virus in which the mutant frequency ranges from 0.7 x 10
-4 to 7.7 x 10
-4 
mutations per nucleotide sequenced (Airaksinen et al. 2003; Arias et al. 2001; Pariente 
et al. 2001; Sierra et al. 2000).  Those studies that compared mutation frequencies in the 
VP1, or P1 region to the 3D region found a decreased mutation frequency in the latter, 
which suggests that the mutation frequency found within the capsid is likely the highest 
that would be seen throughout the genome.  The distribution of the substitutions across 
the sequences and the presence of identical sequences to the consensus provides 
support for the dominance of the consensus sequence.  The majority of substitutions 
seen in this study were in VP3, and this corresponds to the majority of fixed mutations 
noted during the UK 2001 outbreak (Cottam et al. 2006). 
 
It is possible that the mutations observed could be an artefact of the amplification 
process, introduced, for example, by the reverse transcription enzyme, the PCR enzyme, 
the E.coli replication system, or even during the sequencing reaction.  A high fidelity PCR 
enzyme was used that is reported to give an overall reverse-transcription PCR error rate 
of 7.7 x 10
-6 mutations per nucleotide copied (Arezi & Hogrefe 2007; Malet et al. 2003).  
This would result in a mutation being present in less than 2% of capsid sequences.  In 
this experiment in total we found approximately 54% of sequences to be mutant which is 
clearly higher.  It has also been suggested that the reverse transcriptase can be 
responsible for mutations seen and this was investigated by assessing the performance    137
of Accuscript (Stratagene), which is reported to have proof reading qualities, and 
Superscript III (Invitrogen).  No statistical difference was seen between the sequences 
generated by the two enzymes in terms of evolutionary rate (P=0.559) or dN/dS 
(P=0.863), suggesting that their performances did not differ.  High sequence coverage of 
each nucleotide from different forward and reverse sequencing primers was used to 
avoid the introduction of errors through analysis of the sequencing reaction.  In 
consideration of this it seems reasonable to suggest that the mutant frequency recorded 
here is the maximum mutant frequency because it represents the real mutant frequency 
plus minimal artificial mutants.  However, this does assume that the PCR reaction was 
unbiased in terms of cDNA amplified, and that the RNA of the original sample is equally 
represented.  Indeed, if only a low proportion of RNA sequence was sampled then it 
would be expected that many mutations would occur on multiple clones.  However, all 
but one of the observed mutations were unique supporting the view that the RNA 
sampling was not biased. 
 
For the virus population characterised from cow epithelium UKG 14524/2001 the dN/dS 
ratio was 1.228 which is relatively high, in contrast to the dN/dS ratio for mutations 
observed within the virus population from infected sheep epithelium UKG 15101/2001 of 
0.187 which is much lower.  This difference was not found to be significant due to low 
sample numbers.  During the UK 2001 epidemic non-synonymous and synonymous 
mutations were fixed into the consensus sequence at a ratio of 0.09 (Cottam et al. 2006), 
which could thus be regarded as the ratio expected under normal purifying selection.   It 
may be that transmission between animals presents stronger purifying selection than 
replication within an animal, however these data sets are small and more study is 
required to determine this.  The two virus populations (UKG 14524/2001 and UKG 
15101/2001) were not found to differ significantly in terms of diversity. 
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The distribution of substitutions across clones differs between the virus population from 
the cow epithelium UKG 14524/2001 and the sheep epithelium UKG 15101/2001, with 
only 26.6% being identical to the consensus in the population from UKG 15101/2001 
compared with 57.7% for UKG 14524/2001.  However, this data must be analysed with 
caution, because it relies on the assumption that all sequence changes are linked as 
shown and that no recombination has occurred within the PCR reaction (Yu et al. 2006).    
 
For the virus population analysed from UKG 14524/2001 there were 3 changes that 
occurred in antigenic sites, which is higher than what would be expected at random.    It 
is possible that this represents positive selection of variants that can escape the immune 
response, as supported by the high dN/dS ratio of 1.228.  However, both virus 
populations were sampled from relatively early infections and it is unlikely that the 
adaptive immune response would be significant.  An alternative explanation is that these 
sites represent parts of the capsid that are more easily mutated than others, either due to 
some unknown mechanism during replication, or due to relative resistance to deleterious 
mutation. 
 
Three identical synonymous mutations were found within the 26 sequences from the 
virus population UKG 14524-2001.  The mutations showed a thymine (T) residue, 
instead of the consensus cytosine (C).  A comparison of the consensus with the 
sequences from the UK 2001 outbreak revealed that ‘T’ is found at this position in all the 
other viruses sequenced; indeed it may be more accurate to say that those sequences 
harbouring a ‘C’ at this position are the mutant sequences.  This observation 
demonstrates an instance of a nucleotide change becoming fixed within the consensus.  
The relevance of this to the mode by which nucleotide changes become fixed into the 
consensus is discussed further in Chapter 7.  The presence of three sequences 
containing the original nucleotide (‘T’) at this position suggests that those viruses with a 
‘C’ at this residue replicated more abundantly than those with a ‘T’.  This may not    139
necessarily be due to increased fitness, but perhaps a result of the relative diversity of 
the starting population.   
 
Overall 28 transition and 3 transversion mutations were found in this study.  A recent 
paper suggested that poliovirus RNA dependent RNA polymerase also has a 
comparable transition to transversion bias (Freistadt et al. 2007), although slightly less 
(4.3 compared to 9.3) than observed in this study.   It also corresponds to the overall 
transition to transversion ratio reported for sequences during the 2001 UK epidemic of 
7.61 (Cottam et al. 2006). 
 
Although the difference in the genetic make up of the virus populations between the 
infected cow and the sheep epithelium is intriguing it cannot be regarded as conclusive 
because only one sample from each representative animal has been sampled.  However 
the findings of this chapter do encourage further research into virus evolution at the 
single population level in vivo, which may provide additional insight into the fixation of 
mutations during the evolution of the virus in the field. 
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Chapter 6   
 
Investigation of the spontaneous 
mutation rate of Foot-and-mouth disease 
virus O1BFS 
    141
6.1 Summary 
The spontaneous mutation rate of Foot-and-mouth disease virus is thought to be a major 
contributor to the genetic diversity seen in virus isolates in the field.  This rate, however, 
has not been estimated empirically to date.  This chapter describes an approach to 
determine the spontaneous mutation rate of O1BFS FMDV using fluctuation analysis.  
This involved assessing the rate at which mutants arise in parallel cultures, looking for 
monoclonal antibody escape mutants in the first instance.  The initial attempt was 
hindered by the inefficient neutralising ability of the monoclonal antibody.  Also discussed 
is the possibility of completing this experiment by looking for virus that escapes inhibition 
by siRNA. 
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6.2 Introduction 
6.2.1 Overview 
The mutation rate of FMDV per genome replication is an important parameter to quantify 
as accurately as possible because it underpins our understanding of virus evolution and 
replication.  There are many estimates of mutant frequencies for FMDV that are all in the 
order of x10
-4 mutations per nucleotide sequenced (Airaksinen et al. 2003; Arias et al. 
2001; Gu et al. 2006; Pariente et al. 2001; Sierra et al. 2000).  Mutation rates calculated 
from mutation frequency estimates at a single time point should be analysed with caution 
because low probability events occurring early during the growth of a population are 
over-represented in subsequent viral generations.  Indeed to obtain an accurate estimate 
of mutation rate it is important to accurately determine the number of virus replication 
events that have occurred to produce the mutation frequency observed.  To date, there is 
no study that measures the rate of FMDV polymerase error taking into account the 
number of replication events; there are only studies that measure the frequency of 
mutants within a population at a fixed time point (see Chapter 1 section 1.3.5).   
 
Despite no clear study of the spontaneous mutation rate of FMDV it is often reported to 
have a mutation rate of x 10
-3 – x 10
-5 per nucleotide per genome replication, in line with 
other RNA viruses as discussed in Chapter 1, section 1.3.5.  A study which attempted to 
determine a rate from various studies on Poliovirus by applying fluctuation analysis 
(discussed below) again found a large variation in mutation rates, perhaps a result of the 
fact that the studies chosen were not specifically designed for this analysis and many 
assumptions concerning population size etc. were required (Drake 1993).  However, a 
conclusion concerning the FMDV mutation rate, that ranges from x 10
-3 to x 10
-5 per 
nucleotide per genome replication, from observations of Poliovirus is extremely 
uninformative.  At its lowest, the mutation rate would represent 99% or more of virus 
genomes being able to replicate error free; however, at its highest each genome incurs    143
an average of 10 mutations (nearly 1 per gene).  These two scenarios would clearly 
result in different modes of virus evolution; one in which a quasi-species structure is 
relevant and the other where quasi-species are completely irrelevant.  Another problem 
is the assumption that FMDV mutation rates will be the same as for Poliovirus, and other 
RNA viruses.  Studies on experimental evolution suggest that a virus mutation rate will 
evolve to an optimum dependent upon the frequency of transmission through bottlenecks 
and also the degree of adaptation to the host that takes place before the next bottleneck 
(Manrubia et al. 2005).  The transmission and host characteristics of FMDV differ 
considerably from Poliovirus, and thus the mutation rate of FMDV is likely to have 
evolved to be optimum for the frequency of transmission, host range and replication 
opportunities that it encounters.  For these reasons it is imperative to determine the 
specific mutation rate of FMDV.  Although this chapter discusses methods for O1BFS, 
once optimised this method could be applicable in assessing the mutation rates of other 
FMD field viruses. 
  
6.2.2 Fluctuation analysis 
A method to measure the rate of FMDV polymerase error harnesses the theories of Luria 
and Delbruck (Jones et al. 1994); that if the number of new mutations occurring is well 
approximated by a Poisson distribution with a parameter m (the number of mutational 
events) which equals mutation rate (µ) multiplied by the total number of progeny (N): 
then the proportion of mutant free colonies (P0) is equal to e
-m, and µ=m/N.  Thus by 
measuring P0 and N at time zero and time t the mutation rate µ can be determined; 
  µ = -ln (P0)/ (Nt-N0) 
 
This analysis is termed fluctuation analysis and has been used to study bacterial 
populations.  However, it has been applied to RNA viruses indirectly (Drake 1993) and 
also in direct experiments estimating the mutation rate for measles virus (Schrag et al. 
1999) and tobacco mosaic virus (Malpica et al. 2002).  In Drake’s study in 1993 he    144
attempted to assess the mutation rate of Poliovirus using data from experiments 
reviewed in Chapter 1 section 1.3.5.  However, these studies were not designed to 
produce data for this analysis and many assumptions were required concerning 
population size.  As a result, a wide range of estimates of the Poliovirus mutation rate 
were calculated; from 2.2 x 10
-3 to 1.3 x 10
-5 per nucleotide per genome replication 
(Drake 1993). 
 
When applying the fluctuation method to RNA viruses, an assumption is that mutational 
events are distributed randomly across independent virus cultures according to a 
Poisson distribution.  To begin with a number of mutant free cultures are established by 
inoculating cell cultures in micro-titre plates with a very small quantified virus population.  
The virus populations are then grown in parallel until a population size is reached 
resulting in approximately half the virus cultures containing the mutation of interest.  It will 
be necessary to perform initial ranging experiments to determine the appropriate 
population size at which this is true.  The population size at this point is accurately 
quantified by assessing a set of representative cultures, and the remainder of the 
cultures are screened for the presence of mutants.  The average number of newly 
produced viral particles N is approximated by the total number present in each culture Nt 
minus the initial population N0.  The number of mutations is dependent upon the mutation 
rate µ, and hence each virus population should contain µN mutations.  Based on the 
Poisson distribution the proportion of cultures with no mutations P0 is equal to e
-µN.  Thus 
the estimation of N and P0 allows direct estimation of µ.     
6.2.3 FMDV Monoclonal antibody escape mutants 
To use the method described above to determine the mutation rate of Foot-and-mouth 
disease virus it was initially decided to screen for the spontaneous generation of 
monoclonal antibody (MAb) resistant mutants.  Many FMDV MAb escape mutants have 
been characterised, and were found to escape the MAb through the alteration of a limited 
set of possible nucleotide substitutions.  The MAb chosen for use in this study was D9 (a    145
murine IgG antibody raised to FMDV O1Lausanne) which binds to antigenic site 1.  It has 
been shown previously that three amino acid residues are important for escape from 
MAb D9, these are amino acids 144,148 (which lie either side of the RGD in the G-H 
loop region of VP1) and 154 of VP1 (Kitson 1990).  A change at 144 results in the least 
efficient escape, whereas changes at 148 or 154 confer complete resistance.  The only 
mutations found previously were from L to S at amino acid 144, L to R at amino acid 148 
and K to M at amino acid 154.  Analysis of O1BFS sequence suggests that it should be 
neutralised by D9 Mab because it contains a V at amino acid 144, L at amino acid 148 
and K at amino acid 154.  It is not possible to change by a single point mutation from the 
V (GTG) to encode S and thus mutants are unlikely to arise by this route.  However the 
change from L (CTG) to R (CGG) at 148 would require a single transversion from T to G, 
and the change from K (AAG) to M (ATG) at amino acid 154 would require a single 
transition mutation from A to T.  Previous studies carried out by (Kitson 1990) suggest 
that these mutants would be viable. 
 
6.2.4 siRNA escape mutants 
As described in the results section of this chapter it was not possible to complete the 
experiment using the MAb.  For this reason an alternative method was explored.  The 
new concept was to use silencing RNA to inhibit the virus and look for mutants escaping 
its effect.  Small interfering RNA can cause sequence specific destruction of a target 
RNA sequence; (Dallas & Vlassov 2006; Zamore et al. 2000; Zhou et al. 2006).   
Although usually used to silence protein expression by destroying the mRNA, siRNA 
technology has also been targeted to virus genomes preventing viral replication.  Indeed, 
previous studies have shown specific inhibition of FMDV (Chen et al. 2004; Kahana et al. 
2004; Liu et al. 2005b; Mohapatra et al. 2002).   
 
siRNAs are double stranded RNA molecules 21-23 nucleotides in length that contain 2 
nucleotide overhangs at the 3’ ends.  When inside cells they are integrated into a multi-   146
subunit protein complex called the RNAi inducing silencing complex (RISC) in an ATP 
dependant manner (Zamore et al. 2000).  The RISC guides the siRNA to the target RNA 
sequence.  In order to function the siRNA duplex is unwound with the anti-sense strand 
remaining bound to the RISC.  Combinations of endo- and exo-nucleases then degrade 
the target RNA.  The capacity for virus to escape siRNA action relies on nucleotide 
substitutions within the target sequence.   
 
6.2.5 Experiment design 
To complete the experiment to assess the mutation rate of FMDV, it was first essential 
that a method is in place to completely inhibit virus replication so that mutants could be 
screened for with ease.  Secondly, a time course in suitably sized tissue culture dishes 
was performed, to establish the rate at which virus populations increase and the extent to 
which they could grow within the cell monolayer available.  This provided a basis around 
which to perform the ranging experiments to determine at what population size half the 
cultures contained a mutant.  Finally multiple replicas of the experiment would be 
completed to obtain a statistically accurate estimate for the mutation rate.    147
6.3 Methods 
6.3.1 Cells  
Baby-Hamster-Kidney 21 cells (BHK21) were used throughout the experiment.  BHK21 
cells were maintained in complete growth medium (500ml Glasgow Eagles 
supplemented with 10% Foetal Calf Serum (FCS), 25ml Tryptose Phosphate Broth 
(TPB), 5ml Glutamine, 5ml Penicillin/Streptomycin), incubated at 37
oC with 5% CO2.  
Stock cells were split to a ratio of 1:10 every 48-60hrs, by addition of Trypsin and brief 
centrifugation to pellet cells, followed by re-suspension in complete growth medium and 
seeding of new culture flasks. 
 
6.3.2 O1BFS virus 
A cell culture isolate of the British Field Sample O1BFS (donated by Terry Jackson) was 
3 x plaque purified (see below; section 6.3.5) and used throughout the experiment. 
 
6.3.3 MAb D9 
Undiluted ascites fluid of MAb D9 from stocks held at the Institute for Animal Health was 
used.  The concentration of MAb within this fluid was unknown, and difficult to quantify 
due to the presence of other proteins.    However, it is known that ascitic fluid represents 
much more concentrated MAb than can be obtained from cell supernatants from 
hybridomas, and thus this MAb (D9) was the best candidate available for the completion 
of this experiment. 
 
6.3.4 Sequencing of O1BFS 
Virus RNA was extracted and reverse transcribed as described in Chapter 3, section 
3.3.3.  The cDNA was cleaned using the GFX PCR DNA and gel band purification kit    148
(Amersham Biosciences).  The capsid coding region was amplified using primers 
designed against the O1BFS published sequence (AY593815) named O1BFS 
Capsid/For1 and O1BFS Capsid/Rev1 detailed in Table 6.1.  Thermal cycling was as 
follows; initial denaturation at 94°C for 2 minutes followed by 39 cycles of 94°C for 30 
seconds, 62°C for 30 seconds, 72°C for 3 minutes, ending with incubation at 72°C for 7 
minutes.  The PCR product was cleaned using the GFX PCR DNA and gel band 
purification kit (Amersham Biosciences) and sequencing reactions were set up as 
described previously in Chapter 2, section 2.3.1d.  The sequencing primers used are 
detailed in Table 6.1.  Raw data files were assembled into a contig using the DNASTAR 
software package and the consensus sequence was analysed with Bioedit freeware. 
 
Table 6.1 Primers for amplification and sequencing of O1BFS FMDV capsid 
 
  
6.3.5 Plaque purification 
BHK21 cells were seeded into 60mm tissue culture Petri dishes to give 60-70% 
confluence by the following day, and grown in Glasgow Eagles complete growth medium 
(10% FCS, TPB, Glutamine, Pen/Strep).  The growth medium was then removed and the 
Name Direction 
5’ nt position 
wrt 
AY593815  Sequence 5’ to 3’ 
O1BFS Cap/For1  F  1520  catgtgcttggctgatttcc 
O1BFS Cap/For2  F  1926  gactggttctccaaacttgc 
O1BFS Cap/For3  F  2244  ccacaaaggtgtctacggcag 
O1BFS Cap/For4  F  2560  cagatcaaggtgtatgccaac 
O1BFS Cap/For5  F  2841  cagggtgcttgctcagtttg 
O1BFS Cap/For6  F  3153  gagaccacaaatgtgcagg 
O1BFS Cap/For7  F  3458  ggttccatcacacactttgg 
O1BFS Cap/For8  F  3730  gtgaccttcaagtgttggctc 
O1BFS Cap/Rev1  R  4155  cttgataagcttgtaccaggg 
O1BFS Cap/Rev2  R  3678  cctgcactcaccgttgtacac 
O1BFS Cap/Rev3  R  3375  cataatgaacgagacgtccgtg 
O1BFS Cap/Rev4  R  3046  cattcagcatgaatgcagtgc 
O1BFS Cap/Rev5  R  2753  cagccacatcaaggaggttgg 
O1BFS Cap/Rev6  R  2429  gtaatgtgcgcagtcatgttcg 
O1BFS Cap/Rev7  R  2123  gtctcgagaccagaagtgttcg 
O1BFS Cap/Rev8  R  1880  ggaggttgtgtcggtggag    149
cells were washed with serum free medium before inoculation with 200µl of virus, diluted 
appropriately in serum free Glasgow Eagles medium.  The cells were incubated with the 
virus inoculum for 15 minutes before washing twice with serum free medium.  The cells 
were then overlaid with 2ml of agar overlay (0.6g Indubiose A37 agarose (PALL Life 
Sciences) dissolved in 25ml nuclease free water using a microwave, mixed with 75ml 
Glasgow’s overlay medium, 5ml TPB, 1.5ml FCS, 1.5ml Pen/Strep).  Following 
incubation at 37
oC with 5% CO2 for 48 hours the plaques were visible and were picked 
from the appropriate dilution showing distinct individual plaques.  The plaques were 
picked using a sterile plastic pipette tip which was then immersed in 450µl of serum free 
medium for 30 minutes before pippetting up and down and storing at -70
oC.  This 
process was carried out three times to obtain 3x plaque purified virus. 
 
6.3.6 Plaque assays 
Plaque assays were performed in duplicate in 60mm tissue culture Petri dishes, with 
cells seeded as described above. Serial 1 in 10 dilutions of virus were used to infect the 
cells, and the cells were overlaid with agar as described above.  After 48 hours 
incubation, the cells were stained with methylene blue stain overnight, and then washed 
to visualise the plaques.   Plaque forming units (PFU) were calculated from the number 
of plaques visualised at a countable dilution to give PFU per ml of the starting virus 
inoculum. 
6.3.7 Monoclonal Antibody inhibition 
Cells were seeded into 6 well tissue culture plates to give 60-70% confluence by the 
following day.  The cells were inoculated as described above, however before inoculation 
the virus dilution was mixed with the appropriate dilution of MAb (diluted in Glasgow 
Eagles medium).  After the inoculation, the cells were not washed (this was found to 
improve the neutralisation capacity of the MAb; data not shown).  The cells were overlaid    150
with agar as described above and incubated at 37
oC with 5% CO2 for 48hrs before 
staining and plaque visualisation. 
 
6.3.8 ELISA for assessing adherence of D9 MAb to fixed antigen 
Polyclonal O1BFS rabbit serum (IAH) and coating buffer (Carbonate-bicarbonate, Sigma) 
were used to coat the wells of a 96 well plate overnight at 4
oC.  The wells were washed 
three times with PBS before addition of BEI (Bromoethyleneimine, Sigma) inactivated 
O1BFS virus antigen in PBS followed by 1hr incubation at room temperature.  Following 
another three washes in PBS either D9 MAb, or guinea pig O1BFS anti serum as a 
positive control, were added and diluted across the plate in PBS and Tween.  The plate 
was then incubated at room temperature for 1hr.  The wells were then washed three 
times in PBS prior to addition of the conjugate; anti-mouse Horse-Radish-Peroxidase for 
D9 and anti-guinea pig Horse-Radish-Peroxidase for the positive control.  The plate was 
then incubated at room temperature for 1hr, followed by three washes in PBS.  O-
phenylenediamine (OPD) (Sigma) plus hydrogen peroxide was added to each well 
followed by incubation in the dark for 15 minutes.  The reaction was then stopped by the 
addition of stop acid (H2SO4).  The optical density (OD) was read at 492nm. 
 
6.3.9 Time course 
BHK21 cells were seeded into 24 well tissue culture plates, to give 60-70% confluence 
by the following day.  The growth medium was removed and the cells were washed with 
serum-free medium before addition of the virus, followed by Glasgow Eagles medium 
supplemented with 1% FCS (total volume of 1ml per well).  At specific time points the 
infection was stopped by freezing the plate at -20
oC.  The plate was then thawed and the 
contents of each well were harvested into a 2ml tube and stored at -70
oC.  For each time 
point, the virus population in PFU was calculated from two wells by duplicate plaque 
assays as described above.    151
 
6.3.10 siRNA Transfection 
Glass cover slips were placed into the bottom of wells in a 24 well tissue culture plate 
and washed with 70% ethanol, and then Glasgow Eagles medium.  Cells were then 
seeded into the wells to give 50% confluence the following day.  Cells were transfected 
following the manufacturer’s protocol for the TransIT-siPAK Plus Trial Kit (Mirus).  Briefly, 
the transfection reagent was mixed with 50µl of serum free medium, followed by addition 
of siRNA for a final concentration of 25nM per well and incubated at room temperature 
for 15 minutes.  The transfection reagent/siRNA complex mixture was then added drop 
wise onto cells in complete growth medium and the cells were incubated at 37
oC with 5% 
CO2.  Two different reagents were tested for their efficiency at transfecting the Label IT 
RNAi Delivery Control fluorescein; TransIT-siQUEST and TransIT-TKO.   
 
6.3.11 Confocal microscopy 
After 18 hours, the transfected cells were fixed with 4% paraformaldehyde in PBS, at 
room temperature for 40 minutes.  The fixing agent was then removed and the cells were 
stained with diluted DAPI (1µl 1000x DAPI in 10ml ddH2O) for 10 minutes at room 
temperature.  The cover slip was then removed using forceps and washed in ddH2O and 
blotted on tissue paper before placing cell side down onto a drop of vecta shield (Vector 
Laboratories Inc) on a glass microscope slide.  After blotting with tissue paper the cover 
slip was sealed with clear nail varnish.  The slides were then visualised using a confocal 
microscope. 
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6.4 Results 
6.4.1 O1BFS complete capsid sequence 
The complete capsid sequence of the original virus stock prior to plaque purification was 
obtained.  Analysis of the sequence data showed that there were two non synonymous 
changes in the antigenic site 4 of VP3 from the published sequence AY593815.  These 
changes were both from an adenine to a guanidine and result in changes to amino acids 
VP3
56 and VP3
60, which are indicative of adaptation to growth in cell culture. 
 
6.4.2 D9 MAb ELISA 
As shown in Figure 6.1 the OD readings suggest that the MAb D9 activity is greatly 
reduced at a concentration less than x 10
-3.  Although this represents MAb binding to 
fixed antigen, these ranging experiments indicated a range of dilutions to test on live 
virus i.e. no less than 1 in a 1000. 
6.4.3D9 MAb inhibition 
Three different MAb volumes were used (0.5µl, 2µl, 5µl corresponding to final dilutions of 
2.5 x 10
-3, 1 x 10
-2, and 2.5 x 10
-2 respectively) to inhibit different concentrations of 
O1BFS virus ranging form 1 x10
2 to 5 x10
6 PFU in 200µl.  The results are shown in 
Figures 6.2 – 6.4.  The graph in Figure 6.2 shows that 0.5µl of D9 MAb failed to 
completely inhibit even low virus numbers i.e. less than 100 PFU.  Volumes of 2 or 5µl of 
D9 MAb were more successful, but were unable to inhibit virus by more than 50% at PFU 
higher than 10
4, and at PFU lower than this struggled to give 100% inhibition with 1 or 2 
plaques often visible.    153
 
Figure 6.1  
Analysis of D9 MAb by ELISA.  The graph shows the optical densities measured following 
ELISA on dilutions of two separate aliquots of D9 monoclonal antibody ascitic fluid (D9 MAb 1 
and 2), compared to guinea pig antiserum as a positive control (see material and methods 
section 6.3.8).  The activity of D9 is greatly reduced at a dilution higher than one in a 
thousand. 
 
    154
 
Figure 6.2  
Inhibition of virus growth with varying concentrations of D9 MAb.  The graph shows the 
percentage inhibition of O1BFS virus plaque formation on BHK21 cells caused by different 
amounts of monoclonal antibody D9 (0.5µl in green, 2µl in blue and 5µl in red) on varying 
starting concentrations of virus (PFU).  None of the volumes of MAb tested could substantially 
inhibit virus growth at a titre above 104 PFU. 
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            5μl MAb     2μl MAb        negative 
 
 
Figure 6.3  
Inhibition of different quantities of O1BFS virus plaque formation by 2 and 5µl of D9 MAb.  
Three times plaque purified O1BFS virus (5.9 x 106 PFU and 10 fold dilutions down to 5.9 x 
103 PFU) was mixed with 5, 2 or 0µl of D9 MAb before inoculation of BHK21 cell monolayer in 
a 6 well plate.  The cells were stained 48 hours post infection, and the extent of virus induced 
CPE visualised, as shown above, for the different amounts of virus and MAb D9.  Even at 
virus PFU of 5.9 x 103 the MAb was unable to completely inhibit plaque formation as 
illustrated by the bottom left hand and bottom middle well. 
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Figure 6.4  
Inhibition of different quantities of O1BFS virus plaque formation by 2, 5 and 10µl of D9 MAb. 
Three times plaque purified O1BFS virus (1.06 x 106 PFU and 10 fold dilutions down to 1.06 x 
103 PFU) was mixed with 5, 2 or 0µl of D9 MAb (and in one case (1.06 x 105 PFU) 10µl of D9 
MAb) before inoculation of BHK21 cell monolayer in a 6 well plate.  The cells were stained 48 
hours post infection, and the extent of virus induced CPE visualised, as shown above, for the 
different amounts of virus and MAb D9.  Even with virus PFU of 1.06 x 103, the MAb was 
unable to completely inhibit plaque formation as illustrated by the bottom left hand and 
bottom middle well. A-F denote plaques that were picked to test to see if they were D9 MAb 
escape mutants.    157
 
Figure 6.5 
Testing whether picked virus populations A-F are D9 MAb escape mutants.  Virus harvested 
from plaques A-F (Figure 6.4) was used neat and diluted 10-2 (as indicated) to infect BHK21 
cell monolayers in 6 well tissue culture plates, either in the presence of 2µl of D9 MAb red 
boxes or not.  All virus populations were inhibited by the MAb confirming that they were not 
MAb escape mutants. 
  
6.4.4No MAb escapes detected 
Plaques visualised under high MAb concentrations were tested for the ability to escape 
the MAb.  The picked viruses were incubated with 2µl of MAb before inoculation.  The 
results are shown in Figure 6.5, and clearly show that all 5 suspected mutant virus 
populations are inhibited by the MAb and are therefore not mutants.    158
6.4.5 O1BFS time course 
Initially, a time course experiment was begun with <10 PFU virus inoculum per tissue 
culture well.  At 24 hours, there was a large variation in PFU between the different wells 
(0 to 1x 10
6 PFU) and so it was concluded that it would not be possible to accurately 
determine the virus population size in all wells from representative wells.  To obtain more 
consistent results the experiment was repeated starting with <100 PFU per well.  The 
results for two different 3x plaque purified viruses, shown in Figure 6.6, are very similar.  
This suggests that virus populations could be reliably quantified from representative wells 
if the population was initiated with more than 10 but less than 100 PFU. 
 
6.4.6 siRNA transfection 
Following confocal analysis, it was found that 4µl of the TransIT-TKO transfection 
reagent gave the best transfection, shown in Figure 6.7.  The Label IT RNAi was found to 
give a cytoplasmic distribution suggesting that it had been taken up into the BHK-21 
cells.  In this experiment, it appeared to show a close to 100% transfection rate.  For the 
TransIT-siQuest reagent it was not possible to confirm that the RNA had been taken up 
into the cells because the fluorescence seen was very clumped and was not localised to 
the cells (data not shown). 
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Figure 6.6  
Time course of two 3 x plaque purified O1BFS viruses’ growth on BHK21 cells in a 24 well 
tissue culture plate measured by duplicate plaque assay.  Two separate three times plaque 
purified viruses pp3.3.14 (green) and pp3.3.15  ( p i n k )  w e r e  u s e d  t o  i n f e c t  B H K 2 1  c e l l  
monolayers in 24 well plates at approximately 100 PFU (dilution determined from previous 
plaque assay, data not shown).  Total PFU present in the 1ml of cell and medium solution 
within two or more representative wells at each time point shown were assessed by duplicate 
plaque assays. 
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Figure 6.7  
Transfection of BHK21 cells with Label IT RNAi Delivery Control fluorescin.  The two confocal 
images (a and b) show Label IT RNAi Delivery control fluorescin (green) transfected into 
BHK21 cells using TransIT-TKO transfection reagent (Mirus).  The nuclei of the cells are 
stained blue with DAPI. 
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6.5 Discussion 
The O1BFS virus capsid sequence of the starting stock was found to be comparable to 
that sequenced previously, AY593815 (Carrillo et al. 2005).  The two sequences differed 
by two non-synonymous variations at two sites in the antigenically important site 4 in 
VP3.  All of the variant amino acids have been seen in other isolates previously 
sequenced, as they represent changes that are indicative of adaptation to cell culture. 
 
Although the MAb worked well at high concentrations it was not able to satisfactorily 
completely inhibit virus, nor to select true MAb escape mutants.  Thus to complete the 
experiment a large amount of MAb would be required as any putative escape viruses 
would need to be picked and checked to see if they were real escape mutants.  There 
was only 1 ml of D9 MAb ascetes fluid available which would not be enough to complete 
this experiment, as a minimum of 100 replicate populations would need to be screened, 
and then any putative escapes re-screened.  If the mutation rate is 1 x 10
-4 this would 
require more than 2ml of MAb which was not available.  Thus, it would only be possible 
to complete the experiment if the mutation rate was in the order of x 10
-3, which is an 
unlikely scenario.  To use up an irreplaceable commodity such as MAb to test to see if 
the mutation rate is equal to this would be a waste of a valuable resource.   Previous 
studies to generate escape mutants have involved serial growth of virus with low levels 
of MAb, which would not be suitable approach for the fluctuation experiment (Kitson 
1990). 
 
For an ideal fluctuation experiment the starting population needs to be as low as 
possible, and so with this in mind it was initially attempted to grow replicate populations 
from less than 10 PFU.  However, it was found that in order to obtain reliable estimates 
of population size at different time points closer to 100 PFU were required as a starting 
point as this reduced the inter population variation.  However, if the mutation rate is    162
below 1 x 10
-3 mutations per nucleotide site per genome replication (highly probable) 
then 100 PFU is sufficiently low in comparison with the end population to be able to 
accurately estimate the mutation rate by fluctuation analysis. 
 
A possible way to overcome the limitation of the experiment due to low stocks of 
concentrated MAb, is to use an alternative method for detecting mutants.  Such a screen 
could be carried out by using silencing RNA to silence the virus, and thus requiring a 
nucleotide mutation to arise to allow escape from the silencing agent.  For this reason 
the feasibility of transfecting BHK21 cells with siRNA was investigated to assess the 
percentage transfection that might be possible.  The results suggest that the TransIT-
TKO reagent is a good candidate for efficient transfection of siRNA into BHK21 cells.  A 
high transfection rate would be required if the virus is to be inhibited effectively.  Looking 
for MAb mutants allows only the assessment of mutation rates for specific regions within 
the capsid sequence of the virus genome.  siRNA however, offers the opportunity of 
assessing mutation rates in any location across the whole genome, which is a clear 
advantage. 
 
This study, although it has not provided a formal conclusion, has been a pilot study for 
the assessment of the virus spontaneous mutation rate through fluctuation analysis.  The 
data obtained concerning the growth rate of the virus and the method for siRNA 
transfection of BHK cells could facilitate future experiments to quantify this extremely 
important parameter. 
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Chapter 7   
 
Conclusions and Discussion    164
7.2 Overview of Thesis 
7.2.1 Overview 
The potential of genetic data to enhance our understanding of FMDV evolution and 
transmission within a single epidemic has been investigated within this thesis through 
complete genome sequencing of FMDV.  Figure 7.1 summarises the main findings of this 
thesis, and also illustrates how the separate chapters link together.  The consensus 
genetic variation seen in the UK 2001 epidemic described in Chapter 3 was a result of 
nucleotide substitutions becoming fixed upon replication within, and transmission 
between, animals and farms.  These mutation rates are described as µc and µd 
respectively in Figure 7.1.  Although it was possible to investigate many farm-to-farm 
transmissions (described in Chapter 4), the data regarding underlying nucleotide 
changes upon animal-to-animal transmission are much more limited (mainly due to a 
lack of suitable samples).  The nucleotide substitutions that become fixed into the 
consensus sequence of the virus were thought to arise from the within population 
diversity of virus genomes (db Figure 7.1), which has been studied in Chapter 5.  The 
data obtained suggested that the within host diversity of virus needs to be investigated 
more thoroughly in the natural animal host if we are to understand the complexity of virus 
genetic evolution.  Finally, as illustrated by Figure 7.1, the diversity of the virus 
population is dependent upon the spontaneous mutation rate of the virus (µa) which has 
not been precisely quantified to date.  This problem is addressed in Chapter 6, however 
progress was hindered due to time constraints and recent events that prevented work on 
the virus strain O1BFS. 
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Figure 7.1  
Conclusions of thesis.  The main findings of each chapter are shown.  On the left of the figure 
µa is the spontaneous mutation rate that determines the within population diversity (db), 
which in turn impacts upon the rate at which nucleotide substitutions occur upon 
transmission between animals (µc), by determining the extent of bottleneck required to 
enforce a sequence change within the consensus.  The rate of nucleotide change upon    166
animal-to-animal transmission will influence the number of nucleotide substitutions that are 
apparent upon transmission between farms (µd), which resulted in the genetic variation 
observed across the whole UK 2001 FMDV outbreak. 
 
7.3 FMDV evolution in the field 
7.3.1 Observations 
A key finding of this thesis was the extent of genetic nucleotide evolution of FMDV that 
occurred during the 2001 FMD outbreak in the UK.  This was previously unknown, and 
not quantified across complete genomes, for any other such epidemic.  Virus sequenced 
from the last infected premises in the outbreak differed by 52 nucleotide changes from 
the primary case, and 83 variant nucleotides were noted between an isolate from Wales 
and one from Northumberland.  This extent of nucleotide change enabled further in depth 
study of the evolution of the virus during this epidemic.  This genetic variation is 
illustrated in Figure 7.2, a Bayesian majority rule consensus tree of all the UKG 2001 
FMDV complete genomes sequenced during this study. 
 
Nucleotide substitutions were shown to accrue throughout the entire genome, and the 
VP1 gene was not found to be more variable than other genes in this situation.  A higher 
number of synonymous changes than non-synonymous were observed which suggested 
that the virus has evolved mainly by genetic drift and purifying selection.  However, these 
findings do not exclude positive selection since a single amino acid in the VP1 protein 
(positioned at VP1
42 adjacent to neutralising antigenic site 3), was mutated twice through 
different nucleotide point mutations on independent lineages (Chapter 3).  Additionally 
antigenic variants were noted when studying intra-population sequence differences in 
Chapter 5. 
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Figure 7.2 
A Bayesian majority rule consensus tree of all UK 2001 complete genome sequences studied 
to date.  The majority rule consensus tree (based on 1000 trees sampled from 1 million 
generations) was estimated using the software package Mr Bayes (Huelsenbeck & Ronquist 
2001), assuming a Generalised Time Reversible model with gamma-distributed rate variation 
across sites and a proportion of invariable sites. Posterior probabilities are indicated on the 
tree, and each sequence is labelled by its UKG WRL number, and geographic location of the 
source. Dark green shows those isolates studied in Chapter 4 from Darlington. 
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The rate at which nucleotide substitutions accumulated within the consensus genome 
was shown to adhere to a molecular clock, with a rate of 2.26 x 10
-5 per nucleotide site 
per day.  It was also found that in the majority of cases nucleotide substitutions that were 
fixed into the consensus sequence were inherited, and represented in virus sampled at 
later dates from the same outbreak.  The virus was shown to acquire changes such that 
2 to 8 substitutions were apparent between closely related farms, with a mean of 4.2 
upon transmission.   
 
Although an average of 2.5 x 10
-5 nucleotide substitutions/site/day was found over the 
whole outbreak (Chapter 3), for some consecutive farm-to-farm transmissions a much 
higher rate was seen, for example 3.1 x 10
-4 between IP6 and IP7, and 1.2 x 10
-4 
between IP16 and IP38.  Thus a high number of nucleotide substitutions occurred for the 
expanse of time that elapsed.  This lends argument to the theory that nucleotide changes 
are fixed upon transmission of the virus.  In consideration of this, the adherence of the 
rate of FMDV genetic evolution to a molecular clock is also a result of the environmental 
conditions that determine the rate at which virus is transmitted.  Interestingly on going 
experiments at IAH suggest that transmission is almost always around onset of clinical 
signs and accordingly, the main variable in terms of inter-transmission period would be 
expected to be the incubation period which can be short or long, but is perhaps also 
most often around 2-5 days.  Thus it is likely that the incubation period is a parameter 
that contributes to the adherence of the virus evolutionary rate to a molecular clock. 
 
7.3.2 Implications and epidemiological tools 
At the start of this PhD project it was acknowledged that an increased understanding of 
FMDV genetic evolution could potentially provide a framework with which to develop 
tools applicable to epidemiology and disease control.  As a result of this the genetic data 
generated as part of this thesis have been applied in different epidemiological contexts. 
    169
As noted in Chapter 3, the accumulation of mutations into the UK Pan Asia O virus 
genome correlated with time.  This molecular clock allowed us to extrapolate back in time 
to determine the date on which the virus started replicating in the UK, using coalescent 
methods.  This date was shown to be identical to that estimated from lesion dating.  This 
has established a new, molecular genetic method for dating the start of a FMD outbreak; 
a useful epidemiological tool.   
 
The use of the genetic data for disease transmission tracing is discussed in depth in 
Chapter 4, and it is clear that it was possible to trace the transmission of the UK Pan 
Asia O serotype virus in the UK in 2001.  Although genetic data provides high resolution 
data concerning the relationships between farms, it can be limited in determining exact 
transmission links between farms.  However, integrating epidemiological data concerning 
the timing of infection supplements the conclusions that can be drawn from the data.  
The importance of the genetic tracing technique was demonstrated during the 2007 
FMDV outbreak of O1BFS virus in Surrey, where it was used to assist in identifying the 
source of the outbreak and also the order in which farms were infected. 
 
To date tracing of FMDV transmission has been limited to the level of premises-to-
premises.  Within this thesis it has been shown that animals on a single premises can 
differ from 1 to 3 nucleotides from each other.  A recent paper (Carrillo et al. 2007) 
shows that nucleotide changes do occur on transmission of virus between pigs in an 
experimental setting at a rate of 6.4 x 10
-4 substitutions per nucleotide per transmission.  
Although this implies that deciphering animal-to-animal transmission networks will be 
possible, an important factor to take into consideration is the mode by which animals 
upon a single farm or epidemiological unit become infected.  For example, do many 
become infected simultaneously or is there a chain of sequential infections? In the case 
of the former tracing between the animals would not be possible because the virus was 
not necessarily spread between them.  Interestingly one of the IP diagnosed in 2007 in    170
the UK was shown to have a large proportion of the herd PCR positive for virus (18 out of 
48), even though no animal was showing clinical signs of disease.  It is usually 
suggested that FMDV is transmitted from cattle when they are showing clinical signs and 
not before, and thus these data would suggest that the animals were indeed infected 
simultaneously.  It is likely that both infection scenarios are possible in the field during an 
outbreak.  Another important consideration is whether or not nucleotide substitutions are 
inherited and therefore apparent within the virus consensus sequence of the recipient 
animal.  A recent study (Carrillo et al. 2007) suggests that not all substitutions are 
inherited into the consensus virus sequence within the recipient following transmission, 
although they can re-occur upon subsequent transmission.  This suggests that during 
close contact direct pig-to-pig transmission, the plasticity of the consensus genetic 
sequence is apparent, fluctuating between animals.  However, such fluctuation within the 
genetic consensus sequence was not seen within the studies on the UK 2001 outbreak 
reported in this thesis, where nucleotide substitutions were fixed into the population and 
there was no evidence of reversion.  This difference could possibly be a consequence of 
the mode of transmission; it is possible that herd-to-herd transmission across different 
premises during the 2001 epidemic represented a more extreme bottleneck situation 
than direct contact animal-to-animal transmission as studied by Carrillo et al 2007.  Due 
to little data concerning the mode in which a herd of animals are exposed to FMDV and 
the limited data available concerning the inheritability of nucleotide substitutions, the 
potential utility of genetic tracing from animal-to-animal remains currently unclear.   
 
The investigation of genetic tracing for FMDV in this study has concentrated on a single 
cluster of outbreaks in Darlington, County Durham.  More studies in different areas and 
scenarios (i.e. airborne spread) should be done to validate this procedure and there are 
many more cases from the UK 2001 outbreak that could be investigated.  To carry this 
project further, a new DEFRA funded project has begun, sequencing more viruses from 
the UK 2001 epidemic.    171
7.3.3 Further work 
Within this thesis, investigation of genetic tracing of FMDV transmission has been limited 
to studying the behaviour of virus in a naïve country formerly FMDV free.  Although 
beyond the scope of this project, it would be interesting to explore the potential of these 
techniques in situations where FMDV is endemic.  This could alter the way in which the 
virus evolves, possibly enforcing increased selection pressures as not all animals are 
naïve, and also allows recombination between viruses to play a greater role.   
Additionally, it would be interesting to study genetic transmission tracing in FMD viruses 
of different serotypes, the substitution rate and extents of which are reported to differ.  
For example, serotype A viruses have been shown to change genetically within the VP1 
coding region at a faster rate than serotype O viruses (Haydon et al. 2001). 
 
Finally, it was speculated that missing farms within a network of transmissions could be 
located if the number of changes expected upon transmission to a new farm, and the 
rate at which changes accumulate upon a farm, were known.  This was investigated in 
Chapter 4 of this thesis.  The main difficulty encountered was in determining how many 
nucleotide changes should occur on transmission, as a wide variation was found possibly 
arising from uncertainty surrounding whether or not all premises involved had been 
identified, or possibly due to the varying nature of each farm and its own infection and 
transmission scenario.  Further work on the model is required that incorporates the farm 
type and characteristics when considering the rate at which mutations are fixed into the 
consensus sequence of the population.  Also characterising further at which point during 
the virus life cycle nucleotide changes are most likely to be fixed, i.e. upon replication 
and selection or upon transmission through a bottleneck, would assist in the 
development of this method.  This could include more in depth study of within herd and 
also within host virus variation. 
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7.4 FMDV within-host evolution 
7.4.1 Observations 
With the intention of furthering our understanding of the evolution of FMDV and the mode 
by which mutations are fixed into the consensus sequence, the virus variability within a 
population was investigated in Chapter 5 and the spontaneous mutation rate of FMDV 
was investigated in Chapter 6.  The spontaneous mutation rate is an extremely important 
parameter to quantify accurately as discussed in Chapter 6 section 6.2, and should be 
investigated further.  Although a final result for the spontaneous mutation rate of O1BFS 
was not achieved, this study represented a pilot study.  A considerable proportion of the 
preliminary work required for the completion of a fluctuation analysis experiment to 
determine the spontaneous mutation rate was completed.   
 
The extent of genetic variability that surrounds the consensus sequence of the virus 
genome could potentially impact upon the rate at which mutations are fixed within the 
consensus sequence.  Within the study described in Chapter 5, the genetic variability of 
the virus within the host animal did not differ from previous in vitro estimates of mutant 
frequency in cell culture (Airaksinen et al. 2003; Arias et al. 2001; Gu et al. 2006; 
Pariente et al. 2001; Sierra et al. 2000).  Evidence was found to suggest that different 
populations of virus can exhibit different characteristics such as evolutionary rates and  
dN/dS ratios. These differences could possibly be due to the age and size of populations 
influencing the mutant spectrum characteristics, or host environment. 
 
7.4.2 Implications and prospects for further study 
During the study of within population genetic diversity, it was noted that in one particular 
population investigated that the sequence of an ancestral virus consensus was present 
as a minor population.  This suggests that the change in the consensus sequence 
apparent in the virus population studied might not be due solely to a bottleneck event on    173
transmission causing a founder effect, but could also be due to a mutation occurring 
early on upon replication within the new host.  This highlights the requirement to define in 
greater detail precisely how nucleotide substitutions become fixed into the virus 
consensus population.  Interestingly a UKG virus strain sequenced (using the protocol 
developed within this thesis, data not shown) from a secondary lesion from a needle 
challenged cow inoculated with virus that was derived from a pig UKG 34/2001 from 
Cheale’s Abattoir infected in 2001, (epithelium from UKG 34/2001 was used to needle 
infect 2 cattle, the epithelium from which was ground and combined to form the inoculum 
for the needle challenged cow) was found to be identical to virus sequenced from 
another pig from the same abattoir UKG 35/2001 that was passaged twice in pigs prior to 
sequencing (Mason et al. 2003b).  The fact that no nucleotide changes were fixed within 
the consensus through any of these needle challenge passages would corroborate the 
view that bottleneck events or selection play an important role in the fixation of mutations 
into the virus consensus sequence such that they are inherited. 
 
Further study of the nature in which the virus population changes and evolves (for 
example, detailed clonal sequence analysis of virus populations within the natural host 
and also the down stream recipient) could provide the opportunity to apply coalescent 
methodology and determine the size of bottleneck that occurs upon transmission.  As 
discussed earlier the size of bottleneck appears to be an important factor in the rate at 
which nucleotide substitutions are fixed into the consensus population.  An interesting 
study (Edwards et al. 2006) applied coalescent theory to HIV-1 and determined that 
>99% of diversity is lost upon transmission.  If the extent of bottlenecking is known, then 
it will assist estimates of virus intra-population diversity from data concerning the rate of 
consensus sequence nucleotide evolution.  Additionally it may enable estimates of the 
degree of virus genetic heterogeneity that is compatible with defined amounts of 
consensus sequence evolution. 
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Many studies on other viruses have found correlations between nucleotide diversity 
within the virus population and specific disease pathogenicities such as virus persistence 
(see Chapter 5: section 5.1).  It is feasible that this could also be important for FMDV, 
and the extent of genetic diversity could play a role in virus persistence in some hosts 
and not others, for example.  On finding within this thesis that virus populations within 
hosts do differ in characteristics and diversity (perhaps due to age or size of population 
or animal host), it is essential to take these studies further to compliment our current 
understanding of FMDV disease dynamics. 
 
7.5 Conclusion 
As demonstrated in previous studies, and within this thesis, viral genetic diversity can be 
measured at defined levels; within host cells or tissues, between host groups (herds and 
farms), between regional populations, and also at an international scale.  Although, in 
order to understand transmission, epidemiologists are primarily concerned with the larger 
scale distribution of virus within and between host populations, it is important to be aware 
that the processes that give rise to the virus diversity seen at higher levels inevitably 
occur at far smaller scales within a single host.  At each distinct level at which viral 
genetic diversity can and has been studied, various processes operate to determine the 
distribution and abundance of viral genotypes.  Remarkably little is known about the 
interplay of these processes that result in the patterns of genetic diversity observed at a 
larger scale, and it is within this area that future research should be focused.  Modelling 
the population genetic processes characteristic of viral transmission systems (supported 
by empirical data that is increasingly available) at all levels, from within cells to 
international spread of disease (both previously studied in isolation), could potentially 
inform epidemiologists of virus genetic variation and transmission and as such improve 
the design and implementation of methods for disease control.    175
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8.1 Summary 
Foot-and-mouth disease virus (FMDV) (family Picornaviridae, genus Aphthovirus) 
causes an acute vesicular disease of domesticated and wild ruminants and pigs. 
Identifying sources of FMD outbreaks is often confounded by incomplete epidemiological 
evidence and the numerous routes by which virus can spread (movements of infected 
animals or their products, contaminated persons, objects and aerosols). Here, we show 
that the outbreaks of FMD in the UK in August 2007 were caused by a derivative of 
FMDV O1 BFS 1860, a virus strain handled at two FMD laboratories located on a single 
site at Pirbright. Genetic analysis of complete viral genomes generated in real-time 
reveals a chain of transmission events, predicting undisclosed infected premises, and 
connecting the second cluster of outbreaks in September to those in August.  
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8.2 Introduction 
Foot-and-mouth disease (FMD) outbreaks in the UK during August and September 2007 
have caused severe disruption to the farming sector and cost hundreds of millions of 
pounds. Investigating and determining the source of these outbreaks is imperative for 
their effective management and future prevention. Foot-and-mouth disease virus (FMDV) 
has a high mutation rate resulting in rapid genetic evolution (Domingo et al. 2002) and 
genome sequencing has been used to retrospectively trace virus spread (Cottam et al. 
2006). We now show how complete genome sequences (acquired within 24-48 h of 
sample receipt) can be used to track FMDV movement from farm-to-farm in real-time. 
This helped to determine the most likely source of the outbreak, assisted ongoing 
epidemiological investigations as to whether these field cases were linked to single or 
multiple releases from the source, and predicted the existence of undetected 
intermediate infected premises. 
 
The UK 2007 FMD outbreaks have been characterised by the emergence of two 
temporally and spatially distinct clusters. Eight infected premises (IP1-8: designation of 
IP numbering is according to The Department for Environment, Food and Rural Affairs 
[Defra], UK) have been identified (Figure 8.1 and Table 8.1), two in August and six in 
September. The first case (IP1b) was recognised in beef cattle in a field in Westwood 
Lane, Normandy, Surrey, UK. Samples collected on 3
rd August 2007 from animals 
exhibiting suspect clinical signs were submitted to the World Reference Laboratory for 
FMD located at the Institute for Animal Health (IAH), Pirbright, Surrey. Within 24 hours, 
FMDV sequence data obtained from the first IP (holding IP1b) revealed a VP1 gene-
identity of 99.84% to FMDV O1 British Field Sample 1860 (O1 BFS 1860) (Knowles & 
Samuel 2003). O1BFS 1860 is a widely used reference and vaccine strain, originally 
derived from bovine tongue epithelium received at the World Reference Laboratory for 
FMD at Pirbright in 1967 from a farm near Wrexham, England. The Pirbright site,    178
comprising the laboratories of the IAH and Merial Animal Health Limited (Merial), is 
situated 4.4 km from the first IP. Both laboratories were working with the O1 BFS 1860 
virus strain, making this site a likely source of the outbreak. Three days after the case at 
IP1b, a second infected premises (IP2b) was identified at Willey Green, approximately 
1.5 Km from IP1b. Cattle at a further holding (IP2c) near to and under the same 
ownership as IP2b were found to be incubating disease at the time of slaughter. Animals 
on both the affected farms were destroyed and the premises were disinfected. 
Subsequent clinical and serological surveillance within a 10 km control zone found no 
evidence of further dissemination of FMD. However, on 12
th September 2007, five weeks 
after the IP1 and IP2 cattle had been culled, FMD was confirmed on the holding of a new 
IP (IP3b) situated outside the 10 km control zone surrounding IP1 and IP2 (Figure 8.1). 
FMD outbreaks were subsequently reported on an additional holding (IP3c) and five 
more premises (IP4, 5, 6, 7 and 8) all located close to IP3b and outside the original 
surveillance area (Figure 8.1). 
 
These outbreaks of FMDV in the UK during August and September 2007 have caused 
severe disruption to the farming sector and cost hundreds of millions of pounds. 
Investigating and determining the source of these outbreaks has been imperative for 
their effective management and is vital for future prevention. The aim of this study was to 
trace FMDV movement from farm-to-farm by comparing complete genome sequences 
acquired during the course of the epidemic. These “real-time” analyses helped to 
determine the most likely source of the outbreak, assisted ongoing epidemiological 
investigations as to whether these field cases were linked to single or multiple releases 
from the source, and predicted the existence of undetected intermediate infected 
premises that were subsequently identified. 
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Figure 8.1  
The geographical location of FMDV infected premises and holdings (Δ with official numbering) 
in August and September 2007 in Surrey (UK). The grey shaded area denotes the extent of 
the 10 km control and surveillance zone established for the first phase of the outbreak. 
Cases that occurred in September (IP3b, IP3c, IP4b, IP5, IP6b and IP7) were outside of this 
zone. The location of the Pirbright site is indicated by the star. 
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Table 8.1 Details of FMDV infected premises and the virus isolates that were sequenced 
IP/holding 
designation 
Date 
collected 
WRLFMD 
Ref. No. 
GenBank 
accession 
no. 
Date animals 
examined 
Species 
sampled 
Sample 
Estimated lesion age 
of individual (days) 
Oldest lesion 
on farm (days) 
Affected/total stock 
03/08/2007 UKG/7/2007      bovine  epithelium  6 
IP1b 
04/08/2007 UKG/7B/2007     
04/08/2007 
bovine epithelium  3 
10 38/38  cattle 
IP2b  06/08/2007  UKG/93/2007     07/08/2007  bovine  epithelium  6  7  44/49 cattle 
IP2c  07/08/2007  UKG/150/2007     07/08/2007  bovine  blood  none  none  0/58 cattle 
IP3b  12/09/2007  UKG/643/2007     12/09/2007  bovine  epithelium  4-5  5  36/47 cattle 
IP3c 15/09/2007  UKG/1153/2007     15/09/2007  bovine  blood?  not known  5  9/15 cattle 
IP4b  13/09/2007  UKG/800/2007     13/09/2007  bovine  epithelium  5-7  10  54/54 cattle 
IP5 17/09/2007  UKG/1421/2007     17/09/2007  ovine 
oesophageal/ 
pharyngeal 
scrapings 
not known  21* 
10/16 sheep; 16/24 
cattle; 0/2 pigs 
IP6b 21/09/2007  UKG/1484/2007     21/09/2007  bovine  epithelium  2-4  4  2/32 cattle 
IP7 24/09/2007  UKG/1679/2007     24/09/2007  bovine  epithelium  1-2  5  14/16 cattle 
IP8 29/09/2007  UKG/2366/2007     29/09/2007  bovine  epithelium  2  2  1/54    181
The Pirbright site, comprising the laboratories of the Institute for Animal Health (IAH) and 
Merial Animal Health Limited (Merial), is situated 4.4 km from the first IP. Both 
laboratories were working with the O1 BFS 1860 virus strain, making this site a likely 
source of the outbreak.  Complete genome sequences of viruses from the Pirbright 
laboratories and those from the outbreak were studied in real time to assist with 
epidemiological investigation and control of the outbreak.  
 
8.3 Materials and Methods 
Total RNA was extracted directly from a 10% epithelial suspension using the RNeasy 
Mini Kit (Qiagen, Crawley, West Sussex), or from blood or oesophageal/pharyngeal 
scrapings using TRIzol (Invitrogen, Paisley, UK). Reverse transcription of the RNA was 
performed using Superscript III reverse transcriptase (Invitrogen) and an oligo-dT primer 
(see table of primers, supplementary information). Twenty four PCR reactions per 
genome were performed with Platinum Taq Hi-Fidelity (Invitrogen), using 23 primer sets 
tagged with forward and reverse M13 universal primer sequences, and one primer set 
with a oligo-dT reverse primer to obtain the very 3' end genomic sequence (Table 8.2). 
The PCR products overlap such that each nucleotide is covered by two products. The 
reactions were run on a thermal cycling programme of 94ºC for 2 min, followed by 40 
cycles of 94ºC for 30 s, 55ºC for 30 s, 72ºC for 1 min, with final step at 72ºC for 7 min. 
Sequencing reactions were performed using the Beckman DTCS kit, with M13 universal 
forward and reverse primers and specific forward and reverse primers for each PCR 
product. This resulted in an average of 7.4 times coverage of each base. The raw data 
was assembled using the Lasergene
® 7 Software package (DNASTAR, Madison, WI) 
and all further sequence manipulations were performed using BioEdit (version 7.0.1 (Hall 
1999)) and DNAsp (version 3.52 (Rozas & Rozas 1999)). The data were analysed by 
statistical parsimony methods (Templeton et al. 1992) incorporated in the TCS freeware 
(Clement et al. 2000). A Bayesian majority rule consensus tree (based on 10,000 trees    182
sampled from 10 million generations) was estimated in MrBayes (Huelsenbeck & 
Ronquist 2001) assuming a General Time Reversible model of nucleotide substitution 
with invariant sites (the model most strongly supported by more extensive genome data 
from the UK 2001 outbreak).    183
Table 8.2 Oligonucleotide primers used for the amplification and sequencing of the FMDV 
genomes studied (designed by NJ Knowles). 
 
PCR 
set 
Primer 
name* 
Primer sequence (5' to 3')† 
Location 
on 
genome‡ 
Amplicon 
size (bp)§ 
BFS‐1F  TTGAAAGGGGGCRCTAG  1‐17 
1 
BFS‐379R  GGGGGGGGGGGGTGAAA  363‐379 
413 
BFS‐370F  CCCCCCCCCCCCCTAAG  370‐386 
2 
BFS‐1070R  AGGTGCCGGCCTCCGGT  1054‐1070 
735 
BFS‐720F  TTTGACTCCACGCTCGA  720‐736 
3 
BFS‐1420R  GTGCTTGATGTTCCAGATC  1402‐1420 
735 
BFS‐1068F  CCTTTCCTTTTATAACCACTGA  1068‐1089 
4 
BFS‐1768R  GTTGTTTATTATGCTGCCAG  1749‐1768 
735 
BFS‐1418F  CACTTGCTCCACACCGGC  1418‐1435 
5 
BFS‐2118R  ACAACTCTGGTCTCGAGA  2101‐2118 
735 
BFS‐1773F  ACATGCAGCAGTATCAAAAC  1773‐1792 
6 
BFS‐2473R  GTGAACCTTGTACTGGTCG  2455‐2473 
735 
BFS‐2123F  GCAGAACGGTTTTTCAAAAC  2123‐2142 
7 
BFS‐2823R  ACCCTGTCCGAGTCTGTT  2806‐2823 
735 
BFS‐2476F  GCCTTGGACCCTTGTGGTT  2476‐2494 
8 
BFS‐3176R  GTGTAATTTGAAACAAGCAG  3157‐3176 
735 
BFS‐2826F  TTGCTCAGTTTGATATGTCT  2826‐2845 
9 
BFS‐3526R  GGTGAGGTCTCCCTCGTG  3509‐3526 
735 
BFS‐3176F  CATGGCAAGGCCGACGGC  3176‐3193 
10 
BFS‐3876R  TTCTGTTTGTGTCTGGCTTCA  3856‐3876 
735 
BFS‐3526F  CTGGGTTCCAAATGGAGC  3526‐3543 
11 
BFS‐4232R  CGGTGTCGGCCAGCATGAT  4214‐4232 
741 
BFS‐3876F  AAATTGTGGCACCGGTGA  3876‐3893 
12 
BFS‐4576R  CTGCTTTTCAAGGATGCCAG  4557‐4576 
735 
BFS‐4226F  GACACCGGTCTCGAGATT  4226‐4243 
13 
BFS‐4926R  AAGTCCTTGCCGTCAGGGT  4908‐4926 
735 
BFS‐4576F  GCGGGATCTGAACGACC  4576‐4592 
14 
BFS‐5275R  TTGAGGCTTGAACATGTCTTG  5255‐5275 
734 
BFS‐4929F  AATACTTTGCCCAAATGGTCT  4929‐4949 
15 
BFS‐5626R  CACCATTTTCTGCCTCTTG  5608‐5626 
732 
BFS‐5276F  CCACCCCTCCAGAATGTG  5276‐5293 
16 
BFS‐5966R  CCTTCACGACCGGGGCT  5950‐5966 
725 
BFS‐5626F  GGATGATGCAGTGAATGAG  5626‐5644 
17 
BFS‐6326R  CGCGGTTCCCACGGTGGA  6309‐6326 
735 
BFS‐5976F  ACGAGGGACCGGTGAAGA  5976‐5993 
18 
BFS‐6676R  GTGATGTGGTTCGGGGTC  6659‐6676 
735 
BFS‐6328F  GAGGGACATCACGAAGCAC  6328‐6346 
19 
BFS‐7025R  CTGTRTCTGGTTCCATGGC  7007‐7025 
732 
20  BFS‐6676F  CGAGGGGTTGATTGTGGA  6676‐6693  735    184
BFS‐7376R  ACTGGGCGAAGTGTGTGC  7359‐7376 
BFS‐7026F  CGCCCGGCCTCCCCTGG  7026‐7042 
21 
BFS‐7733R  CCTCGAAGTCCAAGTCATAAT  7713‐7733 
742 
BFS‐7376F  TACAGAAACGTGTGGGATGT  7376‐7395 
22 
BFS‐7965R  CCTGCCACGGAGATCAACTTCT  7944‐7965 
624 
BFS‐7685F  TACGGAGACGACATCGTG  7685‐7702 
23 
BFS‐8193R  TTTTTTTTTTTTTTGATTAAGG  8172‐8193 
543 
BFS‐7685F  TACGGAGACGACATCGTG  7685‐7702 
24 
UKFMD/Rev6  GGCGGCCGCTTTTTTTTTTTTTTT poly(A) 
536 
‐  Uni‐1F  GTAAAACGACGGCCAGT ‐      
‐  Uni‐1R  CAGGAAACAGCTATGAC ‐      
        
*, the last letter indicates a Forward or Reverse primer. 
†, a duplicate set of primers (except for UKFMD/Rev6) were synthesized which 
were preceeded by M13 forward (Uni‐1F) or reverse (Uni‐1R) primer sequences. 
‡, numbering according to GenBank sequence AY593815. 
§, amplicon size includes 34 bp derived from the M13 sequences at the 5' end of 
each primer.    185
8.4 Results and Discussion 
The genetic relationships of FMDV present in eleven field samples from the 2007 
outbreak, three cell culture derived laboratory viruses (see Table 8.3) used at the 
Pirbright site during July 2007 (designated IAH1, IAH2 and MAH) and a published 
sequence of O1 BFS 1860 (AY593815) are illustrated in Figure 8.2a . Whereas IAH1 and 
the virus from which the published sequence was derived are believed to have been 
passaged no more than ten times in cell cultures, the IAH2 and MAH viruses had been 
extensively adapted to grow in a baby hamster kidney cell line (Table 8.3). In natural 
hosts, FMDV attaches to integrin receptors on the cell surface (Jackson et al. 2000). 
However, when grown in cell cultures, the virus may adapt to attach to heparan sulphate 
(HS), through acquisition of positively charged amino acid residues on the virus coat at 
positions VP2
134 and VP3
56  (Fry et al. 1999; Sa-Carvalho et al. 1997). An additional 
change from a negatively charged amino acid residue at VP3
60 to a neutral residue often 
occurs but may not be essential for HS binding (Sa-Carvalho et al. 1997). IAH1 and the 
previously sequenced isolate of O1 BFS 1860 have none of the changes associated with 
HS binding, whereas the changes at VP3
56 and VP3
60 are present in MAH and IAH2, 
consistent with their history of extensive culture passage (Table 8.3). The presence of 
the HS binding residue at VP3
60 in all but one of the field viruses provides evidence that 
a cell culture adapted virus is an ancestor of the outbreak. The wild type configurations at 
VP3
56 in all of the outbreak viruses and at VP3
60 in the IP5 virus most likely reflect 
reversions that have been selected upon replication within the animal host. It is known 
that there is a strong selection pressure for the reversion at VP3
56 when FMDV replicates 
in cattle (Sa-Carvalho et al. 1997).  
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Table 8.3 Passage histories of the reference viruses studied. 
 
CP, cattle passage 
BTy, primary bovine thyroid cells 
BHK, BHK-21 (baby hamster kidney) cells 
LK, lamb kidney cells. 
 
The viruses from the outbreaks differ by at least five unique synonymous substitutions 
from the laboratory viruses examined (Table 8.4, Figure 8.2A). In terms of nucleotide 
substitutions, two very closely related laboratory viruses (MAH and IAH2) are closest to 
the sequence of the virus from IP1b (6 and 7 substitutions respectively) compared with 
IAH1 (12 substitutions). Viruses IAH2 and MAH differ by only one non-synonymous 
change at amino acid residue 2 of the Leader-b (Lb) polypeptide (a papain-like cysteine 
proteinase) (Table 8.4). Since FMDV is known to exist as variant populations of 
genetically related viruses (Domingo et al. 2002), it is possible that virus containing the 
MAH consensus sequence was present as a minority component within the virus 
population of IAH2. It is also possible that a reversion of the amino acid change at 
residue 2 of Lb could be selected when the virus goes back into the natural host. 
Consequently, either of these viruses could be the source of the 2007 outbreak. 
Identifier Passage  history 
Genbank 
accession no. 
Origin 
O1 BFS 1860  Presumed CP1, BTy3, LK1  AY593815  Carrillo et al., 2005 
O1 BFS 1860 
(IAH1) 
BTy4, BHK2    In use at the IAH. 
O1 BFS 1860 
(IAH2) 
Between 18 and 24 passages in BHK cells 
including at least one passage in suspension 
cells. 
 
In use at the IAH; derived from 
the Wellcome vaccine strain. 
O1 BFS 1860 
(Merial) 
Unknown  
Vaccine seed virus used by 
Merial Animal Health Ltd.    187
Table 8.4 Nucleotide and amino acid substitutions observed in the genomes of the FMD 
viruses studied 
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159  C  C  C C  C  C  C C C C C C C C A 5' UTR  -  -  -
170  C  C  C C  T  T  T T T T T T T T T 5' UTR  -  -  -
262  T  T  T T  T  T  T T T T T T T C T 5' UTR  -  -  -
792  G G G G G G G AGGGGGGG5 '  U T R   -   -   -
913  A  A  A A  A  A  A A T T T A T T T 5' UTR  -  -  -
1083  C  C  A A  A  A  A A A A A A A A A 5' UTR  -  -  -
1181  G  G  A G  G  G  G G G G G G G G G Lb 2 E  K  (aaa)
1951  C  C  C C  C  T  C C C C C C C C C VP4 -  -  -
2184  G  A  G G  G  G  G G G G G G G G G VP2 78  C  (tgc) Y (tac)
2377  T  T  T T  C  C  C C C C C C C C C VP2 -  -  -
2446  C  C  C C  C  C  C C T T T T T T T VP2 -  -  -
2558  A  A  A A  A  A  G A A A A A A A A VP2 203  I  (att) V  (gtt)
2772  A  A  G G  A  A  A A A A A A A A A VP3 56  H  R  (cgc)
2784  A  A  G G  G  G  G G G G G A G G G VP3 60  D  G  (ggc)
3043  A  A  A A  A  A  A G A A A A A A A VP3 -  -  -
3157  C  C  C C  C  C  C C C T C C C C C VP3 -  -  -
3433  T  T  T T  C  C  C C C C C C C C C VP1 -  -  -
3862  C  C  C C  C  C  C C C C C C C C T VP1 -  -  -
3994  G G G G G G GGGGGGGA A2 B -  -   -
4045  T  T  T T  T  T  Y T T T T T T T T2 B -  -   -
4407  A  A  A A  A  A  A A A A A A A A G 2B 152 E  G  (ggg)
4639  A  A  A A  A  A  A AGA A AGGG2 C -  -   -
4927  C  C  C C  C  C  C C C C C T C C C2 C -  -   -
5152  C  C  C C  C  C  C C C C C Y C C C2 C -  -   -
5335  C  C  C C  T  T  T T T T T T T T T2 C -  -   -
5462  G G G G G G GGGGGGGA A 3A 32 D  N  (aac)
5473  A  A  A A  A  A  A AGGGGGGG3 A -  -   -
5492  A  A  C C  C  C  C C C C C C C C C 3A 42 I  (atc) L (ctc)
5592  C  T  T T  T  T  T T T T T T T T T 3A 75 T( M  (atg)
5599  T  C  T T  T  T  T T T T T T T T T3 A -  -   -
5655  A  A  A A  A  A  A A A A A AGA A 3A 96 K  R  (aga)
5808  A  A  A A  A  A  A A A A A AGA A 3A 147 E  G  (ggg)
6175  T  T  T T  T  T  T T C T T T C C C3 C -  -   -
6616  A  A  A A  A  A  A A A A A A A A G 3C - -  -
6673  T  T  T T  T  T  T T C C C T C C C3 C -  -   -
7021  C  C  T T  T  T  T T T T T T T T T3 D -  -   -
7162  C  C  C C  C  C  C C T C C C T T T3 D -  -   -
7729  C  C  C C  C  C  C C T T T C T T T3 D -  -   -
7750  T  T  T T  T  T  T T C C C T C C C3 D -  -   -
8149  A  A  G G  G  G  G G G G G G G G G 3' UTR  -  -  -
8152  C  C  C C  T  T  T T T T T T T T T 3' UTR  -  -  -
8176  A  A  A A  A  A  A A A A A G A A A 3' UTR  -  -  -
8180  A  A  A A  A  A  T A T T T T T T T poly(A-  -   -
 
*, numbered according to AY593815; the following positions were not sequenced: 1-17and 
363-466 
†, only listed where an amino acid substitution has occurred.    188
 
Figure 8.2  
A)  Statistical parsimony analysis by TCS (Clement et al. 2000) of complete genome 
sequences of four laboratory and 10 outbreak FMDV; connecting lines represent a nucleotide 
substitution, thicker lines represent non-synonymous substitutions, with substitutions 
indicative of adaptation to cell culture coloured green. Sequenced haplotypes (●), and 
putative ancestral virus haplotypes (○) are shown. AY593815 is a previously published 
sequence (Carrillo et al. 2005) of FMDV O1 BFS 1860.  
  
B) Lesion age derived infection profiles of holdings overlaid with the outbreak virus 
geneology. The orange shading estimates the time when animals with lesions were present 
from the oldest lesion age at post-mortem (Anon 1986). For IP2c, there were no clinical signs 
of disease. The light blue shading represents incubation periods for each holding, estimated 
to begin no more than 14 days prior to appearance of lesions (Garland & Donaldson 1990). 
The dark blue shading is the most likely infection date based on the average incubation time 
for this strain of 2-5 days (Hugh-Jones & Tinline 1976). Each UK 2007 outbreak virus 
haplotype is plotted according to the time it was isolated (x axis). The dashed lines link the 
TCS tree together but do not denote any genetic change. 
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Sequence analysis of virus from the first affected holding identified in the second cluster 
of outbreaks (IP3b) demonstrated that it had evolved from virus from the first cluster of 
outbreaks (Figure 8.2A and B). The sequence data are not consistent with a second 
escape of virus from the Pirbright site, as the virus from IP3b shares five common 
nucleotide changes with IP1b and IP2c and six in common with IP2b. A Bayesian 
majority rule consensus tree, Figure 8.3, estimated in MrBayes (Huelsenbeck & Ronquist 
2001) indicated that the group linking the second cluster of outbreaks to the first is 
strongly supported with a posterior probability of 1.00.  
 
The virus from IP3b was nine nucleotides different from the virus from IP1b (Table 1, 
Figure 8.2a). This is a high number of changes for a single farm-to-farm transmission [a 
retrospective study of virus genomes acquired from sequentially infected farms during 
the UK 2001 outbreak in Darlington, County Durham, found a mean of 4.5 (SD 2.1) 
nucleotide changes, see Chapter 4], and indicated that there were likely to be 
intermediate undetected infected premises between the first outbreaks in August and 
IP3b. Subsequent field investigations discovered IP4b and IP3c, which differed by one 
nucleotide from each other. IP4b was three nucleotides closer to virus from the first 
outbreaks, and IP3c also branched off the tree at this point. However, there were still six 
nucleotide differences between FMDV sourced from IP4b and FMDV sourced from the 
August outbreaks. Serosurveillance of all sheep within 3 km of the September outbreaks 
revealed the existence of IP5, on which it was estimated that disease had been present 
for at least two, and possibly up to five weeks. As Figure 8.2b shows, IP5 is a likely link 
between the August and September outbreaks.  
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Figure 8.3 
A Bayesian majority rule consensus tree of eleven viruses from the UK2007 outbreaks and 
four laboratory viruses, labelled as described in figure legend for figure 8.2. 
 
 
 
The genetic relationships between viruses from individual animals shown in Figure 8.2A 
and B follows an identical topology to the Bayesian majority rule consensus tree (Figure 
8.3) and ingroup relationships are strongly supported by posterior probabilities on 
0.001
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genome groupings that were never less than 99%. Although a more confident resolution 
of the IP-to-IP transmission pathways might be achieved by characterising additional 
virus haplotypes present on individual holdings, previous sequencing of virus from 
different animals from the same farm conducted following the UK 2001 outbreaks 
indicated very limited intra-farm sequence variability. Furthermore, the relationships 
presented here reveal a transmission pathway between outbreaks that is consistent with 
the estimates of when holdings became infected and infectious (Figure 8.2B). The small 
number of nucleotide substitutions observed between viruses from source and recipient 
IPs suggests that there has been direct transmission without the involvement of other 
susceptible species, e.g. sheep or deer.  
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Complete genome sequencing overview 
 
Original Sample Suspension 
WRL Fume Hood 
 
 
RNA Extraction 
RNA extraction room hood 
 
 
Reverse Transcription 
Fume hood PCR assembly room 
 
 
cDNA Clean-up 
Fume hood and centrifuge in PCR assembly room 
 
 
PCR 
Clean room, PCR assembly room 
 
 
PCR Product Clean-up 
Post PCR room 
 
 
Sequencing Reaction 
Robot in PCR assembly room 
 
 
Ethanol Precipitation 
Post PCR Room 
 
 
Sequencing and Analysis 
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Original Epithelium Sample Suspension 
 
Class II Safety Cabinet 
 
Method 
 
Fill fish kettle with water (put to boil after) 
Weigh Bijou 
Blot epithelium sample on tissue to remove glycerol and place in bijou 
Re-weigh bijou and calculate weight of epithelium sample 
Require a 1/10 suspension – multiply weight by 9 and add that many mls (*) of buffer 
solution 
Use scissors and forceps to cut tissue up into small a bits as possible 
Add approximately same amount of sand as epithelium sample and grind into a paste 
with pestle and mortar 
Add *ml of buffer solution (kept under centrifuge) 
Pour into centrifuge universal 
Centrifuge for 10 minutes 
Remove supernatant and pour into a fresh bijou 
Aliquot into tubes and store at -70◦C 
Add 0.2ml to trizol 
 
 
 
 
RNA Extraction in TRIZOL 
 
Class II Safety Cabinet  
 
Method 
 
Ensure any samples frozen and previously stored in TRIZOL are thawed.  Or add 200μl 
of sample to 1ml of TRIZOL.  Incubate at room temperature for 5 minutes 
Add 200μl of chloroform direct to the tube. 
Vortex mix the tube for 10-15 seconds, then leave at ~22oC for 3 minutes. 
Centrifuge for 15 minutes at 13000 rpm at 2-8oC 
Label a fresh 1.5ml eppendorf and add 1μl of glycogen. 
Remove as much of the top phase as possible (650-700μl) from centrifuged tubes and 
add to corresponding glycogen filled tubes 
Add an equivalent volume (650-700μl) of  Isopropyl alcohol to each tube 
Vortex mix each tube for a few seconds 
Incubate at ~22oC for 10 minutes  
Centrifuge for 15 minutes at 13000 rpm at 2-8oC 
Discard the supernatant and add 1000μl of 70% ethanol to each one.  Gently mix by 
flicking the tube 
Centrifuge for 15minutes at 13000 rpm at 2-8oC 
Remove by pipetting as much supernatant as possible and air drying 
Re-suspend the RNA pellet by adding 12μl nuclease free ddH2O 
Maintain on ice for reverse transcription or store at -70oC 
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Reverse Transcription 
 
Class II Safety Cabinet  
 
Method 
 
Add 4μl Primer UK/FMD Rev6, 1μl Random hexamers (50 ng/μl), 3μl dNTP to 12ul RNA. 
Place at 70oC for 3 minutes 
Place on ice for 3 minutes 
Add 18μl of RT mix made fresh (4μl 10x RT buffer, 8μl 25mM MgCl, 4μl 0.1M DTT, 2μl  
ddH2O) 
Add 2μl Superscript III Reverse Transcriptase 
Incubate at 42oC for 4 hours followed by termination of the reaction at 85oC for 5 
minutes.  Thermocycler programme Revtran1 
 
 
cDNA Clean-up 
 
Class II Safety Cabinet  
 
Method 
 
Add 200μl of buffer PB to the 40μl reverse transcription product 
Transfer to a spin column tube and centrifuge at 13000 rpm for 1 minute 
Discard flow through 
Add 0.7ml of buffer PE and centrifuge for 1 minute at 13000 rpm to wash 
Discard the flow through 
Centrifuge again for 1 minute at 13000 rpm 
Add 30μl of Elution Buffer, leave for 1 minute 
Place into a fresh labelled 1.5ml eppendorf and centrifuge for 1 minute at 13000 rpm to 
elute the DNA 
 
 
PCR set up 
 
Class II Safety Cabinet  
 
Method 
 
Set up PCR master mix in 96 well PCR plates in clean room for the 5 primer sets (F1/R1, 
F2/R2, F3/R7,F4/R4, F5/R6) as described in Table A1. 
Add 2.5 μl cDNA to each reaction in hood 
Run primer sets 1-4 on programme FMD-EC1, and primer set 5 on FMD-EC2 
programmed onto thermocycler. 
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Table A1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reagent   x1 
10x buffer  5 μl 
MgSO4 2  μl 
10mM dNTP mix  1 μl 
UK/FMD For?  1 μl 
UK/FMD Rev?  1 μl 
Platinum TAQ HiFi  0.2 μl 
ddH2O 37.8  μl 
 48  μl 
FMD-EC1 
Step Temp  oC Time 
1 94  2  min 
2 94  30sec 
3 68  30sec 
4 72  3min 
5  Go to step 2 x 39 
6 72  7min 
7 4 ∞ 
8 END    207
Table A3 
 
 
PCR Clean-up 
 
Method 
 
Run 2μl of PCR product on 1.2% agarose gel at 105v for 30 minutes to check reaction 
has worked 
Add 240μl of buffer PB to the 48μl PCR product 
Transfer to a spin column tube and centrifuge at 13000 rpm for 1 minute 
Discard flow through 
Add 0.7ml of buffer PE and centrifuge for 1 minute at 13000 rpm to wash 
Discard the flow through 
Centrifuge again for 1 minute at 13000 rpm 
Add 50μl of Elution Buffer, leave for 1 minute 
Place into a fresh labelled 1.5ml eppendorf and centrifuge for 1 minute at 13000 rpm to 
elute the DNA 
Run 1μl product on gel to quantitate DNA concentration. 
Dilute products to give the following concentrations and volumes for sequencing (Table 
A4) 
 
 
 
Table A4 
 
 
 
 
 
FMD-EC2 
Step Temp  oC Time 
1 94  2min 
2 94  45sec 
3 60  45sec 
4 72  3min 
5  Go to step 2 x 39 
6 72  7min 
7 4 ∞ 
8 END 
Primer Set  DNA concentration  Volume 
1 20ng/8μl 40μl 
2 70ng/8μl 112μl 
3 100ng/8μl 184μl 
4 100ng/μl 152μl 
5 100ng/μl 216μl    208
Sequencing reaction 
 
Method 
 
Make up primer plate of 1mM Forec 1-42 and Revec 43-84 primers in clean room (Fig 1). 
Use the robot programme FMD genome sequencing to add 8μl of Mastermix to 84 wells 
of a 96 well Beckman sequencing plate, 4μl of Forec#/Revec# Primer (from pre-made 
plate) and 8μl of PCR product. 
Spin plate in centrifuge briefly to accumulate reagents in bottom of well. 
Run on programme Cycleseq on Thermocycler. 
 
 
 
Figure A1 
 
 
1  9  17  25 33 41 49 57  65  73  81  
2  10  18  26 34 42 50 58  66  74  82  
3  11  19  27 35 43 51 59  67  75  83  
4  12  20  28 36 44 52 60  68  76  84  
5  13  21 29 37 45 53 61  69  77    
6  14  22 30 38 46 54 62  70  78    
7  15  23 31 39 47 55 63  71  79    
8  16  24 32 40 48 56  64  72  80    
 
X = Fragment 1 
X = Fragment 2 
X = Fragment 3 
X = Fragment 4 
X = Fragment 5 
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Ethanol Precipitation 
 
Method 
 
Turn on centrifuge to be at 4oC 
Make up stop solution using 170μl of 100mM EDTA, 170μl 3MNaOAc, and 85μl of 
glycogen. 
Add 5μl of freshly prepared stop solution to each reaction 
Add 60μl ice cold 95% ethanol to each well 
Seal plate with adhesive foil and mix thoroughly by vortexing 
Centrifuge at maximum speed (>1100 x g) for 30 minutes at 4oC 
Invert plate and pour out supernatant over sink – three gentle shakes 
Gently add 200μl ice cold 70% ethanol 
Centrifuge at maximum speed for 15 minutes at 4oC 
Invert plate over sink and pour off supernatant  
Gently add 200μl ice cold 70% ethanol 
Centrifuge at maximum speed for 15 minutes at 4oC 
Invert plate over sink and pour off supernatant keep plate upside down and gently blot on 
tissue paper 
Vacuum dry for - until dry! 
Re-suspend pellets in 40μl Sample Loading Solution 
Leave for 5 minutes then vortex. 
Either put in freezer or add a drop of mineral oil and run on sequencing machine 
 